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Abstract  
 Hindsight (HNT) is a zinc finger transcription factor that is required for morphogenesis 
of the Drosophila embryo, having roles in germ band retraction (GBR) as well as dorsal closure 
(DC). HNT expression is also found in sensory organ precursors (SOP) of the developing pupal 
peripheral nervous system, and muscle progenitor cells, but the role of HNT in neurogenesis and 
myogenesis during embryogenesis has not been investigated in any depth. Microarray analysis of 
embryos over-expressing HNT during GBR and DC identified 1290 genes with significant 
changes in expression. This data set included many potential HNT targets, including genes 
associated with myogensis, and a disruption of muscle development was observed in embryos 
over-expressing HNT. It is possible that HNT may function to repress muscle identity genes in 
muscle founder cells. In addition, HNT over expressing embryos were found to resemble the 
neurogenic class of mutants. Among the potential target genes, D-Pax2 (shaven, sparkling, 
CG11049) expression, which is known to be expressed in the developing peripheral nervous 
system, was confirmed to be up-regulated following HNT over-expression. Interestingly, D-Pax2 
and HNT expression were found to co-localize at the onset of their expression at stages 10-12 in 
embryos, but were not co-localized in later stages of embryogenesis. The up-regulation of D-
Pax2 by HNT over-expression was further characterized and was found to be associated with 
strong ectopic HNT expression. The relevance of HNT to the regulation of D-Pax2 during 
normal development remains to be determined, but it is possible that endogenous expression of 
HNT is involved in D-Pax2 repression.  
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Chapter 1. Introduction 
 
1.1 Morphogenesis 
 Morphogenesis is the formation of tissues and organisms through the precise control of 
cell shape, cell proliferation, cell death, and cell-cell adhesion, which are an integral part of 
Drosophila development (Stronach & Perrimon, 2001). During Drosophila embryogenesis there 
are four major morphogenetic movements occurring at stages 11 to 15 of development: germ-
band extension, germ-band retraction (GBR), dorsal closure (DC) and head involution (Irvine & 
Wieschaus, 1994). 
Due to the restriction imparted by the vitelline membrane that surrounds the developing 
embryo, the germ-band folds over itself on the dorsal side as its length increases in the anterior-
posterior axis (Schock & Perrimon, 2002) (Figure 1.1 A). This results in the germ-band extended 
state that persists for approximately 3.5 hours during normal development. GBR follows, 
whereby cell shape changes in the lateral epidermis allow the amnioserosa (an extra-embryonic 
epithelium that forms a covering connecting the developing lateral epidermis) to unfold on the 
dorsal side of the embryo (Figure 1.1 B-C). Immediately after GBR, DC is initiated; the lateral 
epidermal cells flanking the amnioserosa migrate and fuse along the dorsal midline, internalizing 
the amnioserosa that is subsequently degenerated by programmed cell death (Hartenstein, 1993; 
Scuderi & Letsou, 2005) (Figure 1.1 D). Lastly, head involution involves the progression of the 
epidermis over the head segments that simultaneously regress into the embryo (VanHook & 
Letsou, 2008).  
In addition to these morphogenetic movements, the specification of muscle progenitors 
and sensory organ precursors (SOP) from the mesoderm also occur during stages 11 to 14 of 
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development. One of the genes that has been known to be involved in the proper completion of 
GBR and DC, and most recently has been found in muscle and SOP is Hindsight (HNT).  
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1.2 Hindsight 
HNT encodes a large nuclear protein with fourteen C2H2-type zinc fingers whose 
functions suggest it acts as a transcription factor, specifically as a repressor. The 
human/mammalian homolog of HNT is known as Ras responsive element binding protein 1 
(RREB1). RREB1 has been suggested to regulate prostate cancer by down-regulating the zinc 
transporter hZIP1, and in response to DNA damage, RREB1 has been implicated in modulating 
the expression of the p53 tumour suppressor and its target genes (Irvine & Wieschaus, 1994; 
Milon, Agyapong, Bautista, Costello, & Franklin, 2010). RREB1 and HNT have a conserved 
role in regulating dynamic morphological changes, cell-cell adhesion, and the collective 
migration of epithelial cells (Melani, Simpson, Brugge, & Montell, 2008). HNT is also expressed 
in the amnioserosa, midgut and tracheae during Drosophila embryogenesis, and is required for 
the proper completion of GBR, DC, and the programmed degradation of the amnioserosa (Reed, 
Wilk, & Lipshitz, 2001). In addition, HNT is expressed in the ovary and retina of adult flies, 
where it has been implicated in the regulation of cell-cell adhesion, coordination of the F-actin 
cytoskeleton, and regulation of these processes by the Notch signalling pathway; in addition, 
HNT is also involved in the regulation of the mitotic-to-endocycle switch in adult follicle cells 
(Melani et al., 2008; Pickup, Lamka, Sun, Yip, & Lipshitz, 2002; Sun & Deng, 2007).  
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1.3 Hindsight’s role in the amnioserosa during Germ Band Retraction and 
Dorsal Closure 
 HNT expression in the amnioserosa has been found to down-regulate the c-Jun N-
terminal kinase (JNK) pathway, and this has been suggested to be required for successful 
completion of GBR and DC (Reed et al., 2001; Yip, Lamka, & Lipshitz, 1997). Without HNT, 
mutant embryos display head involution defects and undergo premature amnioserosa loss, 
indicating that the amnioserosa is associated with a failure in GBR and DC (Frank & Rushlow, 
1996). Nullomorphic hnt mutants are embryonic lethal and fail in GBR. A hypomorphic 
mutation of HNT (hnt
308
) successfully completes GBR, but subsequently fails in DC (Reed et al., 
2001). hnt loss-of-function mutants have been found to show persistent activation of the JNK 
signaling pathway in the amnioserosa, while an inactivation of JNK signaling is essential for DC. 
Studies have found that HNT expression in those amnioserosal cells that abut the leading edge of 
the epidermis is required to direct the epidermal cells to undergo the shape changes that drive 
GBR (Lamka & Lipshitz, 1999). The premature loss of the amnioserosa may be due to the 
disruption of cell-cell communication from the amnioserosa to the adjacent epidermis, which 
suggests a consequence of an underlying defect in the amnioserosal epithelium (Wilk, Reed, 
Tepass, & Lipshitz, 2000). While cell-cell communication may be the cause of premature 
amnioserosa loss, failure in DC is linked to HNT’s inability to inactivate the JNK signaling 
pathway, resulting in the disruption of the JNK pathway in the amnioserosa (Reed et al., 2001).  
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1.4 Notch signaling  
As mentioned above, HNT has been implicated in the regulation of processes in the ovary 
and retina of adult flies through the Notch signalling pathway. Notch signalling is a simple but 
highly conserved framework that controls the development of cell fates and allows cell 
differentiation. The basis of Notch signalling, as seen in Figure 1.2, is achieved through cell-cell 
communication between its ligands Delta and Serrate (known as Jagged in mammals), and the 
Notch receptor on an adjacent cell.  Both the receptor and ligands are transmembrane proteins 
with large extracellular domains that consist primarily of epidermal growth factor (EGF) repeats. 
Ligand binding triggers two proteolytic cleavages of the Notch receptor. The second cleavage, 
by γ-secretase, releases the notch intracellular domain (NICD) which translocates into the 
nucleus. Upon entering the nucleus, the NICD promotes transcription by activating the DNA-
binding protein complex CSL (named after the C-promoter binding factor-1 (CBF1), Suppressor 
of Hairless (Su(H)), and LAG-1, and its co-activator Mastermind (Mam)) (S. Bray, 1998; S. J. 
Bray, 2006; Eric C Lai, 2004).  
Notch signaling appears to act through three different modes: lineage decisions, 
establishing boundaries, and lateral inhibition. Lineage decisions are a type of directional 
inhibitory Notch signaling that occurs during asymmetric cell divisions. In this situation, two 
daughter cells are capable of sending and receiving Notch signals, but directionality is imposed 
by the asymmetric segregation of regulators that influence Notch signaling, such as Numb, and 
as a result the daughter cells adopt different fates from one another (Eric C Lai, 2004). Notch 
signaling is also involved in establishing boundaries. In this process Notch is activated in cells at 
the interface between two regions, creating an organizer at the boundary. The organizer is 
involved in cell-cell communication between the two regions that keeps them distinct. The 
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positive outcome of this Notch signaling function contrasts Notch’s inhibitory role in other 
signaling functions (Neumann & Cohen, 1997).  
Lastly, Notch signaling is involved in lateral inhibition. Lateral inhibition is a process by 
which one cell is selected from a group of equivalent precursors. In the group, all cells initially 
express the Notch ligand and receptor, and have the capacity to signal to one another; however, 
subtle differences between the cells become reinforced through a feedback loop. This process 
ensures that the cell with the least amount of Notch activation  is singled out as the ‘source’ of 
the ligand, which sends inhibitory signals to all of the surrounding cells (Simpson, 1997). Lateral 
inhibition is of particular interest since it is involved in the selection of SOP and muscle 
progenitors from clusters in the embryonic epithelium.  
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1.5 Hindsight in the sensory organ precursor   
 Most recently, in a genome-wide transcriptome analysis of SOP’s that were isolated 
using laser microdissection from the dorsal epithelium of Drosophila pupae, HNT was found to 
be highly expressed (Buffin & Gho, 2010). The early cell fate specification of the SOPs in pupae 
into microchaetes, is not unlike the SOP selection during other forms of Drosophila 
development, such the peripheral nervous system (PNS) during embryogenesis (Pi & Chien, 
2007). In both cases, the SOPs are selected from a small group of cells, termed the proneural 
cluster (PNC). The PNC is defined by the expression of members of the so-called proneural 
genes, including lethal of scute (l’sc). Early in the establishment of the SOP, all cells of the PNC 
have the potential to adopt neural cells fates. Eventually, however, only one cell of the PNC is 
selected as the SOP, and as shown in Figure 1.3, the SOP will generate all cells of the 
microchaetes, of the pupae, also known as external sense (es) organs. The expression of 
proneural proteins of basic helix-loop-helix (bHLH) transcription factors is required in the PNC 
to initiate and execute neurogenic programs (Villares & Cabrera, 1987). Achaete (ac) and scute 
(sc), from the achaete-scute complex, are the first identified members of the bHLH proteins, and 
are required for cells in the PNC to develop into SOPs, through a process called lateral inhibition 
mediated by the Notch signaling pathway.  
Lateral inhibition is a key process by which a single SOP is selected from the proneural 
cluster. A popular model for SOP selection involves a single cell within a PNC that expresses 
more Delta ligand than its surrounding cells. This cell then activates Notch in adjacent cells to 
trigger an intracellular signalling cascade that leads to the inhibition of proneural gene 
expression and results the acquisition of non-noneural neighbouring cells, as outlined in Figure 
1.3 (Artavanis-Tsakonas et al., 1990; Artavanis-Tsakonas, Rand, & Lake, 1999).The SOP then 
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proceeds to divide to produce five cell types, four of which mature into es organs (Campuzano & 
Modolell, 1992).  
The embryonic PNS consists of three types of sensory organs: es organs, chordotonal 
(Ch) organs, and multiple dendritic (MD) neurons. The mechanism of their cell specification is 
similar to the specification of microchaetes of the pupae. The major difference being that ac and 
sc are required for the formation of es organs, whereas atonal directs the formation of Ch organs 
(Campuzano & Modolell, 1992; Jarman, Grau, Jan, & Jan, 1993). The MD neurons are derived 
in two different ways; the most common way is from either es or Ch organ lineages, while the 
remaining MD neurons, also known as solo-MD neurons derive directly from SOP cells 
(Brewster & Bodmer, 1995). While HNT was found to be expressed in the SOPs of pupae, the 
role of HNT has yet to be determined, nor has HNT’s function in embryonic SOPs, of the PNS, 
been investigated. 
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1.6 Hindsight in muscle progenitor cells 
 An additional recent study investigating short term transcriptional responses to Notch in a 
Drosophila cell line similar to adult muscle progenitor cells also identified HNT as a direct 
transcriptional target of the Notch signaling pathway. HNT was confirmed to be present in adult 
myoblasts, and determined to have an effect on differentiation in adult muscle progenitors 
(Krejci, Bernard, Housden, Collins, & Bray, 2009). The process of muscle progenitor 
differentiation and development is shown in Figure 1.4. During embryogenesis, muscle 
development starts with the segregation of progenitor cells from an area of the mesoderm 
expressing high levels of twist (Borkowski, Brown, & Bate, 1995; Carmena, Bate, & Jimenez, 
1995). Muscle progenitors are singled out from clusters of the mesoderm that expresses a 
proneural gene, such as l’sc, by a process of lateral inhibition (Bate, Rushton, & Frasch, 1993; 
Carmena et al., 1995; Corbin et al., 1991). The muscle progenitor cells are then specified into 
two types of myoblasts, founder cells (FCs), which contain information required for 
morphogenesis, and fusion competent myoblasts (FCM). Muscles develop from the fusion of the 
FC with the FCM, and the characteristics of the muscle are specified by the specific identity gene 
expressed in the FC (Bate, 1990; Dohrmann, Azpiazu, & Frasch, 1990). Identity genes expressed 
in the FCs include apterous (ap), even skipped (eve), kruppel (kr), ladybird (lb) and nautilus 
(nau) and slouch (slou) (Tixier, Bataille, & Jagla, 2010). 
Similar to the selection of SOP’s within the PNC, the process by which progenitor cells 
become FCs, or FCMs, also occurs by lateral inhibition coupled to mitogen-activated protein 
kinase signalling through multiple feedback loops. This process allows only one cell to express 
the specific muscle identity gene thereby becoming a FC, while the other remaining cells become 
FCMs (Carmena & Baylies, 2006). Following the initial diversification steps, each FC fuses with 
13 
 
the FCM and this is thought to enable the formation of functional muscles with unique features. 
However, the exact role of HNT in embryonic muscle development has yet to be investigated.  
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1.7 Objective 
Previous studies have demonstrated that HNT plays a potential role in SOP’s isolated 
from the dorsal epithelium of pupae as well as in muscle precursors isolated from adult muscle 
precursor cells; however, the function of HNT in these precursors remains unknown. This project 
was designed to identify HNT’s direct and/or indirect targets in muscle progenitors and SOPs 
during embryogenesis, and to determine if HNT may play a role in their development. The 
approach involved microarray analysis of stage 13-16 embryos in which HNT was either over-
expressed or depleted by RNAi.  
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Chapter 2: Materials and Methods 
 
2.1 Drosophila Stocks and Fly Husbandry 
 Drosophila stocks were obtained from the Bloomington Drosophila Stock Centre 
(Department of Biology, Indiana University), the Kyoto Drosophila Genetic Resource Center 
(Kyoto Institute of Technology, Kyoto, Japan), from other Drosophila research labs, or were 
created previously in our laboratory. A list of all genetic stocks used, including sources and full 
genetic nomenclature is found in Appendix A. Drosophila cultures were raised on standard 
Drosophila media at 25
o
C on a 12 hour light/dark cycle.  
 
2.2 GAL4/UAS system  
 The GAL4/UAS system serves as a standard technique for inducing gene expression in 
Drosophila.  As outlined in Figure 2.1 the GAL4/UAS system commonly involves the use of two 
stocks: the first stock expresses the yeast Galactose 4 (GAL4) transcription factor in a specific 
spatiotemporal pattern, while the second stock possesses a target gene located downstream of the 
GAL4 binding site, otherwise known as the Upstream Activating Sequence (UAS). Such stocks 
are stable transgenic lines and carry the GAL4 and UAS sequences within engineered forms of 
the highly studied Drosophila transposable genetic element known as the P element. GAL4 
expressing lines or associated GAL4 insertions are frequently referred to as “GAL4 drivers” and 
their counterpart UAS lines (or the UAS insertions) are often called “UAS reporters”. The 
transcription of the gene of interest, on the UAS line, requires GAL4 to activate transcription. 
Thus, in the absence of GAL4 expression, the gene of interest on the reporter line remains silent. 
To activate transcription of the gene of interest, individuals possessing the UAS reporter gene are 
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mated with an individual from the GAL4 transgenic line. The resulting offspring will, therefore, 
express the gene of interest, in only those cells that express the GAL4 driver (Duffy, 2002). 
Many GAL4 lines are available, each associated with a unique spatiotemporal pattern of GAL4 
expression.  In many cases, however, a particular GAL4 driver and UAS reporter combination 
may be carried together as a viable genetic stock.  For example, many GAL4 lines are readily 
maintained with UAS-GFP reporters and these have become very useful for a variety of live 
imaging strategies.  In addition, the GAL4/UAS system is mildly responsive to temperature. The 
level of UAS reporter gene expression is routinely increased by raising the temperature to 29
o
C 
degrees, or decreased by reducing the temperature to 18
o
C degrees (Kramer & Staveley, 2003).  
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2.3 GAL80
ts
 
 Within the GAL4/UAS system another technique arises: repression via GAL80. GAL80 
is a yeast repressor under the control of a tissue-specific enhancer alongside the GAL4 driver. 
When co-expressed with GAL4, GAL80 blocks GAL4 activity by binding to its transcriptional 
activation domain (Suster, Seugnet, Bate, & Sokolowski, 2004). GAL80
ts
 is a temperature 
sensitive form of the GAL80 repressor.  At 25
o
C degrees, the GAL80
ts
 represses the activity of 
GAL4; however, when the temperature is shifted to 29
o
C degrees, the GAL80
ts
 is inactivated, 
allowing for the GAL4 transcription factor to bind to the UAS binding sites and express the gene 
of interest (Zeidler et al., 2004).   
 
2.4 Overnight embryo collection for Microarray Analysis and Fluorescent In-
Situ Hybridization 
  To ensure that embryos collected for Microarray Analysis and in situ hybridization were 
at the same developmental stage, 3 hour collections of embryos on grape agar dishes were aged 
for 10 hours. Incubation at 25
o
C for 10 hours ensures that the embryos are between stages 13-16 
of development (Campos-Ortega & Hartenstein, 1997). 
 
2.5 Embryo Fixation and Dechorionation  
 Dechorionation is the removal of the outer chorion layer (Pascucci, Perrino, Mahowald, 
& Waring, 1996). Embryos were dechorionated in a mixture of 50% bleach and 50% water with 
PBT (0.1% Triton X-100 in 1xPBS) for 3 minutes. After thoroughly washing the embryos with 
water, they were fixed in a solution of 5 mL of heptane and 5 mL of 3.7% formaldehyde in PBS 
for 20 minutes. The formaldehyde and PBS mixture was replaced with either methanol or 
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absolute ethanol, and the embryos were shaken until they separated from their vitelline 
membrane.  
 
2.6 Phalloidin stain  
 Phalloidin is a high-affinity, filamentous (F) actin stain, and was used for the 
visualization of muscle strands. Since phalloidin actin binding sites are degraded in the presence 
of methanol during fixation, absolute ethanol was used as a replacement (Narasimha & Brown, 
2006). The fixed embryos were stained with 0.1mg/ml phalloidin diluted with PBS at a 1:1000 
dilution for 30 minutes, and then scanned using Confocal Imaging (section 2.11).  
 
2.7 Immunostaining: Double and Single Antibody stain 
 Protocols for double and single antibody staining were modified from Nipam H. Patel’s 
Imaging Drosophila Embryos and Larvae using antibody probes (Patel, 1994). Modifications 
included blocking the embryos for 1 hour in 5% Bovine serum albumin (BSA) and normal goat 
serum. In addition, after removing the secondary antibody and PBT washes, the embryos were 
hydrated with a glycerol/PBS series.  
 Primary antibodies used were rabbit anti-D-Pax2 polyclonal at 1:2000 (Joshua Kavaler, 
Colby College, Maine), mouse monoclonal anti-HNT antibody at 1:25 (Howard Lipshitz 
,University of Toronto), and mouse monoclonal anti-22C10 at 1:500 (Developmental studies 
Hybridoma Bank, University of Iowa). The secondary antibodies were Alexa Flour® 488 goat 
anti-mouse and goat anti-rabbit, and TRITC goat anti-mouse (Cedarlane Labs); used at a 1:1000 
dilution.  
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2.8 RNA extraction  
  RNA extraction from embryos followed a modified Medium scale RNA extraction using 
TRIZOL protocol from FlyChip, Functional Genomics for Drosophila at the University of 
Cambridge.  Before the addition of isopropanol, the supernatant was centrifuged at 13,000 RPM 
for 10 minutes at 4
o
C degrees, and the supernatant was removed while leaving behind a small 
amount at the bottom. This was done to ensure that any potential contamination that may have 
been in the supernatant was centrifuged and discarded.  
 
2.9 Microarray  
 cDNA production, labelling, hybridization and scanning of the microarray plates were 
conducted at the Microarray Centre at the University of Toronto, Mississauga campus. Before 
cDNA production, RNA samples were analysed in a Bioanalyzer to determine RNA purity and 
quantity. A Molecular Devices (Axon) GenePix 4000B scanner was used. The arrays used were a 
custom version of the Nimblegen Drosophila melanogaster 4 x 72K array. There were 72,000 
oligo probes on each of the sub-arrays of the 4-plex array with each gene having 2-5 probes per 
gene. The probes used in the array represent the coding sequence of approximately 17,000 
different transcripts of the version 4.3 of the Drosophila melanogaster genome. A single channel 
scan was used, and the levels of expressions were compared to one another.   
 
2.9.1 Bioinformatics Analysis of Microarray Results 
 For the microarray analysis, a total of 4 sample sets were used for comparison, with each 
set consisting of a control cross, daGAL4 x yw, a HNT over-expression cross, daGAL4 x UAS-
GFP-HNT, and a HNT RNAi depleted cross, daGAL4 x UAS-HNT-RNAi2A;UAS-HNT-
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RNAi2B. The resulting data were analyzed using the program ArrayStar. The expression values 
of the control and mutants were averaged. The HNT over-expression and depleted results were 
compared to the Control in a Scatter plot, and Student’s t-test with false discovery rate (FDR) 
correction (Benjamini and Hochberg procedure) was used to test for significance. Genes with at 
least a two-fold change in expression and a FDR corrected p-value < 0.05 were retained as 
significant; to produce a list of genes with 2-fold, 4-fold, and 8-fold changes in expression, along 
with genes that had an 99% 95% and 90% confidence range.  
The data were isolated based on at least a 2-fold change in expression, along with a 95% 
confidence. The FlyBase identifier (FBtr) code was used to find the gene symbol the code 
represented using the FlyBase Drosophila data website (http://flybase.org). The HNT over-
expression data is presented in Appendix B, and the HNT RNAi depleted data is represented in 
Appendix C. 
 
2.10 Fluorescent In situ hybridization  
 Embryo fixation followed the Fluorescent in situ Hybridization (FISH) protocols in 
Drosophila embryos and tissues by Eric Lécuyer, Neela Parthasarathy and Henry M. Krause 
(Lecuyer, Parthasarathy, & Krause, 2008). 
 The Single FISH, along with post-fixation, hybridization, post-hybridization and scans 
were performed by Ronit Wilk from the Krause Lab at the University of Toronto. Probes for the 
FISH were acquired from either the Krause lab or the Drosophila Genomics Resource Center 
(Indiana University). Both HNT over-expression and control embryos were probed for MyO10A 
(CG43657), scabrous (CG17579), AP-2 (CG7807), Scute (CG3827), Slowpoke binding protein 
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(CG6772), Nplp1 (CG3441), Enhancer of split mγ, helix-loop-helix (CG8333), shaven/D-Pax2 
(CG11049), Pox Meso (CG9610), unpaired 3 (CG33542), and CENP-ana (CG33695).  
2.11 Confocal microscopy  
 All stained embryos were imaged using a Nikon Eclipse 90i microscope fitted with a 
Nikon D-eclipse C1 scan head, Nikon EZ-C1 software and a 20x objective Nikon CFI Plan Apo 
VC lens, unless stated otherwise. Z-stack scans through embryos used slices averaging between 
0.40 µm – 2.00 µm. Z-stack projections were obtained with using the Nikon EZ-C1 or the NIH 
ImageJ software. Live imaging was performed as previously described (Reed, McMillan, & 
Chaudhary, 2009; Reed, Wilk, Schock, & Lipshitz, 2004). 
 
2.12 Cell count  
To compare the amount of cells with co-localized expression or cell expressing either one 
of the antibodies from the double antibody stain, confocal images of embryos were taken that 
represented each co-localized and individual antibody expression of the genetic crosses. The 
number of confocal images for each developmental stage, of each genetic cross, contained at 
least 5 embryos; the exact number of embryos is represented as an “n” value within the graphical 
comparisons. To count the number of cells, each confocal image had a section cropped out for 
cell counting. Sections, as outlined in Figure 2.2 denote the area where the numbers of co-
localized and single antibody expressing cells were counted. Lining the sections up in parallel 
aided in determining which cells had co-localized expression or just expressed a single antibody. 
The cell counts from each developmental stage, of a genetic cross, were averaged using the 
MEAN function on the Excel program. The standard deviation for each mean was calculated 
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using the Excel STDEV function. p-values were determined using a type 2 student T-test with 2 
tails, and trends in the graph were analyzed using one- or two-way ANOVA. 
 For each stain, embryos were compared on the stage of development: early stage, stage 
11, a middle stage, stage 12, and a late stage, stages 13-14 (Campos-Ortega & Hartenstein, 
1997). If the developmental stage of the embryo was undetermined, based on the appearance of a 
severe phenotype that has arrested development, the embryos were denoted as having only one 
stage, since early, middle, or late stages were indistinguishable. 
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Chapter 3. Results  
 
3.1 Design of experimental Drosophila models for the analysis of embryos in 
which HNT is over-expressed or depleted 
 To identify genes as potential targets of HNT during embryogenesis, a variety of GAL4 
drivers were tested in combination with UAS-HNT (over-expression) or UAS-HNT-RNAi 
(depletion) reporters. In order to proceed with a microarray analysis, it was necessary to use 
driver and reporter lines that were homozygous viable; it was also desirable to identify 
driver>reporter combinations that were associated with a disruption of normal development, 
which would enhance any chance of identifying genes affected by the over-expression and 
depletion of HNT.  
 
3.1.1 Phenotypic consequences of a variety of GAL4-driver>UAS-reporter 
combinations  
A variety of GAL4-driver>UAS-reporter combinations were tested to determine the best 
available experimental model for microarray analysis. Two GAL4 drivers were tested: NP3312 
and daGAL4, which drive expression of GAL4 under control of the promoters for the genes hnt 
and daughterless (da), respectively. Table 3.1 compares the severity of the mutant phenotypes 
associated with each GAL4-driver>UAS-reporter combination. The genetic stock 
NP3312+Apoliner/FM7 carries a GAL4 driver and the apoliner reporter that expresses a GFP-
mCherry fusion protein which normally serves as a biosensor for caspase activity, but is simply 
used here as a reporter for the NP3312 driver. In addition, the UAS-DT is a mCherry-GFP-
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DrAtg8a construct that simply serves as a reporter for the NP3312 driver, although it is normally 
used to detect autophagy. When the NP3312 driver was crossed with the HNT over-expression 
line UAS-GFP-HNT, progeny displayed a strong embryonic lethal phenotype that included a 
failure in DC and a persistent amnioserosa tissue. A second HNT over-expression reporter line, 
EP55, was also tested with the NP3312 driver. NP3312>EP55 embryos displayed a mild 
embryonic phenotype where there was a persistent amnioserosa tissue, but was ultimately not 
associated with embryonic lethality. The HNT RNAi depleted line tested was UAS-HNT-
RNAi2A; UAS-HNT-RNAi2B, which also produced a mild embryonic phenotype that did cause 
lethality. 
Despite the strong phenotypes observed, the NP3312 driver, which maps to the X 
chromosome, was also found to be associated with strong dosage compensation. As a 
consequence, the NP3312 driver displayed a twofold increase in expression in male embryos 
compared to female embryos. Such a lack of homogeneity in resulting embryonic phenotypes 
was deemed undesirable and the NP3312 driver was not used.  
The other driver tested was daGAL4. When crossed with another HNT depleted line 
(UAS-Dicer; UAS-HNT-RNAi2B), embryos displayed an embryonic phenotype most similar to 
wild type, which will be designated as an weak embryonic phenotype, where no obvious 
phenotype was detected and was not embryonic lethal.  The daGAL4>EP55 embryos were 
associated with a persistent amnioserosa tissue, but were not embryonic lethal. Lastly, 
daGAL4>UAS-GFP-HNT displayed a strong embryonic mutant phenotype that ended in 
embryonic lethality, while the HNT depleted line: UAS-HNT-RNAi2A; UAS-HNT-RNAi2B 
embryos displayed a mild mutant embryonic phenotype that did not end in lethality. Given the 
phenotypes seen with the daGAL4 driver and the HNT over-expression line: UAS-GFP-HNT, 
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and HNT depleted line: UAS-HNT-RNAi2A; UAS-HNT-RNAi2B, this combination of GAL4-
driver>UAS-reporters was selected for microarray analysis.  
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Table 3.1 Comparison of phenotypes for GAL4-drivers>UAS-reporter combinations.  
The two main drivers tested is a Hindsight NP3312 driver, and a daGAL4. The reporters 
consisted of two HNT over-expression lines: UAS-GFP-HNT and EP55, and two HNT RNAi 
depleted reporter lines: UAS-HNT-RNAi2A; UAS-HNT-RNAi2B and UAS-Dicer; UAS-HNT-
RNAi2B. The severity of the mutant phenotype is denoted as being weak: +, mild: ++, and 
strong: +++.  
 
 
 
 
GAL4-drivers>UAS-reporter Combinations Degree of Mutant 
Phenotype 
NP3312 driver  
NP3312 + Apoliner/FM7  
       > UAS-GFP-HNT +++ 
       > UAS-HNT-RNAi2A; UAS-HNT-RNAi2B ++ 
       > EP55 ++ 
NP3312; Dp/+  
       > UAS-GFP-HNT +++ 
NP3312; (Dp)/(UAS-DT)  
       > EP55 ++ 
daGAL4 driver   
KrGAL4+UASGFPClc5/TM3  
       > UAS-Dicer; UAS-HNT-RNAi2B + 
w; (YET1); daGAL4  
       > EP55; dpplacZ/CYO ++ 
w; UAS-mCherry-DrAtg8a;daGAL4+Spider/TM3,Ser  
       > UAS-GFP-HNT +++ 
       > UAS-HNT-RNAi2A; UAS-HNT-RNAi2B ++ 
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3.1.2 Hindsight expression in the experimental models 
 To confirm HNT expression with the daGAL4 driver during GBP and DC, an HNT 
antibody stain, as shown in Figure 3.1, was conducted on HNT over-expression embryos using 
the reporter line UAS-GFP-HNT and on HNT RNAi depleted embryos using the reporter line 
UAS-HNT-RNAi2A; UAS-HNT-RNAi2B. As seen in Figure 3.1 B, the daGAL4>UAS-GFP-
HNT embryos had greater HNT expression throughout the embryo, than in the control, yw, 
embryos (Figure 3.1 A). In the UAS-HNT-RNAi2A;UAS-HNT-RNAi2B RNAi depleted line, 
when compared to the control, there was less HNT expression (Figure 3.1 C), but the expression 
of HNT was not reduced completely, which indicated that there was not a constant depletion of 
HNT. However, since the reporter line was still able to reduce HNT expression, it was used as a 
part of the experimental model for the study of HNT using microarray analysis.  
 
 In summary, the experimental models for this study consisted of a reporter-less control, 
yw, and the driver daGAL4 driving expression of the HNT over-expression, UAS-GFP-HNT, 
and the HNT RNAi depleted, UAS-HNT-RNAi2A; UAS-HNT-RNAi2B, reporter lines. 
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3.2 Microarray Analysis of Hindsight targeted genes 
 In the comparison of the HNT over-expression microarray analysis profile with the 
control, approximately 1,300 cDNA transcripts were identified as having at least a 2-fold change 
in expression, along with 95% confidence rate with p values of less than 0.05 after False 
Discovery Rate (FDR) correction, as shown in Appendix B. The number and functions of these 
under-expressed or over-expressed genes in each developmental category is presented in Figure 
3.2. Genes whose transcriptional activity is affected by HNT over-expression are involved in a 
number of different processes including neurogenesis and eye development, transmembrane 
transport, morphogenesis, and myogenesis systems of development. These gene ontology 
assignments were based upon gene ontology terms from the FlyBase database.  
In the HNT RNAi depleted line, when compared to the control, approximately 100 cDNA 
transcripts demonstrated a minimum 2-fold change in their expression, along with 95% 
confidence rate with p values of less than 0.05 before and after the False Discovery Rate (FDR) 
correction, as seen in Appendix C. The categorized genes are shown in Figure 3.3, which 
indicates that most genes affected by reduced HNT expression are associated with 
transmembrane transport, reproduction, morphogenesis, and sensory/olfactory related 
development.  
 Previous studies have shown that HNT plays a role in down-regulating the JNK signaling 
pathway in the amnioserosa, which is needed for the proper completion of GBR and DC (Reed et 
al., 2001; Yip et al., 1997). Surprisingly though, only two genes were found to be involved in the 
JNK pathway: omega (ome) and cln3, and only one gene, aside from HNT, was found to be 
involved in DC: Myosin binding subunit (Mbs). However, other data confirm the validity of the 
microarray data, such as the up-regulation of pebbled/HNT, yellow (y), and white (w). y and w 
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can act as controls for the HNT over-expression microarray analysis since the control and the 
HNT over-expression embryos are associated with dosage differences for the wild-type copies of 
these loci: Control embryos carry only single copies of y
+
 and w
+
, whereas the experimental 
HNT over-expression embryos carry two copies of y
+
 and w
+
. Therefore, when the HNT over-
expression is compared to control embryos in the microarray data, y and w would be expected to 
be up-regulated (Table 3.2), which is also seen when comparing the microarray linear expression 
values of yellow and white between the control and the HNT over-expression.  
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Table 3.2   
 The number of yellow and white gene copies is compared between the Control and 
HNT over-expression that was used in the microarray data. Females of the y w and +w; 
UAS-GFP-HNT were crossed with +w; daGAL4 males. The daGAL4 carries a y/+ and 
contains one copy of [w
+
] (white) in the w
1118
 on the driver. The y and w, in the stock 
notation indicates that the stock is mutant for that gene, while the + notation in the stock 
indicates that the stock is not mutant for that gene. The Microarray linear expression 
values also compares the yellow and white gene copies between the Control and the HNT 
over-expression. 
 
Genetic Cross Number of yellow and white 
gene Copies 
Microarray Linear 
Expression Values 
Control   
y w  X  + w; daGAL4  yellow: y/+ = 1X (copy) yellow: 9.0 
 white: w
1118
; 1X[w
+
] = 1X 
(copy) 
white:10.4 
HNT over-expression   
+ w; UAS-GFP-HNT  X + w; 
daGAL4 
yellow: +/+ = 2X (copy) yellow:10.5 
 white: w
1118
; 2X[w
+
] = 2X 
(copy) 
white: 12.1 
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3.2.1 Confirmation of Hindsight expression in experimental models (HNT 
over-expression versus RNAi depletion) 
 The substantial difference between the number of genes affected by the HNT over-
expression compared to the RNAi depleted line suggested that the UAS-HNT-RNAi2A; UAS-
HNT-RNAi2B line may not have provided a strong enough depletion of HNT. To confirm this 
hypothesis, the expression of HNT in these lines was re-examined using the microarray analysis 
data. Figure 3.4 displays a graph comparing the microarray linear expression of HNT in the 
control against the over-expression and RNAi depleted reporter lines. The over-expression line 
had significantly over-expressed HNT, while the depleted reporter line appeared not to be strong 
enough to deplete HNT; since the HNT depleted linear expression value was not significantly 
different from the control. Therefore, further investigation into the potential targets of HNT was 
only carried out using the HNT over-expression microarray data. 
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3.3 Association of Hindsight expression with Muscle Development    
 In a cell line that has characteristics similar to Drosophila adult muscle progenitor cells, 
HNT was documented to be a target of Notch in a genome-wide response to Notch activation, 
after 30 minutes in these cell lines (Krejci et al., 2009). HNT’s potential involvement in muscle 
development was supported by the microarray analysis data, as indicated by the number of 
muscle identity genes down-regulated by HNT over-expression, shown in Table 3.3.  
From the list of candidate genes in Table 3.3, Pox meso was selected for further 
investigation using fluorescent in-situ hybridization (FISH) stain, which was done by Ronit Wilk 
from the Krause Lab at the University of Toronto. FISH staining revealed the wild-type 
expression pattern of Pox meso, which is that it’s usually seen along the ventral side, head and 
tail end of the embryo. The Pox meso expression along the ventral side potentially shows its 
expression in muscle progenitor cells. As indicated in the microarray data, Pox meso was down-
regulated in a 21.9 fold change in expression, in the presence of HNT over-expression (Table 
3.3). Similar to this result, the in-situ of the control compared to HNT over-expression embryos 
showed that Pox meso expression was almost completely absent in HNT over-expression 
embryos (Figure 3.5).  
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Table 3.3  
 Known muscle identity genes in the list of differentially expressed genes on HNT over-
expression (Appendix B). These genes have a known role in muscle development during 
embryogenesis 
 
 
 
 
 
 
Fbgn_ID 
(Flybase ID) CG Name(symbol) 
Protein 
function 
Up/Down 
expression 
Fold 
Change Description [ref] 
       Myogenesis 
      
FBgn0003129 CG9610 
Pox meso 
(Poxm) 
Transcription 
factor Down 21.856 
Regulates the development of larval 
body wall muscles and a muscle 
identity function  (Duan et al., 2007) 
FBgn0000606 CG2328 
even skipped 
(eve) 
Transcription 
factor Down 2.387 
Regulates segment polarity and in 
selecting muscle identity in muscle 
founder cells (Dobi, Metzger, & 
Baylies, 2011; Liu, Qian, Han, Wu, & 
Bodmer, 2008) 
FBgn0003975 CG3830 vestigal (vg) 
Presumptive 
transcription 
factor Down 2.295 
Required in ventral longitudinal 
muscles to induce formation of stable 
intermusclar attachments and is a 
muscle identity gene (Deng, Bell, & 
Simmonds, 2010) 
FBgn0002941 CG6534 
slouch/S59 
(slou) 
Transcription 
factor Down 2.181 
Expression in muscle founder cells 
responsible for the origin of specific 
musculature of each segment  (Cox & 
Baylies, 2005) 
FBgn0002922 CG10250 nautilus (nau) 
Transcription 
factor Down 3.070 
Defines the subset of mesodermal 
muscle founder cells and a 
differentiation role in mature fibers  
(Wei, Rong, & Paterson, 2007) 
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3.3.1 The regulation of muscle formation by Hindsight 
 To investigate the effect of HNT on muscle development TRITC-Phalloidin, which labels 
filamentous actin (F-actin) in the embryo (Warn & Magrath, 1983), was used to examine muscle 
morphology. F-actin expression was examined in embryos of the following genotypes: control 
(yw), HNT over-expression (daGAL4>UAS-GFP-HNT), HNT null (hnt
XE81
), and Notch null 
(Notch
55ell
), embryos, as shown in Figure 3.6. Control embryos exhibited organized muscle 
filaments along the lateral side of the embryo (Figure 3.6A), as represented by the organized F-
actin expression, whereas embryos with HNT over-expression showed a disorganized 
arrangement of the F-actin filaments, indicative of disorganized muscle filaments (Figure 3.6B). 
The HNT null mutants displayed a characteristic phenotype of a failure in GBR, as indicated by 
the embryo having arrested in development (Yip et al., 1997); however, the HNT null also 
displayed organized muscle filaments, similar to the control, and unlike the disorganized muscle 
filaments in the HNT over-expression (Figure 3.6C). The organized muscle pattern seen in the 
HNT null suggested that the complete loss of HNT expression has no severe effect on muscle 
development. The Notch null in this study could be considered as a positive control for muscle 
formation failure because previous research by Baker and Schubiger showed that embryos 
without Notch function had too many muscle founder cells and failed to properly differentiate 
somatic muscle, suggesting that Notch is needed for muscle development (Baker & Schubiger, 
1996). Indeed, this experiment showed that the Notch null demonstrated a disorganized muscle 
filament expression, similar to the HNT over-expression (Figure 3.6D).  
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3.3.2 The regulation of muscle strand development by Hindsight 
 To further study the effects of HNT over-expression on muscle development, a 
DmefGAL4>UASmoesinCherry stock was used to outline muscle fibres in live embryos. Dmef-
GAL4 drives expression of GAL4 in mesodermal precursors that represent muscle fibres 
(Sandmann et al., 2006). As shown in Figure 3.7, when the Dmef expression in the control was 
compared to HNT over-expression, the muscle strands in the HNT over-expression cross 
appeared disorganized and fragmented, while the Dmef expression demonstrated normal 
organized muscle strands in the control. These results support the finding that muscle fibre 
development can be disrupted by HNT over-expression.  
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3.3.3 Investigation of the sensitivity of muscle development to HNT over-
expression during development  
 To investigate the effects of inducing HNT expression on fully developed muscle fibres, 
the DmefGAL4>UASmoesinCherry stock was crossed to the reporter line UAS-GFP-HNT;tub-
GAL80
ts
. The reporter line carries tub-GAL80
ts
, a temperature sensitive repressor of GAL4 
(described in the Materials & Methods). This technique allows the induction of HNT expression 
following muscle specification and differentiation, which allows the question of HNT’s role in 
muscle maintenance to be addressed.  
 The effect of HNT over-expression on embryonic muscle strands was examined by 
inducing HNT expression in fully formed embryonic muscle strands and in larvae muscle 
strands. Embryos aged between 0-16 hours following an overnight collection at 25
o
C, were 
shifted to 29
o
C for 4 hours. The effect of the 4 hour temperature shift (HNT induction) is 
illustrated in Figure 3.8 D-F. Confocal live imaging showed that the embryos exhibited strong 
HNT expression, as demonstrated in Figure 3.8 F, confirming HNT expression. The embryos 
that were temperature shifted for 4 hours were compared to embryos aged 0-16 hours that were 
also temperature shifted to 29
o
C, but for 24 hours (Figure 3.8 A-C). The embryos shifted for 24 
hours demonstrate the effects of early induction of HNT expression, which acts as a control for 
the GAL80
ts
 function, since we know that HNT can affect muscle fibres at the beginning of 
muscle development. The moesinCherry expression of the muscle fibres, in embryos shifted for 
4 hours, was more or less the same as what was seen in the control embryo (Figure 3.7 A-C), 
suggesting that the 4-hour induction of HNT may not have a significant effect on the muscle 
fibres. In addition, using the same embryos as in Figure 3.8, the embryos were allowed to 
develop into 1
st
 in-star larvae at 25
o
C, at which point they were temperature shifted to 29
o
C for 
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48 hours. The resulting larvae remained viable and motile, suggesting that induction of HNT by 
DmefGAL4 did not disrupt somatic muscle function during larval stages (Data not shown). 
Overall, these results suggest that HNT does not play a role in muscle maintenance, but does 
perhaps have a role in specification or differentiation of embryonic muscles.  
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3.3.4 The Hindsight expression in Muscle founder cells 
 The microarray analysis showed that a number of muscle identity genes, present in 
muscle founder cells that are required for the specification of muscle types, were down-regulated 
following HNT over-expression. These included genes even-skipped (eve), nautilus (nau), slouch 
(slou), vestigial (vg), and Pox meso (Poxm). These data suggest that HNT could be affecting 
muscle development by disrupting the specification of muscle founder cells. To investigate this 
possibility, an anti-HNT antibody stain was performed on embryos of the muscle founder marker 
driver RP298-GAL4, driving expression of UAS-GFP
nls
. The aim of this experiment was to 
determine if HNT is expressed in muscle founder cells, and in part to address the question as to 
whether HNT could function autonomously in these cells. Figure 3.9 A-C displays embryos at 
stages 13-14 of development, while Figure 3.9 D-C represents later stage 16 embryos. Earlier 
staged embryos demonstrated potential co-localization between the RP298 marked and HNT 
expression cells, which was not seen in the later staged embryos (Figure 3.9 C). The absence of 
co-localization in the stage 16 embryos, however, may be attributed to the apparent lack of 
robust nuclear localization of the GFP
nls
 in muscles, making interpretation difficult. Ideally, we 
would want to look at muscle identity gene expression in the RP298>UAS-GFP-HNT, to 
reaffirm HNT’s potential down-regulation of identity genes in muscle founder cells. However, 
the localization of HNT in the muscle founder cells in the early stages of the embryo could still 
suggest that HNT can affect muscle development by regulating gene expression the muscle 
founder cells.  
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3.3.5 The effect of inducing Hindsight expression in Muscle founder cells  
 Results from the above experiments implied that HNT might regulate muscle 
development by a previously unknown role in the specification of muscle founder cells. To test 
this hypothesis, the effect of over-expressing HNT in muscle founder cells on muscle fibers was 
investigated. Figure 3.10 shows phalloidin stained embryos carrying an RP298 driver and UAS-
GFP-HNT reporter (Figure 3.10 D-F); compared to control embryos (Figure 3.10 A-C) at 
embryonic stages 12-13. Over-expressing HNT in the muscle founder cells using the RP298 
driver, decreased the amount of F-actin filaments (Figure 3.10 D), when compared to the control. 
At later embryonic stages, the phenotype of HNT overexpressing embryos (Figure 3.11 D-F) was 
significantly different from that of control embryos (Figure 3.11 A-C). In the control, there was 
organized and non-striated muscle and actin filament formation; however, in the HNT over-
expression embryos the actin filaments were disorganized, and nuclear GFP expression again 
was not well localized to the nuclear compartment. From these results it can be suggested that 
over expressing HNT may be affecting muscle development by acting on muscle founder cells 
expressing identity genes, despite it not being necessary for muscle development as seen with the 
HNT null (Figure 3.6 C).  
 
 
 
 
 
 
 
52 
 
 
 
 
 
 
53 
 
 
 
 
 
54 
 
3.3.6 Summary: the roles of Hindsight in muscle development  
 The data suggests that over-expressing HNT can affect myogenesis during the early 
stages of embryogenesis, despite the fact that HNT is not necessary for muscle maintenance. The 
mode of HNT action may involve down-regulating identity genes in the muscle founder cells, 
especially since those genes were down-regulated in the microarray analysis of HNT over-
expression embryos. However, the precise nature of how over-expressing HNT can affect muscle 
development in the muscle founder cells has yet to be determined. 
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3.4 The association of Hindsight with Neuron development, and Notch 
signaling 
 A recent study by Buffin and Gho shows that HNT is expressed in sensory organ 
precursor cells (SOP), which are precursor cells for peripheral nervous system (PNS) and 
microchaete bristle development (Buffin & Gho, 2010). Microarray analysis of HNT over-
expression embryos also supports the idea that HNT may affect neurogenesis, given the large 
number of neurogenesis related genes that were over- and under-represented in the presence of 
HNT over-expression (Table 3.4). All of the genes selected for FISH had at least a 2-fold change 
in expression in the presence of HNT over-expression, and were selected based on their 
involvement in neural development. Figure 3.12 compares that the FISH levels of shaven, 
otherwise known as D-Pax2, scute, scabrous and Nplp1 between the control and the HNT over-
expression embryos. 
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Table 3.4 
 Known muscle identity genes in the list of differentially expressed genes on HNT over-
expression (Appendix B). These genes have a known role in neuron development during 
embryogenesis 
 
Fbgn_ID 
(Flybase ID) CG Name(symbol) 
Protein 
function 
Up/Down-
expression 
Fold 
Change Description [ref] 
Neural 
      
FBgn0000216 CG3096 Bearded (Brd) 
Counteracts 
neurogenic 
genes Up 5.573 
Activated by proneural genes as 
a direct target of Notch and 
antagonizes Notch signalling by 
directly competing with Delta 
(E. C. Lai, Bodner, Kavaler, 
Freschi, & Posakony, 2000) 
FBgn0003326 CG17579 scabrous (sca) 
Lateral 
inhibition Up 2.637 
Plays role in restriction of neural 
precursor fate in cells which 
defines the pattern of Notch 
signalling  (Li, Fetchko, Lai, & 
Baker, 2003) 
FBgn0004170 CG3827 scute (sc) 
Transcription 
factor Up 4.055 
Target of Notch signalling and a 
proneural gene  (Stagg, 
Guardiola, & Crews, 2011) 
FBgn0035092 CG3441 
Neuropeptide-like 
precursor 1 
(Nplp1) 
Neuropeptide 
hormone 
activity Up 3.060 
A marker for subtype-specific 
terminal differentiation gene in 
neurons (Overend et al., 2012) 
FBgn0005561 CG11049 
shaven/DPax2 
(sv) 
Transcription 
factor Up 2.262 
Direct Notch target for the 
proper differentiation of PNS 
define external sensory organ 
development and likely  
antagonist of Notch signalling 
(Charlton-Perkins et al., 2011) 
FBgn0003651 CG11502 seven up (svp) 
Transcription 
factor Down 2.087 
Acts as a switching factor in the 
temporal cascade for embryonic 
neuroblasts to generate different 
cell types  (Benito-Sipos et al., 
2011) 
FBgn0004644 CG4637 hedgehog (hh) Growth factor Down 2.614 
Growth factor signalling system 
is necessary for the initiation of 
proliferation of neural stem 
cells/neuroblast (Nfonsam, 
Cano, Mudge, Schilkey, & 
Curtiss, 2012) 
FBgn0003130 CG8246 Pox neuro (Poxn) 
Transcription 
factor Down 2.098 
Involved in development of 
larval poly-inverted external 
sensory organs and in 
specification of neuro identity 
(Awasaki & Kimura, 2001) 
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3.4.1 Shaven/D-Pax2 
 From the microarray data (Table 3.4) and the FISH analysis (Figure 3.12), one of the 
candidate genes that had increased expression in response to HNT over-expression was 
shaven/D-Pax2. D-Pax2 encodes a transcription factor, and is suggested to function as an 
antagonist of Notch signaling, while Notch has been noted to function as an inhibitor of D-Pax2 
expression in the PNS (Cau & Blader, 2009). The microarray data implies that D-Pax2 could be 
a transcriptional target of HNT, since over expressing HNT appears to up-regulate the expression 
of D-Pax2. To validate the up-regulation seen in the FISH analysis, antibody staining was 
performed on control and HNT over-expression embryos.  
 
3.4.2 The relationship between Hindsight and D-Pax2 expression in wild type 
embryos  
To investigate HNT and D-Pax2 expression in wild type embryos, the relationship 
between these two proteins was examined by a double antibody stain with anti-HNT and anti-D-
Pax2 at different embryonic stages: an early stage, stage 11, a middle stage, stage 12, and a late 
stage, stages 13-14 (Figure 3.13) (Campos-Ortega & Hartenstein, 1997).  
Figure 3.13 A-C shows the early staged embryos with D-Pax2 expression (0.6±0.89 
cells/per view), HNT expression (3.6±2.07 cells/per view), and the co-localized expression of the 
two proteins (23.2±1.79 cells/per view). At the early stage, almost every D-Pax2 expressing cell 
contained HNT expression. Figure 3.13 D-F displays middle staged embryos expressing D-Pax2 
(6.71±4.11 cells/per view), HNT (9.43±4.72 cells/per view), and co-localized expression 
(43.57±9.43 cells/per view). In comparison to early staged embryos (Figure 3.13 A-C), middle 
staged embryos have more cells that express D-Pax2 or/and HNT, and there was also an increase 
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in the proportion of single-stained D-Pax2 cells to double–stained D-Pax2 and HNT cells. Figure 
3.13 G-I shows the later staged embryos expressing D-Pax2 (34.7±7.33 cells/per view), HNT 
(61±6.10 cells/per view), and co-localization (24.17±6.97 cells/per view), at this stage of 
development, when compared to those at the middle stage, the number of D-Pax2 or HNT 
expressing cells increased, while the number of the cells with co-localization between these two 
proteins decreased.  
Figure 3.14 compares the cell count representing HNT expression of the control embryos 
at the early, middle, and late stages (p < 0.0001 one-way ANOVA). The graph shows a steady 
increase in HNT expression from early to middle, but a large spike of HNT at the later stage.   
Overall, there is a general trend whereby HNT and D-Pax2 expression appears to co-
localize in early and middle, but not in later staged embryos. In later staged embryos, the 
expression of the two proteins appears to be found in neighbouring cells in the PNS. HNT 
appears to be expressed within the neurons, whereas D-Pax2 appears to be expressed in 
accessory cells. Given D-Pax2’s role in neural development, specifically in the PNS, we also 
wanted to test if over-expressing HNT can effect neural development. 
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 3.4.3 The analysis of neurogenesis defects associated with HNT over-
expression 
 To determine the effect of HNT over-expression in the embryonic nervous system, a 
22C10 stain was used to outline the peripheral and central nervous systems in developing 
embryos. 22C10 is an monoclonal antibody that is a widely used as a neuronal marker to 
visualize neuronal morphology and axonal projections (Hummel, Krukkert, Roos, Davis, & 
Klambt, 2000). Figure 3.15 compares of the nervous system of HNT over-expression embryos 
(Figure 3.15B) to that of the control - yw (Figure 3.15A). In comparison to the control, the HNT 
over-expression embryos display a neurogenic phenotype, which could be the specification of 
neuronal cells at the expense of epidermal cells. This phenotype is similar, but not exact, to the 
Notch null (Notch
55ell
), which displays an expected neurogenic mutant phenotype: a hypertrophy 
of neural cells at the expense of epidermal cells (Figure 3.15D) (Cabrera, 1990). 
 The HNT null, hnt
XE81
, on the other hand, did not display a neurogenic phenotype similar 
to the HNT over-expression and Notch null embryos, instead there appeared to be fewer neural 
cells (Figure 3.15C). Unfortunately, since these embryos were not staged, it is difficult to say 
whether without HNT expression there is a reduction of neural cells or whether these cells just 
have not fully developed. However, HNT null embryos do have a reduction in the number of 
chordotonal (Ch) organs, which are components of the PNS. In wild type embryos there are 
usually 5-8 found in each abdominal hemisegment (Okabe & Okano, 1997), the HNT null 
appears to have only 3-4, which could be indicative of a role of HNT in neural development.  
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3.4.4 The co-localization of D-Pax2 and Hindsight in different experimental 
models 
Despite the complementary pattern observed between HNT and D-Pax2 at later stages of 
embryonic development, the microarray data showed that increased HNT expression also 
increased D-Pax2 expression. This suggests that HNT may function to co-regulate D-Pax2 
during neural development. This up-regulation could involve the Notch signaling pathway, 
which is well known to be required for the differentiation of neuroblasts (Artavanis-Tsakonas et 
al., 1990; Artavanis-Tsakonas et al., 1999). This is an compelling model since previously 
published studies, such as those on adult muscle progenitors, have reporter that HNT is a direct 
transcriptional target of Notch (Krejci et al., 2009). If this is also the case in neural progenitors, 
then Notch null mutants would expect to have reduced HNT expression, and if the effect of HNT 
expression on D-Pax2 was dependent on Notch signaling, than Notch null mutants should also 
have reduced HNT and D-Pax2 expression.  
To investigate whether or not the up-regulation of D-Pax2 following the over-expression 
of HNT involves the Notch signaling pathway, anti-HNT and anti-D-Pax2 double staining was 
examined in the control (Figure 3.16 A-C), HNT over-expression (Figure 3.16 D-F), and Notch 
null (Figure 3.16 G-I) embryos. In comparison to the control, HNT over-expression embryos 
(Figure 3.16 D-F) had an increased number of cells with co-localized HNT and D-Pax2 
expression, as well as an increase in the number of cells expressing D-Pax2 without HNT 
expression. Notch null (Notch
55ell
) mutant embryos (Figure 3.16 G-I) were found to have 
excessive HNT expression, but displayed only barely detectable levels of D-Pax2 expression. 
This suggested that Notch could be required to inhibit HNT expression, but not D-Pax2 
expression, and Notch signaling is required for the maintenance of D-Pax2 expression. In 
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addition, the relationship between HNT and D-Pax2 does not appear to involve Notch signaling, 
as evident by the lack of HNT inhibition in the Notch null mutants, and the increased D-Pax2 
expression in HNT over-expression mutants.  
The inhibitory effects of Notch on HNT expression were reaffirmed by an HNT antibody 
stain on Notch null (Notch
55ell
) and Delta mutants (Delta-GAL4/TM6) (Figure 3.17). The over 
expression of HNT on the Notch null (Figure 3.17 B) resembles the pattern seen with the 22C10 
stain on the Notch null (Figure 3.15D), suggesting that the neural hypertrophy is constituent with 
the over-expression of HNT in neural cells. The signaling pathway by which Notch inhibits HNT 
in neural cells is potentially through the Delta ligand, since the HNT antibody stain on Delta 
mutants (Figure 3.17C) resembles the over-expression of HNT in the Notch null.  
 The number of cells with co-localized HNT and D-Pax2 was also quantitatively 
compared between the control, HNT over-expression (daGAL4> UAS-GFP-HNT), and the 
Notch null (Notch
55ell
). As shown in Figure 3.18, the HNT over-expressing embryos had a 
greater number of co-localized cells (148±9.43 per view) than the control (43.6±9.43 per view) 
and the Notch null (0); please note that the amount of D-Pax2 expression observed in the Notch 
null could be attributed to the late stage of the embryo, and the barely detectable number of D-
Pax2 expressing cells could not be properly counted and was denoted as being 0 for comparison 
purposes  (p < 0.0001, Control vs. UAS-GFP-HNT, Student t-test).This result further reaffirms 
the idea that D-Pax2 may still be an indirect or direct target of HNT, and the over-expression of 
D-Pax2 in the HNT over-expression reporter line seen in Figure 3.16 does not require Notch 
signaling pathway. 
 This result appears to contradict previous studies that showed HNT is transcriptionally 
activated by Notch, in the muscle progenitor cells (Krejci et al., 2009); however, this could be 
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due to the fact that neural development is a different developmental system. This suggests that 
during muscle development Notch may be needed to activate HNT expression, while in neural 
development, Notch may or may not be needed to inhibit HNT expression. 
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3.5 D-Pax2 expression may be dependent on the level of HNT expression 
 
3.5.1 D-Pax2 expression is not robustly increased using the hnt reporter line 
EP55 
 Double immunostaining of HNT and D-Pax2 on HNT over-expressing embryos did 
reveal a dramatic up-regulation of D-Pax2, but this effect was not observed in all embryos 
(therefore D-Pax2 over-expression was not 100% in daGAL4>UAS-GFP-HNT embryos). To 
address this issue, this experiment was repeated using the hnt reporter line EP55, which is 
associated with a less severe phenotype when expressed in the pupal eye and is associated with 
lower levels of HNT expression. Using EP55 to over express HNT in the embryo with the 
daGAL4 driver did not result in a dramatic up-regulation of D-Pax2 (Figure 3.19).  
 Although there was no immediate obvious change in D-Pax2 expression in 
daGAL4>EP55 embryos, some embryos did appear to show some mild differences. For this 
reason, a statistical analysis of D-Pax2/HNT co-localization and D-Pax2 expression was 
performed. As shown in Figure 3.20 A, the number of D-Pax2/HNT co-localized expressing cells 
compared the control (early stage: 23.2±1.79 cells/per view, middle stage 43.57±9.43 cells/per 
view, and late stage 24.17±6.97 cells/per view) to the EP55 cell count (early stage: 24.3±2.31 
cells/per view, the middle stage: 41.75±2.75 cells/per view, and the late stage: 45.5±16.3 
cells/per view). When compared to the control, statistical analysis of, which HNT and D-Pax2 
were co-localized, cells indicated that there was not a significant difference between EP55 and 
the control at an early to middle stage (p=0.4625 and p=0.7173), but at a later stage there was a 
significant difference (p=0.0199). This suggests that despite there not being a significant 
phenotypic difference in HNT/D-Pax2 co-localized expressing cells between the control and 
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EP55 embryos, EP55 embryos were able to increase the number of co-localized cells at later 
staged embryos.  
Figure 3.20 B compared the amount of D-Pax2 expressing cells in the EP55 embryos at 
the early (5.33±1.53 cells/per view), the middle (13.5±3.41 cells/per view), and the late 
(58.75±8.42 cells/per view) stages, to the control. In comparison, the statistical analysis 
suggested that D-Pax2 expression had significantly increased, in EP55 embryos compared to the 
control, in all stages of development (p<0.05, two-way ANOVA).  
Taken together, this data indicated that even though EP55 did not result in dramatic D-
Pax2 over-expression (as seen in the UAS-GFP-HNT reporter line), there was an increase in the 
number of cells co-expressing HNT and D-Pax2 at later embryonic stages, in addition to an 
increase in the number of cells expressing D-Pax2 throughout all embryonic developmental 
stages.  
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3.5.2 Hindsight over-expression via the UAS-GFP-HNT reporter is greater 
than the EP55 reporter 
 Even though EP55 was able to induce a mild but significant effect on D-Pax2 expression, 
the strong D-Pax2 expression in the UAS-GFP-HNT reporter line was not seen. Despite both 
reporters being HNT over-expression lines, it is possible that the difference between the two 
reporter lines might be the cause behind the significant difference in D-Pax2 expression. To test 
this hypothesis, the HNT expression levels of EP55 and UAS-GFP-HNT was compared under 
identical confocal settings that allowed the HNT expression between these two constructs to be 
directly compared with anti-HNT immunostaining.  
Figure 3.21 demonstrates the difference between HNT expression of these two reporter 
lines, using the same driver daGAL4. The data showed that despite randomly choosing the 
embryos from a larger sample pool, the reporter line UAS-GFP-HNT displayed much stronger 
HNT expression than the EP55 reporter line, suggesting that there might be a threshold level of 
HNT expression that needs to be met to induce the strong over-expression of D-Pax2, as seen 
with the UAS-GFP-HNT reporter line. Especially since daGAL4>EP55 embryos, which from 
Figure 3.21, has lower HNT expression than daGAL4>UAS-GFP-HNT embryos, and was 
unable to produce the same strong D-Pax2 expression.  
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3.5.3 Increasing Hindsight expression in EP55 embryos is unable to give 
strong D-Pax2 expression 
 The greater level of HNT over-expression when using the UAS-GFP-HNT line suggests 
that there could be a threshold level of HNT that needs to be met in order to elicit strong D-Pax2 
expression. To investigate this threshold idea, levels of HNT expression were modulated by 
increasing and decreasing the temperature the genetic crosses were incubated at, to determine if 
it will have an impact on D-Pax2 expression. First, we attempted to over-induce the endogenous 
HNT in the EP55 embryos by temperature shifting it to 29
o
C.  As shown in Figure 3.22, even 
with the temperature shift on EP55, the same level of D-Pax2 over-expression as the UAS-GFP-
HNT reporter line was not phenotypically seen.  
In addition, when comparing the number of HNT/D-Pax2 co-localizing (48.86±8.63 
cells/per view) and D-Pax2 expressing (29.86±5.75 cells/per view) cells in the temperature 
shifted EP55 line to the co-localizing (148±9.43 cells/per view) and D-Pax2 expressing cells 
(61±14.25 cells/per view) in the UAS-GFP-HNT line, the statistical analysis showed that the co-
localized and D-Pax2 cell counts in UAS-GFP-HNT embryos were still significantly higher 
(p<0.05) (Figure 3.23). Demonstrating that just by increasing the temperature the genetic cross is 
incubated at is unable to increase HNT expression enough in EP55 embryos to provide the strong 
level of D-Pax2 expression.  
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3.5.4 Reducing Hindsight expression in the UAS-GFP-HNT line has little 
effect on D-Pax2 expression 
 In addition, we also tried to reduce HNT expression in the UAS-GFP-HNT reporter line 
by temperature shifting it to 18
o
C. Figure 3.24 indicates that at the later development stage there 
is still a strong D-Pax2 over-expression. However, when the HNT/D-Pax2 co-localizing cell 
counts  (early stage: 10±4.58 cells/per view; middle stage: 28.7±5.51 cells/per view;  and late  
stage: 96±37.75 cells/per view) of the UAS-GFP-HNT at 18
o
C,  as shown in Figure 3.25 A, were 
compared to the EP55 at 25
o
C (early  stage: 24.3±2.31 cells/per view, the middle stage: 
41.75±2.75 cells/per view, and the late stage: 45.5±16.3 cells/per view) there was a significant 
difference between the two groups at the early stage (p=0.0084), and at the later stage 
(p=0.0428), with more expression in UAS-GFP-HNT than EP55, but no significant difference 
was found  at the middle stage (p=0.3684). 
 In addition, when comparing the D-Pax2 expression (early stage: 14±1.73 cells/per view; 
middle  stage: 52.3±9.5 cells/per view;  and late  stage: 56.6±7.79 cells/per view) of the UAS-
GFP-HNT at 18
o
C, as shown in Figure 3.25 B, to those of EP55 at 25
o
C,  at both the early and 
middle stages, the UAS-GFP-HNT line still has significantly higher expression of D-Pax2 than 
in the EP55 (p=0.0029 and p=0.0006, respectively); but at the later stage there was no significant 
difference between the two groups (p=0.07031). These results suggest that temperature shifting 
the UAS-GFP-HNT to 18
o
C can reduce the HNT expression enough to have a noticeable effect 
on cells just expressing D-Pax2, but not on cells expressing both HNT and D-Pax2.  
Overall, trying to modulate temperature increases or decreases on HNT expression was 
not sufficient enough to affect the threshold needed to induce strong D-Pax2 expression levels in 
embryos. This suggests that the large amount of HNT expression produced by the 
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daGAL4>UAS-GFP-HNT embryos causes the strong D-Pax2 expression seen in those embryos, 
and perhaps it’s the GFP-HNT construct of the UAS-GFP-HNT reporter line that causes the 
strong D-Pax2 expression.  
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3.5.5 The UAS-GFP-HNT construct is not the cause of the strong D-Pax2 
expression 
 The UAS-GFP-HNT reporter line expresses a GFP-HNT-fusion protein, which could 
stabilize the HNT protein, resulting in the strong D-Pax2 expression. HNT could be an unstable 
protein, and fusing the GFP molecule to the HNT protein could be somehow stabilizing HNT, 
thus allowing for increased D-Pax2 expression.   
To study whether or not the construct contributes to the strong D-Pax2 expression, a 
double antibody stain of HNT and D-Pax2 was done on UAS-GFP-HNT
J18
 embryos. UAS-GFP-
HNT
J18
 has the exact same GFP-fusion construct as the UAS-GFP-HNT, the only difference in 
the UAS-GFP-HNT
J18
 reporter line is that the UAS-GFP-HNT construct was jumped (by Dr. 
Bruce Reed) to a different site of the HNT genome via a genetic P-element mobilization scheme, 
producing a less severe phenotype. The double antibody stain on UAS-GFP-HNT
J18 
embryos, as 
indicated in Figure 3.26, demonstrates that UAS-GFP-HNT
J18 
does not have same D-Pax2 
expression seen in the UAS-GFP-HNT embryos, suggesting that the construct itself does not 
attribute to the strong D-Pax2 expression.  
Figure 3.27 A compares the numbers of the HNT/P-Pax2 co-localizing cells between 
EP55 (41.75±2.75 cells/per view) and UAS-GFP-HNT (148±9.43 cells/per view) to the UAS-
GFP-HNT
J18
 embryos (39.2±4.49 cells/per view), which suggested that there was not statistically 
difference between EP55 and UAS-GFP-HNT
J18
 (p=0.3559). However, when the D-Pax2 
expression of EP55 (13.5±3.41 cells/per view) or UAS-GFP-HNT (61±14.25 cells/per view) was 
compared to UAS-GFP-HNT
J18
 (21.4±5.73 cells/per view), as shown in Figure 3.27 B, there was 
barely a significant difference between EP55 and UAS-GFP-HNT
J18 
(p=0.0463). 
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 Overall, Figure 3.27 suggested there little to no significant difference in the level of 
expression caused between EP55 and UAS-GFP-HNT
J18
. There was a significant difference, 
however, when comparing the co-localized (p<0.05) and D-Pax2 (p<0.05) expressing cells of the 
UAS-GFP-HNT line to EP55 and UAS-GFP-HNT
J18
. The UAS-GFP-HNT reporter line has 
significantly more co-localized and D-Pax2 expressing cells than in EP55 and UAS-GFP-
HNT
J18
, reinforcing the idea that the construct itself is not the cause of the strong D-Pax2 
expression seen in the UAS-GFP-HNT reporter line, and it could still be the high level of HNT 
expression. 
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3.6 Summary: The role of Hindsight in Neuron development  
 Microarray analysis of HNT over-expression embryos has also suggested a role for HNT 
in neural development, and one of the ways HNT could be affecting neural development though 
the regulation of D-Pax2. Overall, there is a general trend for HNT and D-Pax2 expression in 
control embryos whereby they appear to co-localize in early and middle, but not in later staged 
embryos. The separation of cells expressing HNT and D-Pax2 at the later stages of 
embryogenesis appears not to involve Notch signaling, as suggested by the over expression of 
HNT and the lack of D-Pax2 expression in Notch null mutants; which demonstrates that Notch 
may be needed to inhibit HNT but activate D-Pax2 expression. Furthermore, the strong D-Pax2 
expression seen in UAS-GFP-HNT embryos could be due to a threshold effect where a high 
level of HNT expression is needed to induce the dramatic D-Pax2 expression. A model for the 
normal function of HNT might be as a negative regulator of D-Pax2 expression, but when HNT 
is inappropriately over-expressed, HNT could function as an activator of D-Pax2 expression. 
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Chapter 4. Discussion  
  
Microarray analysis has shown that the HNT RNAi depleted reporter line was unable to 
successfully deplete HNT expression, this could be due to the ineffectiveness of the technique on 
Drosophila embryos, or it could also be due to the degree of RNAi depletion of the reporter line 
suggesting that the UAS-HNT-RNAi2A; UAS-HNT-RNAi2B reporter line is not strong enough 
to fully deplete HNT expression. In addition, the microarray analysis of HNT over-expression 
embryos was able to transcriptionally affect many gene targets. Given the physical appearance of 
the HNT over-expression embryos, this could be an indication that development was greatly 
perturbed by over expression HNT, which could have disrupted some of the core signaling 
pathways, such as Notch signaling, thus causing the significant number of microarray targets 
affected by HNT over-expression.  
 
4.1 Muscle Development during embryogenesis 
 
4.1.1 Down-regulation of muscle identity genes by Hindsight  
This study showed that HNT may not be required for the proper development of muscle 
fibres, evidenced by the lack of significant muscle defects, represented by F-actin, in the HNT 
null mutant; however, over expressing HNT may affect muscle development by acting on the 
muscle founder cells. This hypothesis is supported by the microarray data which showed that 
over expressing HNT can down-regulate the expression of a number of muscle identity genes, 
including even skipped (eve), nautilus (nau), vestigial (vg), slouch (slou), and Pox meso (poxm). 
Muscle identity genes are usually activated in muscle founder cells, which derive all individual 
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larval muscles (Tixier et al., 2010). One potential mechanism by which HNT over-expression 
could down-regulate muscle identity gene expression is through the Notch signalling pathway. 
HNT has been documented to be a target of Notch signaling, and in addition, other research has 
shown that HNT can also regulate Notch signaling, such as in cone cells of the pupal eye 
imaginal disc (Pickup et al., 2002; Sun & Deng, 2007). 
 Notch and Delta expression are strongly expressed in subsets of mesodermal cells during 
early muscle differentiation, and Notch signaling is required by mesoderm cells to establish the 
proper ratio of muscle founders by lateral inhibition (Corbin et al., 1991; Kooh, Fehon, & 
Muskavitch, 1993). Mutations in the Notch-Delta signalling pathway have been found to affect 
that ratio of muscle founder cells to fusion competent myoblasts. Notch and Delta loss of 
function mutants display muscle founder hypertrophy, where the number of founder cells is 
increased, and the fusion-competent myoblasts are reduced (Bate, 1990; Corbin et al., 1991; 
Stute, Schimmelpfeng, Renkawitz-Pohl, Palmer, & Holz, 2004). However, when an activated 
form of Notch is expressed in the mesoderm, muscle founder cell hypotrophy is observed. 
Activated Notch protein has been found to strongly inhibit myoblast fusion and can repress 
transcription of putative muscle founder determinants (Baker & Schubiger, 1996).  
 The hypotrophy of muscle founder cells can result in the down-regulation of the muscle 
identity genes; a phenotype that is similar to that of HNT over-expression in this study. Krejci et 
al. also reported that myoblast phenotypes associated with HNT over-expression are similar to 
those associated with excessive activated Notch (Krejci et al., 2009). This suggests that over-
expressing HNT could be activating the Notch signaling in muscle founder cells, which could 
subsequently down-regulate muscle identity gene expression.  
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One potential mechanism by which HNT could activate Notch is by up-regulating Delta 
expression.  In the cone cells of the Drosophila larval eye disc, induction by the R1/R6 
photoreceptor precursors requires the integration of the Notch-Delta signalling pathway (Pickup, 
Ming, & Lipshitz, 2009). HNT is required in the R1/R6 precursor cells to elevate Delta ligand 
concentration to a high-enough level that is sufficient to activate the Notch receptor in the 
adjacent cell (Pickup et al., 2009). Thus, if HNT can up-regulate Delta in the photoreceptor 
precursor cells, over-expressing HNT could potentially elevate Delta past a threshold, resulting 
in an over-activation of Notch signaling in muscle founder cells.  However, further research into 
how HNT and Notch-Delta could interact in the muscle precursors is required.    
 
4.1.2 Down-regulating muscle identity genes by Hindsight through Jelly Belly  
 An alternative mechanism by which HNT down-regulates muscle identity genes is 
through Jelly belly (Jeb) signalling. Jeb encodes a protein that is produced from somatic 
mesodermal cells and taken up by the visceral muscle cells of the Drosophila midgut (Weiss, 
Suyama, Lee, & Scott, 2001). The microarray results in this study also showed that over-
expressing HNT was able to up-regulate Jeb expression 2.619 fold, compared to the control.  
 During gastrulation, mesodermal cells are subdivided into two main types of 
musculature: the somatic and visceral muscles (Hosono, Takaira, Matsuda, & Saigo, 2003). 
Drosophila midgut visceral muscles arise by the fusion of founder cells and fusion-competent 
myoblasts, similar to the formation of the somatic muscles (San Martin, Ruiz-Gómez, Landgraf, 
& Bate, 2001). Mutations in Jeb cause a loss of visceral midgut muscles, resulting in a 
phenotype whereby the visceral mesoderm consists only of fusion-competent myoblasts and is 
devoid of muscle founder cells (Stute et al., 2004); suggesting that the process of founder cell 
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determination in the visceral mesoderm depends on Jeb signalling. Moreover, it has been 
demonstrated that somatic mesoderm determination of the fusion-competent myoblasts, also 
depends on Jeb (Stute et al., 2004). In that sense, Jeb signalling may be involved in crosstalk 
between the somatic and visceral mesoderm, which could be a mechanism by which over-
expressing HNT is able to down-regulate muscle identity genes in the somatic muscle founder 
cells and affect muscle development. However, further investigation needs to examine how HNT 
and the Jeb signaling pathway are interacting before coming to more definite conclusions.  
 
4.2 Neuron development during embryogenesis 
 The microarray result, confirmed by FISH and immunohistochemical staining, indicates 
that HNT over-expression can lead to an up-regulation of D-Pax2. In wild type development, 
HNT and D-Pax2 are initially co-localized in the embryonic SOPs. Throughout the subsequent 
development of the embryonic PNS, HNT and D-Pax2 are not substantially co-localized but 
show complementary expression patterns with HNT being expressed with in the neuronal lineage 
whereas D-Pax2 expression is associated with various accessory cells.  
Given these observations it is compelling to suggest that HNT and D-Pax2 display 
complex regulatory interactions. For example, high levels of HNT expression are capable of 
dramatically up-regulating D-Pax2, but the pattern of expression in later stage embryos would 
suggest that the normal role of HNT does not involve D-Pax2 up-regulation, but rather down-
regulation.  
In addition, 22C10 staining of the HNT null mutant suggested that HNT may be required 
for some aspect of neural development, at least in regards to chordotonal (Ch) development. 
HNT’s involvement in neural development is also supported by two independently conducted 
92 
 
genome wide screens, each of which reported strong HNT expression in SOPs of the larval wing 
imaginal disc and the pupal notum (Buffin & Gho, 2010; Reeves & Posakony, 2005). 
 HNT’s involvement in neural development could also involve the Notch signaling 
pathway. Anti-HNT and Anti-D-Pax2 double antibody staining of the Notch mutant embryos 
demonstrated a large amount of HNT expression, and since the over-expression of HNT 
resembles the 22C10 stain pattern in the Notch null, as indicated by the neurogenic clusters, 
neuronal hypertrophy seen with the 22C10 stain can also be a reflection of an over-expression of 
HNT in neural cells. This could suggest that the Notch signaling pathway could be needed to 
inhibit HNT expression during neural development, or HNT could function as an antagonist of 
Notch signaling. However, Notch signaling is not needed for the interaction between HNT and 
D-Pax2.  
Overexpression of HNT using the UAS-GFP-HNT reporter line was able to significantly 
increase the amount of cells expressing D-Pax2. However, how the UAS-GFP-HNT reporter line 
manages to increase the levels of D-Pax2 expression is still unknown, given that modulating 
HNT expression levels does not increase the D-Pax2 expression in EP55 embryos to the level of 
the UAS-GFP-HNT embryos, nor is the GFP HNT fusion protein involved in increasing the D-
Pax2 expression levels.  
In addition, the effects seen by the HNT over-expression embryo could just be the result 
of the massive amount of HNT over-expression. At the same time, the interaction between HNT 
and D-Pax2 may not be an artifact of the massive HNT over-expression, which could cause HNT 
to behave as an activator, where it would normally function as a repressor.  
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4.2.1 How Hindsight could be affecting neural development 
 Sensory organ development in the peripheral nervous system (PNS) and in microchaete 
bristles is initiated by restricting the expression of proneural genes to define a proneural cluster 
(PNC). The cluster consists of cells that have the potential to development into SOP cells, since 
they all express the basic-helix-loop-helix transcription factors encoded by the achaete-scute 
complex (Cabrera, Martinez-Arias, & Bate, 1987; Cubas, de Celis, Campuzano, & Modolell, 
1991; Romani, Campuzano, & Modolell, 1987; Skeath & Carroll, 1991). SOP cells are then 
specified within each PNC by lateral inhibition mediated by Notch signalling (Cabrera, 1990; 
Hartenstein & Posakony, 1990; Simpson, 1990). Therefore, neural patterning depends on two 
opposing forces, the proneural bHLH genes driving neural determination, and Notch signalling 
opposing them in certain cells.  
 The division of SOP into external sense (es) organ cell types  is mediated by the genes 
Notch-Delta, Numb, and Hairless (Schweisguth & Posakony, 1994). Notch and Delta are 
required in the es organs for the directional inhibitory effect of Notch signaling, in a process 
known as lineage decisions, between es organ cell types, while Numb and Hairless provide 
resistance to, or antagonize, the inhibition. This interaction is so important that the complete loss 
of Notch or Delta causes all the progeny cells to adopt the neuron fate (Hartenstein & Posakony, 
1990; Parks & Muskavitch, 1993), while the loss of Numb or Hairless results in all four cells 
developing into socket cells (Bang, Hartenstein, & Posakony, 1991; Rhyu, Jan, & Jan, 1994).  
D-Pax2 is a key player in the differentiation of es organ cell types, in the bristles (Fu, 
Duan, Frei, & Noll, 1998). During es organ development, D-Pax2 protein is present in the SOP a 
few hours after it is selected from the PNC. Shortly after it is detectable, the SOP divides and D-
Pax2 is present in all of the cells of the es organ lineage throughout the divisions (Kavaler, Fu, 
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Duan, Noll, & Posakony, 1999). The early expression of D-Pax2 in the SOP lineage is initiated 
by the activity of proneural proteins, such as Achaete and Scute, which are also required for the 
specification of SOP es organs, in peripheral nervous system and bristle development (Villares & 
Cabrera, 1987).  
 Immunostaining of Notch mutant embryos demonstrates abundant HNT expression, and 
in the absence of Notch signaling HNT expression is not prevented in neurogenic tissues. This 
suggests that HNT may be expressed in the PNC, of the embryonic PNS, before being confined 
by Notch into individual SOP cells. Furthermore, in the absence of HNT expression there 
appears to be a defect in PNS development, suggesting that HNT may be required in the SOP for 
the differentiation of es and/or Ch organs. Especially since the differentiation of es organs 
requires inhibitory effects of Notch, which suggests that Notch may be needed to repress HNT 
expression in one of the es organs, for the differentiation of either the SOP to pIIa and pIIb, or 
even the differentiation of pIIa and pIIb to their respective cells. Overexpressing HNT may then 
prevent the directional inhibitory effects of Notch, in lineage decisions, which can prevent the 
differentiation of SOP into some of the es organ cells. However, identification of the type of es 
cells produced in the presence of HNT over-expression is needed before it can be concluded 
what the role HNT plays in neural development.  
 
4.2.2 How Hindsight may be effecting D-Pax2 expression  
 Overexpressing HNT was shown to largely increase the number of cells expressing both 
D-Pax2 and HNT, along with cells just expressing D-Pax2. This suggests that HNT is present in 
proneural cells, but when HNT expression is initiated in the proneural cells is unknown; 
therefore, over-expressing HNT could potentially increase the expression of proneural genes, 
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such as scute (sc). Interestingly, increased sc expression was also seen in the microarray analysis 
of HNT over-expression embryos and confirmed by FISH.  sc is a member of the achaete-scute 
complex (Cabrera et al., 1987; Cubas et al., 1991; Romani et al., 1987; Skeath & Carroll, 1991), 
and up-regulating sc could increase the number of proneural cells driving neural determination, 
which could reduce SOP specification as mediated by Notch signaling pathway through lateral 
inhibition (Simpson, 1997). Decreasing lateral inhibition could lead more cells being defined as 
SOP’s, instead of being inhibited by Notch and becoming epithelial cells. Furthermore, 
increasing the number of SOP cells could also increase the amount of D-Pax2 expressing cells, 
which is regulated by proneural proteins in the SOP. This notion is possibly since ectopic 
expression of sc has been found to lead to the early activation of D-Pax2 expression (Kavaler et 
al., 1999). Therefore, over expressing HNT could be affecting proneural gene expression, which 
could then affect D-Pax2 expression, and thus increase the amount of co-localization of D-Pax2 
and HNT.   
 An alternative mechanism by which the over-expression of HNT could affect neural 
development and D-Pax2 expression is through Bearded (Brd). Brd is involved in sensory organ 
development and was found to be up-regulated by the HNT over-expression in the microarray 
analysis. Brd antagonizes Notch signaling pathway in cell fate decisions during adult sensory 
organ development (E. C. Lai et al., 2000). Therefore, if HNT over-expression up-regulates Brd, 
Brd could then down-regulate the Notch signalling pathway, which could either increase 
unspecified SOP cells and/or force the es organs to differentiate into sensory neurons 
(Hartenstein & Posakony, 1990; Parks & Muskavitch, 1993). A down-regulation of Notch 
signaling could account for the large number of cells co-expressing HNT and/or D-Pax2, since 
D-Pax2 is expressed in all es organs, and HNT is expressed in SOP cells (Buffin & Gho, 2010; 
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Reeves & Posakony, 2005). Down-regulating Notch could also explain the observation of cells 
just expressing D-Pax, since D-Pax2 expression in those cells could be a product of other 
asymmetric divisions not dependent on Notch, such as Numb and Hairless, which could also 
allow some differentiation of es organs (Schweisguth & Posakony, 1994). However, an 
examination of the type of neural cells in the HNT over-expression mutant needs to be analyzed 
before determining the precise relationship between HNT and D-Pax2.  
 
4.3 Conclusion 
In conclusion, over-expressing HNT could be affecting embryonic muscle development 
by over activating the Notch signaling in muscle founder cells, which could down-regulate the 
expression of muscle identity genes. Alternatively, HNT could be down-regulating Jeb 
signalling, which is involved in founder cell determination in the visceral mesoderm, and given 
the potential crosstalk between the somatic and visceral mesoderm, HNT could also be down-
regulating somatic muscle identity genes through Jeb signaling.  
In addition, HNT may also be involved in the development of neurons, since Notch 
signaling may be required to inhibit HNT expression in SOP cells, which could suggest a role for 
HNT in the differentiation of SOPs. Furthermore, overexpressing HNT can up-regulate proneural 
gene expression, which could increase D-Pax2 expression by increasing the amount of neuron 
cells, and/or alternatively, overexpressing HNT could also up-regulate Brd, which antagonizes 
the Notch signalling pathway, and that could prevent SOP cells from differentiating into es 
organs and remain as SOP cells, and increase the expression of D-Pax2.  
 Ultimately, however, how representative over-expressing HNT is of normal HNT 
expression in embryonic muscle and neural development would need to be determined.  
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 Chapter 5. Future directions  
 
5.1 Further directions with Microarray Data 
With such a large amount of data collected from the microarray analysis, another logical 
step would be to investigate what effects HNT may have on other developmental systems. For 
example, in the presence of HNT over-expression, a number of genes related to morphogenesis 
were under-expressed, while a number of genes related to sensory and olfactory development 
were over-expressed. The role of HNT in morphogenesis is expected since it is known to down-
regulate the JNK pathway in the amnioserosa, which is required for the successful completion of 
GBR and DC (Reed et al., 2001; Yip et al., 1997). However, the functions of HNT for sensory 
and olfactory development have not yet been investigated, and could be an avenue of 
investigation for the future studies.  
 
5.2 Muscle development  
 The presence of HNT in muscle progenitor cells suggests a role for HNT in muscle 
differentiation. However, due to the broad screen conducted with the microarray analysis, it is 
difficult to pinpoint out exactly how over-expressing HNT can affect muscle development 
through the muscle progenitor cells. One way to determine how over-expressing HNT can affect 
muscle development is by staging the embryos and antibody staining for different muscle 
progenitors and differentiated muscles. Staging the embryos on a per hour or even half an hour 
basis, and then antibody staining them for different identity genes and differentiated muscles can 
determine the how over-expressing HNT may be affecting muscle founder cells at different 
embryonic stages.  
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Furthermore, investigation into potential interaction of HNT with the jelly belly signalling 
pathway can reveal if any form of crosstalk between the developing visceral muscles can affect 
the development of the somatic muscles.  
 
5.3 Neuron development  
 The expression of HNT in SOP suggests a role for HNT in neural development; however, 
the UAS-GFP-HNT over-expression reporter line produces a very severe developmental 
mutation that prevents the precise dissection of HNT activities. The EP55 over-expression 
reporter line was able to induce a less severe phenotype, than the UAS-GFP-HNT line, and had 
significantly more HNT and D-Pax2 co-localizing and D-Pax2 expressing cells, than the control. 
The EP55 line could then be used to identify the potential role HNT in the differentiation of SOP 
into es organs, since the EP55 embryos wouldn’t be arrested in development, and staining for the 
types of es organs could provide information on SOP differentiation, if any. Furthermore, es 
organ staining in the HNT null or knockout mutants may also help determine what could be 
differentiated from a lack of HNT expression.  
 To determine the differences between the UAS-GFP-HNT and EP55 reporter lines, which 
have a significant difference in D-Pax2 expression; these two reporter lines can be genetically 
sequenced and compared. Sequencing the UAS-GFP-HNT line can also provide information on 
what part of the fourteen zinc fingered gene is disrupted by the construct, and if the construct is 
disrupting any potential binding or enhancer sites that can affect D-Pax2 expression. In addition, 
to confirm whether or not D-Pax2 is a direct or indirect target of HNT, any potential HNT 
binding sites on the D-Pax2 gene could be investigated. In line with that investigation, potential 
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HNT binding sites could also be determined for proneural genes, such as scute and Bearded, to 
see if HNT is directly affecting their expression, which can then affect D-Pax2 expression.  
 As mentioned in the discussion, there is the possibility that over expressing HNT may 
cause it to behave as an activator, instead of a repressor. One way to test this would be to turn 
HNT from a repressor into an activator by creating a VP16-HNT fusion protein. This technique 
allows detection of dominant defects associated with the miss-expression of genes that are 
normally negatively regulated by a given transcription factor (Wildonger & Mann, 2005).  
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Appendix A. Genetic Lines  
 
Stock Lines Source 
Driver  
w[*] P{w[+mW.hs]=GawB}NP3312 
+Apoliner / FM7c 
NP3312 from Drosophila Genetic Resource 
Center, Kyoto Institute of Technology; 
Recombinant made in BH Reed  Lab 
NP3312; [Dp(1,2)4FRDup](UAS-mCherry-
GFP-DrAtg8a) 
Dp from Dr. Helen Salz, Case Western 
Reserve University, Ohio; DrAtg8a from Dr. 
Harald Stenmark, Norwegian Radium 
Hospital, Oslo; Recombinant made in BH 
Reed Lab 
w; (YET1); daGAL4  YET1 from Dr. Alan M. Michelson, Harvard 
Medical School; Recombinant made in BH 
Reed Lab 
KrGAL4+UASGFPClc5/TM3 Recombinant made in BH Reed Lab 
NP3312; Dp/+ Recombinant made in BH Reed Lab 
w;Cherry;daGAL4+Spider/TM3,Ser Spider from Dr. Antonio Jacinto, Instituto de 
Medicina Molecular, Portugal; Recombinant 
made in BH Reed Lab 
DmefGAL4>UASmoesinCherry/TM3 Dr. Roger Jacobs, McMaster University 
Delta-GAL4/TM6 Bloomington Drosophila Stock Center, 
Indiana University 
RP298-GAL4 Dr. Aaron Johnson, University of Colorado 
P{da-GAL4.w
-
}3 Bloomington Drosophila Stock Center, 
Indiana University 
Reporter Lines, Controls, and Loss of 
Function Alleles 
 
yw
67
 Bloomington Drosophila Stock Center, 
Indiana University 
UASGFPHNT Dr. Howard Lipshitz, University of Toronto 
UASGFPHNT;GAL80
ts
 Dr. Howard Lipshitz, University of Toronto 
UASHNTRNAi2A; UASHNTRNAi2B Dr. Howard Lipshitz, University of Toronto 
UAS Dicer; UAS HNTRNAi[2B] Dr. Howard Lipshitz, University of Toronto 
EP55 Drosophila Genetic Resource Center, Kyoto 
Institute of Technology 
EP55; dpplacZ
10638
/CYO Recombinant made in BH Reed Lab 
Notch
55e11
 P{neoFRT}19A/FM7c Bloomington Drosophila Stock Center, 
Indiana University 
hnt
XE81
 Dr. Howard Lipshitz, University of Toronto 
w
1118
; P{UAS-GFP.nls}14 Bloomington Drosophila Stock Center, 
Indiana University 
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Appendix B. Microarray Analysis of Hindsight Over-expression 
embryos compared with the Control  
 
Transcript 
FBtr ID  Gene ID 
Official 
Symbol  Official Name  
Control - 
linear 
value 
Over 
expression - 
linear value 
P value 
before 
FDR 
P value 
after 
FDR 
FBtr0070003 CG32825-RA Or19b Odorant receptor 19b 
2561.851 7166.968 9.12x10^-7 0.000363 
FBtr0070031 CG15323 
  
82.756 340.03 7.39E-05 0.00373 
FBtr0070032 CG9571-RA fd19B forkhead domain 19B 283.48 1073.041 0.000255 0.00707 
FBtr0070036 CG12655-RA 
  
521.428 1432.637 0.000519 0.0102 
FBtr0070071 CG3757-RA y  yellow 507.008 2360.99 0.000345 0.00812 
FBtr0070073 CG3827-RA sc scute 409.018 1658.865 3.23E-05 0.00243 
FBtr0070080 CG17778-RA 
  
367.186 1617.892 0.00013 0.00514 
FBtr0070100 CG13374-RA pcl pepsinogen-like 730.305 3062.925 1.61E-05 0.00178 
FBtr0070101 CG32816-RB 
  
2861.966 7164.915 0.00434 0.0334 
FBtr0070139 CG12311-RA tw 
Protein O-
mannosyltransferase 
2 
14534.024 6933.533 0.000774 0.0126 
FBtr0070200 CG14626-RA 
  
1390.227 625.27 0.0075 0.0471 
FBtr0070238 CG11409-RB 
  
3442.178 1256.41 0.0011 0.0148 
FBtr0070271 CG14797 
  
1056.052 475.746 0.000468 0.00959 
FBtr0070328 CG4194-RA 
  
7907.114 3882.99 0.00614 0.0411 
FBtr0070385 CG3630-RA 
  
1510.656 708.163 0.000264 0.00715 
FBtr0070450 CG8310-RA Vha36-3 
Vacuolar H+ ATPase 
subunit 36-3 
1485.848 644.635 0.0022 0.0222 
FBtr0070462 CG12496-RA 
  
783.76 1583.7 0.000275 0.00722 
FBtr0070490 CG2759-RA w white 1313.361 4304.997 0.000142 0.00537 
FBtr0070531 CG16782-RA Pig1 Pre-intermoult gene 1 743.947 247.179 0.000441 0.00921 
FBtr0070547 CG3588 
  
5755.557 2306.739 3.07E-05 0.00241 
FBtr0070549 CG3588 
  
707.375 207.16 0.00132 0.0164 
FBtr0070558 CG3603-RA 
  
1152.963 2663.342 0.000245 0.00694 
FBtr0070575 CG2872-RB AlstR Allatostatin Receptor 92.596 358.611 0.000448 0.00929 
FBtr0070631 CG2913-RA yin 
 
3293.004 1449.079 0.000816 0.0129 
FBtr0070674 CG3556-RA 
  
1250.879 2585.093 0.00548 0.0382 
FBtr0070680 CG12212-RA peb pebbled 10338.607 32084.384 0.000495 0.00993 
FBtr0070691 CG3052-RA HLH4C 
Helix loop helix 
protein 4C 
837.183 413.947 0.00439 0.0335 
FBtr0070720 CG32770 
  
488.459 1003.656 0.0004 0.00874 
FBtr0070755 CG3315-RA TrxT Thioredoxin T 50.464 123.644 0.00607 0.0408 
FBtr0070777 CG15784-RA 
  
552.388 7436.943 0.000235 0.00682 
FBtr0070778 CG16752-RA SPR Sex peptide receptor 1221.939 485.677 0.00131 0.0163 
FBtr0070805 CG4096 
  
714.61 271.369 7.59E-05 0.00377 
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FBtr0070836 CG3097-RA 
  
8529.57 3900.498 0.00461 0.0345 
FBtr0070861 CG6041-RA 
  
908.047 2290.561 0.00449 0.0338 
FBtr0070866 CG5966-RA 
  
3963.024 1861.028 0.00182 0.02 
FBtr0070881 CG32750-RA 
  
1923.211 799.998 0.00131 0.0163 
FBtr0070888 CG4690-RA Tsp5D Tetraspanin 5D 1030.399 337.711 0.0029 0.0261 
FBtr0070891 CG4766-RA 
  
637.676 127.124 0.000139 0.00537 
FBtr0070960 CG14439-RA 
  
879.507 3701.006 8.18E-05 0.00388 
FBtr0071078 CG15478-RA 
  
280.49 128.896 5.88E-05 0.00324 
FBtr0071106 CG1571-RA 
  
182.186 88.61 0.000663 0.0115 
FBtr0071170 CG1632-RA 
  
3724.639 1389.816 0.000396 0.00869 
FBtr0071178 CG15343-RA 
  
471.684 1459.771 1.11x10^-6 0.000377 
FBtr0071186 CG10759-RA Or7a Odorant receptor 7a 
46.7 393.678 1.52x10^-6 0.00044 
FBtr0071193 CG15335-RB cyr cypher 1006.372 401.73 4.06E-05 0.00275 
FBtr0071201 CG15350-RA Cp7Fb 
Chorion protein b at 
7F 
85.997 32.724 1.98E-05 0.00196 
FBtr0071202 CG15351-RA Cp7Fc 
Chorion protein c at 
7F 
158.242 74.368 0.00197 0.0209 
FBtr0071203 CG1478-RA Cp36 Chorion protein 36 75.448 33.272 0.00256 0.0243 
FBtr0071213 CG11265-RE Trf4-1 
 
8558.762 33.544 1.66x10^-7 0.000204 
FBtr0071243 CG32713-RA 
  
200.889 466.089 0.000159 0.00557 
FBtr0071244 CG11202-RA org-1 
optomotor-blind-
related-gene-1 
4906.405 2037.306 0.00259 0.0245 
FBtr0071249 CG1787-RA Hexo2 Hexosaminidase 2 
4961.791 14251.948 1.19x10^-7 0.000203 
FBtr0071310 CG15370-RA 
  
3194.228 1170.536 0.00546 0.0381 
FBtr0071311 CG15371-RA Gr8a Gustatory receptor 8a 268.337 42.34 0.000017 0.00182 
FBtr0071335 CG12120-RA t tan 3576.465 1156.47 0.000971 0.0138 
FBtr0071386 CG32698-RA 
  
428.459 1242.946 1.85E-05 0.00189 
FBtr0071390 CG9689-RA 
  
2187.699 684.573 0.00547 0.0381 
FBtr0071395 CG1986-RA 
  
2051.627 498.775 0.00118 0.0154 
FBtr0071397 CG15247-RA 
  
290.019 89.025 0.00155 0.018 
FBtr0071434 CG12644-RA 
  
125.453 416.499 0.000109 0.00462 
FBtr0071436 CG15311-RA 
  
253.289 833.526 0.00134 0.0164 
FBtr0071457 CG32680 
  
2855.571 1273.203 0.00187 0.0203 
FBtr0071463 CG32683-RA 
  
37.064 80.3 0.00288 0.0259 
FBtr0071480 CG32682 
  
445.246 944.894 0.000265 0.00714 
FBtr0071502 CG11556-RA Rph Rabphilin 294.427 602.363 0.000512 0.0101 
FBtr0071516 CG9236 
  
273.277 662.491 0.00236 0.0231 
FBtr0071542 CG10531-RA Cht9 
 
340.299 2214.1 0.000345 0.00813 
FBtr0071543 CG3986-RA Cht4 Chitinase 4 55.301 1059.678 0.000037 0.00263 
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FBtr0071544 CG30293-RA Cht12 
 
37.807 193.374 0.000853 0.0131 
FBtr0071557 
 
otp 
 
3138.35 1482.026 0.000439 0.0092 
FBtr0071558 
 
otp 
 
311.968 140.739 0.00174 0.0194 
FBtr0071560 CG9993-RA 
  
709.212 246.686 1.37E-05 0.00166 
FBtr0071561 CG17999-RA 
  
542.426 179.916 4.45E-05 0.0029 
FBtr0071566 CG15655 
  
1166.742 351.263 0.00569 0.0391 
FBtr0071579 CG9441-RC Pu Punch 7011.286 3179.657 0.00368 0.03 
FBtr0071580 CG9441-RA Pu Punch 9871.097 4373.77 0.000186 0.00603 
FBtr0071664 CG15675 
  
651.617 2435.4 0.000285 0.00736 
FBtr0071665 CG15675 
  
616.383 2805.109 7.21E-05 0.00365 
FBtr0071669 CG30263 
  
174.27 623.403 0.00638 0.0421 
FBtr0071675 CG17922-RA 
  
448.785 1107.877 0.000585 0.0107 
FBtr0071693 CG30283 
  
2787.879 1317.951 3.81E-05 0.00266 
FBtr0071740 CG4363-RA 
  
99.363 301.698 0.00312 0.0271 
FBtr0071741 CG13492 
  
1884.795 4868.785 0.00619 0.0414 
FBtr0071745 CG4402-RA lox2 lysyl oxidase-like 2 136.084 48.568 9.81E-05 0.00433 
FBtr0071768 CG30279-RA 
  
152.033 485.926 3.98E-05 0.00272 
FBtr0071777 CG3380-RA 
Oatp58D
c 
Organic anion 
transporting 
polypeptide 58Dc 
3422.07 1459.041 0.00277 0.0256 
FBtr0071786 CG11170-RB 
  
1163.862 2413.657 0.00184 0.0201 
FBtr0071798 CG13502  
  
32.304 70.263 0.000743 0.0123 
FBtr0071799 CG13502-RA 
  
148.032 385.523 6.02E-05 0.00328 
FBtr0071823 CG6044-RA 
  
317.861 1131.064 3.53x10^-6 0.000737 
FBtr0071825 CG6044  
  
174.479 664.735 0.000046 0.0029 
FBtr0071826 CG33200-RA ventrally-expressed-protein-D 
1510.599 4797.15 3.21x10^-6 0.000678 
FBtr0071829 
 
rad50 
 
280.519 572.857 0.00348 0.0291 
FBtr0071831 CG10384 
  
507.553 229.009 0.00644 0.0424 
FBtr0071858 CG33143-RC 
  
307.595 628.355 0.00776 0.0481 
FBtr0071886 CG30271  
  
99.363 1163.325 2.33x10^-6 0.00053 
FBtr0071887 CG30266 
  
39.961 308.383 4.82x10^-7 0.000306 
FBtr0071888 CG30274 
  
146.963 560.018 1.97E-05 0.00196 
FBtr0071889 CG30264 
  
430.229 1321.269 7.99x10^-6 0.00127 
FBtr0071925 CG30217 
  
1636.394 737.34 0.0021 0.0216 
FBtr0071926 CG30217 
  
839.764 394.722 0.00293 0.0262 
FBtr0071931 CG30195-RA 
  
2125.541 791.658 0.00584 0.0398 
FBtr0071934 CG4414-RA Ugt58Fa 
 
7562.125 3303.059 0.00128 0.0161 
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FBtr0071979 CG9876-RA 
  
640.498 170.195 0.00375 0.0304 
FBtr0071986 CG9895 
  
590.025 193.042 0.00019 0.00613 
FBtr0072024 CG9815-RA 
  
467.678 120.813 0.000346 0.00813 
FBtr0072049 CG9871-RA 
RpL22-
like 
Ribosomal protein 
L22-like 
135.12 312.446 0.000123 0.00497 
FBtr0072057 CG13559-RA 
  
531.635 179.077 0.00199 0.021 
FBtr0072059 CG33150-RA Gr59f 
Gustatory receptor 
59f 
450.401 217.692 0.00108 0.0148 
FBtr0072079 CG5428 
  
4271.992 1446.046 0.00569 0.0391 
FBtr0072081 CG11293-RA 
  
199.438 91.656 0.00381 0.0306 
FBtr0072094 CG18128-RA 
  
1195.14 504.975 0.00186 0.0202 
FBtr0072117 CG17632-RA bw brown 5184.529 1986.156 0.00289 0.0259 
FBtr0072131 CG5597-RA 
  
1355.88 3124.924 0.000309 0.00759 
FBtr0072135 CG13562-RA 
  
1142.279 394.918 0.00293 0.0262 
FBtr0072150 CG3006-RA Fmo-1 
Flavin-containing 
monooxygenase 1 
568.412 274.311 0.00263 0.0246 
FBtr0072161 CG3121-RA 
  
77.866 34.897 0.000221 0.0066 
FBtr0072181 CG30174 
  
245.782 66.846 0.00346 0.0291 
FBtr0072182 CG30179 
  
360.753 99.797 0.00221 0.0222 
FBtr0072197 CG4324-RA 
  
4446.73 2083.961 0.00185 0.0202 
FBtr0072239 CG4797-RB 
  
151.204 487.734 0.000868 0.0132 
FBtr0072243 CG13561-RA 
  
44.689 102.363 0.00034 0.00801 
FBtr0072246 CG13564-RA 
  
141.488 62.766 0.0042 0.0327 
FBtr0072257 CG3328-RA 
  
2890.999 1140.161 0.000472 0.00966 
FBtr0072289 CG13578-RA 
  
77.253 353.772 0.00072 0.0121 
FBtr0072329 
 
Mmp1 
 
648.752 1378.955 5.53E-05 0.00314 
FBtr0072370 CG9196-RA spz6 spatzle 6 14377.297 6414.548 0.000784 0.0126 
FBtr0072371 CG3880-RA 
  
1687.142 816.818 0.00707 0.0454 
FBtr0072419 CG2857-RA Tpc2 
Thiamine 
pyrophosphate carrier 
protein 2 
90.038 269.288 0.000202 0.00628 
FBtr0072427 CG2928-RA Reg-5 
Rhythmically 
expressed gene 5 
6834.91 3193.374 0.000947 0.0138 
FBtr0072441 CG4871-RB ST6Gal Sialyltransferase 71.101 245.246 0.000405 0.00883 
FBtr0072442 CG4871-RA ST6Gal Sialyltransferase 103.052 271.692 0.00102 0.0142 
FBtr0072443 CG3441-RA Nplp1 
Neuropeptide-like 
precursor 1 
1158.546 3545.543 1.32x10^-6 0.000417 
FBtr0072462 CG32475-RA mthl8 methuselah-like 8 59.507 22.58 0.00142 0.017 
FBtr0072501 CG32476-RA mthl14 methuselah-like 14 666.324 1354.203 0.00103 0.0143 
FBtr0072507 CG12313-RA ttm2 tiny tim 2 57.639 126.99 0.00024 0.00693 
FBtr0072561 CG3200-RA Reg-2 
Rhythmically 
expressed gene 2 
1032.819 488.102 5.17x10^-6 0.000984 
FBtr0072594 CG12191-RA dpr20 
 
170.57 383.253 0.000352 0.00824 
FBtr0072625 CG13912-RA 
  
4036.46 1870.019 0.00636 0.042 
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FBtr0072636 CG32335 
  
759.402 3941.544 6.11x10^-6 0.00104 
FBtr0072651 CG9194-RA 
  
6907.21 2645.562 0.00567 0.039 
FBtr0072659 CG9134-RB 
  
4781.431 1656.229 0.00439 0.0335 
FBtr0072660 CG9134-RA 
  
752.798 239.432 0.00279 0.0257 
FBtr0072765 CG7991 
  
2245.562 1021.103 6.24E-05 0.00333 
FBtr0072796 CG18173-RA 
  
722.281 3667.313 5.16x10^-7 0.000316 
FBtr0072801 CG13932 
  
301.289 91.705 0.00448 0.0338 
FBtr0072802 CG13931-RA 
  
1236.696 566.552 0.000859 0.0131 
FBtr0072836 CG12026-RB Tmhs 
Tetraspan membrane 
protein in hair cell 
stereocilia ortholog 
3271.891 1500.601 0.000907 0.0135 
FBtr0072837 CG12026-RA Tmhs 
Tetraspan membrane 
protein in hair cell 
stereocilia ortholog 
211.507 67.777 0.00258 0.0245 
FBtr0072869 CG1919-RA Cpr62Bc 
Cuticular protein 
62Bc 
3228.655 7617.714 0.00656 0.043 
FBtr0072879 CG13806-RA 
  
1926.808 706.004 0.0033 0.0281 
FBtr0072886 CG13802-RA 
  
54.427 128.37 0.00181 0.02 
FBtr0072950 CG12002-RB Pxn Peroxidasin 91.063 36.522 0.000972 0.0138 
FBtr0072951 CG12002-RA Pxn Peroxidasin 10956.995 4437.229 0.000036 0.00262 
FBtr0072954 CG12002-RE Pxn Peroxidasin 9393.22 3728.96 0.0022 0.0222 
FBtr0072979 CG2113-RA 
  
32.756 68.99 0.00162 0.0186 
FBtr0073051 CG14960-RA 
  
10289.053 4116.817 0.00439 0.0335 
FBtr0073052 CG12017-RA 
  
9299.702 3881.251 0.00396 0.0315 
FBtr0073062 CG10812-RA dro5 drosomycin-5 4338.918 262.126 0.000141 0.00534 
FBtr0073066 CG12013-RC PHGPx 
 
2073.082 4574.076 0.000304 0.0075 
FBtr0073067 CG12013-RA PHGPx 
 
1887.601 3996.157 0.000554 0.0104 
FBtr0073068 CG12013-RD PHGPx 
 
383.361 921.799 0.000233 0.0068 
FBtr0073069 CG14961-RA 
  
171.902 1323.761 0.000638 0.0112 
FBtr0073073 CG10810-RA Drs Drosomycin 41.55 86.514 0.00687 0.0445 
FBtr0073110 CG14964 
  
3639.654 1364.352 0.000703 0.0119 
FBtr0073155 CG1072-RA Awh Arrowhead 3260.316 1281.457 0.00167 0.0189 
FBtr0073156 CG1072-RB Awh Arrowhead 5114.316 2242.171 0.000567 0.0105 
FBtr0073157 CG1079-RA Fie Fire exit 981.203 2461.609 0.000797 0.0127 
FBtr0073162 CR32265-RA Eip63F-2 
Ecdysone-induced 
protein 63F 2 
85.409 41.763 0.00132 0.0164 
FBtr0073172 CG12766-RA 
  
215.798 502.258 0.00294 0.0262 
FBtr0073181 CG14979 
  
33.023 153.828 0.000726 0.0121 
FBtr0073203 CG1136-RA 
  
322.446 776.324 0.00128 0.0162 
FBtr0073231 CG1273-RB 
  
10818.368 5062.201 0.00192 0.0206 
FBtr0073248 CG15009-RA ImpL2 
Ecdysone-inducible 
gene L2 
200.908 76.492 0.000302 0.00749 
FBtr0073260 CG15002-RB mas masquerade 13387.821 5938.179 0.00102 0.0142 
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FBtr0073278 CG14993-RA Faa Fumarylacetoacetase 9599.778 4128.156 0.0061 0.0409 
FBtr0073299 CG11348-RA 
nAcRβ-
64B 
nicotinic 
Acetylcholine 
Receptor beta 64B 
3109.303 1452.907 0.00201 0.0211 
FBtr0073324 CG32244 
  
6202.398 2230.936 0.000388 0.0086 
FBtr0073326 CG32242 
  
5626.345 2150.611 0.000978 0.0139 
FBtr0073328 CG13721-RA 
  
64.443 554.901 0.000656 0.0115 
FBtr0073378 CG15209-RA 
  
1988.032 4324.001 5.87x10^-6 0.00102 
FBtr0073389 CG16922 
  
2200.691 827.96 0.00043 0.00914 
FBtr0073390 CG11160-RA 
  
1400.086 455.609 0.000354 0.00826 
FBtr0073391 CG11160-RB 
  
1419.543 394.279 0.000152 0.00548 
FBtr0073393 CG18085-RA sev sevenless 541.659 240.025 0.008 0.0491 
FBtr0073399 CG15204 
  
310.956 774.827 0.00022 0.00659 
FBtr0073400 CG1567-RA C901 
 
8503.922 3354.177 0.000414 0.00898 
FBtr0073429 CG2061-RA 
  
477.971 963.023 4.44E-05 0.0029 
FBtr0073502 CG17656 
  
68.243 366.528 0.000046 0.00289 
FBtr0073511 CG11697-RA 
  
60.446 327.935 0.00175 0.0195 
FBtr0073543 CG1572-RA 
  
4271.822 10907.067 0.00163 0.0186 
FBtr0073555 CG9369-RA m miniature 7105.943 2405.892 0.00208 0.0215 
FBtr0073594 CG2467-RA pot papillote 4218.193 1945.245 0.0028 0.0257 
FBtr0073612 CG9355-RA dy dusky 4197.114 1341.702 0.000579 0.0106 
FBtr0073623 CG9360-RA 
  
38.182 98.988 0.000134 0.00527 
FBtr0073647 CG15927-RA 
  
2312.756 985.647 0.00469 0.0348 
FBtr0073701 
 
Pde9 
 
1019.414 483.749 0.0011 0.0149 
FBtr0073763 CG1633-RB Jafrac1 
thioredoxin 
peroxidase 1 
2616.341 5566.122 0.00375 0.0304 
FBtr0073769 CG1640-RB 
  
5469.494 10939.566 1.59x10^-6 0.000445 
FBtr0073781 CG15753 
  
329.759 122.297 0.00772 0.048 
FBtr0073913 CG32600-RA dpr8 
 
128.326 285.891 0.00215 0.0219 
FBtr0073920 CG9400-RA 
  
190.147 69.585 0.000397 0.00869 
FBtr0073929 CG12540-RA 
  
603.832 280.273 0.00253 0.0241 
FBtr0073934 CG5321 
  
1995.444 642.216 0.000935 0.0137 
FBtr0073986 CG9522-RA 
  
4400.407 1859.504 3.91E-05 0.0027 
FBtr0074026 CG9095-RA 
  
7851.453 3831.97 0.0041 0.0322 
FBtr0074052 CG12708-RA 
  
184.393 488.056 0.002 0.021 
FBtr0074190 CG8962-RA Paf-AHα 
Platelet-activating 
factor 
acetylhydrolase alpha 
9242.432 4025.08 0.000103 0.00441 
FBtr0074191 CG8962-RB Paf-AHα 
Platelet-activating 
factor 
acetylhydrolase alpha 
8783.576 4189.268 0.000222 0.00657 
FBtr0074206 CG14948-RA dpr18 
 
310.376 1070.175 0.000289 0.00738 
FBtr0074248 CG12507 
  
2328.231 8661.102 8.71E-05 0.00409 
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FBtr0074251 CG32577-RA disco-r disco-related 3352.54 1526.685 0.00441 0.0335 
FBtr0074273 CG4394-RC Traf-like 
TNF-receptor-
associated factor-like 
2027.711 4255.491 0.0012 0.0155 
FBtr0074321 CG4653-RA 
  
692.061 1738.188 0.000776 0.0126 
FBtr0074349 CG13003-RA 
  
546.378 1117.188 0.00074 0.0123 
FBtr0074351 CG13004-RA 
  
1150.782 411.447 0.00333 0.0283 
FBtr0074357 CG9623-RB if inflated 5735.425 2759.664 0.00223 0.0223 
FBtr0074361 CG9672-RA 
  
207.285 529.083 0.00324 0.0278 
FBtr0074419 CG12996 
  
501.393 182.616 0.00132 0.0164 
FBtr0074474 CG12986-RA 
  
202.368 86.504 0.00463 0.0345 
FBtr0074477 CG32556-RA chas chascon 7838.558 3693.222 0.00511 0.0366 
FBtr0074479 CG12990-RA 
  
142.878 301.275 0.000966 0.0139 
FBtr0074499 CR32496-RA 
  
142.861 464.453 2.22E-05 0.00208 
FBtr0074524 CG7178-RG wupA wings up A 5878.465 2890.313 0.00217 0.022 
FBtr0074553 CG6106-RA 
  
421.726 156.74 0.00292 0.0262 
FBtr0074566 CG32547 
  
95.04 324.789 0.000171 0.00574 
FBtr0074579 CG6023-RA 
  
391.95 145.752 0.000516 0.0102 
FBtr0074581 CG5993-RA os outstretched 1753.231 738.28 0.00211 0.0217 
FBtr0074591 CG12611-RA Andorra 
 
82.432 37.686 0.00618 0.0413 
FBtr0074603 CG6578-RA phm phantom 500.243 214.392 0.00187 0.0203 
FBtr0074609 CG6816-RA Cyp18a1 
Cytochrome P450-
18a1 
5096.02 2266.239 0.00497 0.0362 
FBtr0074610 CG6816-RB Cyp18a1 
Cytochrome P450-
18a1 
1373.913 490.477 0.00316 0.0273 
FBtr0074627 CG15044-RA 
  
310.384 762.95 0.00283 0.0258 
FBtr0074628 CG15046-RA 
  
344.623 130.401 0.00421 0.0328 
FBtr0074629 CG6367-RA psh persephone 653.915 249.413 0.00136 0.0167 
FBtr0074630 CG6361-RA 
  
940.713 393.539 0.000188 0.00608 
FBtr0074649 CG7378-RA 
  
568.007 1800.989 0.000792 0.0126 
FBtr0074662 
 
CCKLR-
17D3 
 
225.795 1081.738 3.26E-05 0.00244 
FBtr0074698 CG7537-RB inx5 
 
72.992 210.995 0.000321 0.00771 
FBtr0074701 CG15883-RA Obp18a 
Odorant-binding 
protein 18a 
1234.903 562.832 0.00535 0.0377 
FBtr0074757 CG14225 
  
798.915 303.459 0.000145 0.00537 
FBtr0074790 CG14234-RA 
  
69.981 309.358 5.06x10^-6 0.000985 
FBtr0074824 CG17147 
  
503.294 1041.72 0.00441 0.0335 
FBtr0074827 CG13813 
  
3272.791 7585.859 0.000185 0.00604 
FBtr0074843 CG6663 Spn77Bb Serpin 77Bb 33.318 236.32 1.98E-05 0.00195 
FBtr0074862 CG13811 
  
479.951 977.345 0.00087 0.0132 
FBtr0074863 CG7323 
  
150.703 502.758 0.000125 0.005 
FBtr0074869 CG7385-RA Ir76b 
Ionotropic receptor 
76b 
109.742 825.328 1.54x10^-7 0.000202 
FBtr0074876 CG8533 
  
694.317 214.708 0.000164 0.00564 
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FBtr0074897 CG7978-RA Ac76E Adenylyl cyclase 76E 251.684 590.394 0.000703 0.0119 
FBtr0074945 CG9372-RA 
  
1477.967 680.399 0.00537 0.0378 
FBtr0074980 CG9449 
  
846.452 235.669 0.00276 0.0255 
FBtr0074981 CG9449 
  
8366.324 3101.859 0.00415 0.0324 
FBtr0075004 CG9614-RC pip pipe 3408.365 1654.675 0.00419 0.0327 
FBtr0075040 CG18136-RA 
  
285.394 115.551 0.002 0.021 
FBtr0075046 CG11619-RA 
  
1161.409 429.31 0.0011 0.0148 
FBtr0075047 CG32204 
  
47.311 144.65 0.00572 0.0392 
FBtr0075060 CG6865-RA 
  
239.552 1717.402 3.18E-05 0.00242 
FBtr0075127 CG7330-RA 
  
2134.06 5000.382 0.00447 0.0338 
FBtr0075129 CG7313-RA CheA75a 
Chemosensory 
protein A 75a 
319.464 110.521 0.00799 0.049 
FBtr0075130 CG4345-RA grim 
 
3768.839 8757.353 8.26x10^-6 0.00127 
FBtr0075138 CG32194 
  
158.745 76.969 0.000985 0.0139 
FBtr0075153 CG5485-RA Prestin 
 
1834.105 5285.082 1.22E-05 0.00157 
FBtr0075167 CG5582-RA cln3 
 
227.982 529.721 0.00434 0.0334 
FBtr0075185 CG32183-RA Ccn 
 
310.102 1299.79 3.36E-05 0.00249 
FBtr0075186 CG32183-RB Ccn 
 
439.728 1764.9 1.35E-05 0.00164 
FBtr0075194 CG6034-RA 
  
58.569 283.894 8.92x10^-6 0.00129 
FBtr0075261 CG13028-RA 
  
201.725 1382.923 5.59x10^-6 0.000997 
FBtr0075270 CG14060 
  
5960.592 2724.224 0.000589 0.0107 
FBtr0075271 CG3799 
  
6106.78 2702.273 0.00168 0.019 
FBtr0075290 CG6642-RA a10 antennal protein 10 28.52 89.27 0.00684 0.0444 
FBtr0075300 CG11905-RB 
  
9474.927 3841.684 2.97E-05 0.00236 
FBtr0075305 CG11905-RF 
  
8483.032 3654.441 0.000966 0.0139 
FBtr0075316 CG13032-RA 
  
57.696 941.35 8.59x10^-7 0.000351 
FBtr0075321 CG9701-RA 
  
1215.128 581.384 0.0041 0.0322 
FBtr0075361 CG4098-RA 
  
1051.603 387.256 0.000362 0.00838 
FBtr0075378 CG33257-RA 
  
229.096 98.849 0.0023 0.0227 
FBtr0075384 CG4842-RA 
  
470.593 210.535 0.00624 0.0415 
FBtr0075388 CG4680-RA 
  
955.656 3387.367 6.37x10^-7 0.000331 
FBtr0075391 CG4314-RA st scarlet 2296.567 892.096 0.00148 0.0175 
FBtr0075403 CG32158 
  
2795.566 1141.129 0.00168 0.0189 
FBtr0075405 CG32158 
  
2859.788 1303.027 0.00238 0.0232 
FBtr0075441 CG32156-RE Mbs 
Myosin binding 
subunit 
5299.609 2380.371 0.00284 0.0258 
FBtr0075490 CG5157-RA 
  
208.027 1676.2 2.26E-05 0.00207 
FBtr0075507 CG32151 
  
73.297 159.683 0.000846 0.0131 
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FBtr0075533 CG12486-RA 
  
37.41 93.002 0.00199 0.021 
FBtr0075534 CG32150-RB 
  
2420.867 8494.402 3.91E-05 0.00269 
FBtr0075535 CG32150-RA 
  
1316.49 7522.004 2.30x10^-7 0.000232 
FBtr0075578 CG7297-RA pgant8 
polypeptide GalNAc 
transferase 8 
835.923 309.21 0.00629 0.0418 
FBtr0075589 
 
comm3 
 
372.002 778.544 0.00215 0.0219 
FBtr0075609 CG7255 
  
840.519 410.142 0.000719 0.0121 
FBtr0075619 CG13466 
  
41.428 151.301 0.000617 0.0111 
FBtr0075621 CG3096-RA Brd Bearded 
594.666 3314.608 1.51x10^-6 0.000452 
FBtr0075623 CG3349 
  
159.301 403.75 0.00092 0.0136 
FBtr0075666 CG18581-RA 
  
1617.362 555.093 0.0056 0.0387 
FBtr0075682 CG32143 
  
3714.168 1248.006 0.000421 0.00907 
FBtr0075683 CG32143 
  
197.67 54.702 0.00312 0.0271 
FBtr0075694 CG17839  
  
666.618 3737.146 8.08x10^-7 0.000346 
FBtr0075695 CG17839-RB 
  
555.345 2935.566 7.83x10^-7 0.000344 
FBtr0075747 CG32139-RA Sox21b 
 
2862.609 1310.425 0.000486 0.00984 
FBtr0075751 CG32136-RA Tsp68C Tetraspanin 68C 2451.149 977.224 0.0015 0.0176 
FBtr0075754 CG13737-RA 
  
5146.471 2149.223 0.00273 0.0253 
FBtr0075757 CG32137-RA 
  
3236.069 6717.609 7.92x10^-6 0.00127 
FBtr0075761 CG8937-RC Hsc70-1 
Heat shock protein 
cognate 1 
1128.05 359.337 0.00101 0.0142 
FBtr0075779 CG8100-RA 
  
630.599 112.454 3.73E-05 0.00262 
FBtr0075797 CG17368 
  
265.528 1065.287 0.00125 0.0159 
FBtr0075798 CG8760 
  
422.837 1733.161 0.00286 0.0259 
FBtr0075799 CG32131 
  
656.858 2454.366 0.00624 0.0416 
FBtr0075800 CG32132-RA 
  
876.721 2788.74 0.00665 0.0435 
FBtr0075803 CG8757 
  
49.913 272.204 0.00062 0.0111 
FBtr0075817 CG10710-RA 
  
3546.079 1200.103 0.000506 0.0101 
FBtr0075820 CG10089-RD 
  
239.442 1174.503 5.30x10^-6 0.000976 
FBtr0075821 CG10089-RB 
  
640.965 1603.077 0.00695 0.0449 
FBtr0075843 CG10717-RB ImpL1 
Ecdysone-inducible 
gene L1 
1480.863 407.924 6.05E-05 0.00328 
FBtr0075850 CG14109-RA 
  
3262.538 1245.426 0.00334 0.0284 
FBtr0075866 CG14107-RA 
  
3451.233 1592.325 3.08E-05 0.0024 
FBtr0075868 CG14120-RA 
  
428.098 3216.353 0.000159 0.00557 
FBtr0075882 
 
RpS12 
 
1248.064 497.824 0.00112 0.015 
FBtr0075888 CG14116 
  
239.565 78.151 0.00317 0.0274 
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FBtr0075909 CG10605-RA caup caupolican 1682.105 729.725 0.0034 0.0287 
FBtr0075936 CG10943-RA 
  
27.411 269.298 0.000525 0.0102 
FBtr0075977 CG10663 
  
1322.879 595.054 0.00508 0.0365 
FBtr0075985 CG14122-RA Smyd4 
SET and MYND 
domain protein 4 
3979.059 1302.243 0.00355 0.0295 
FBtr0076001 CG6906-RA CAH2 Carbonic anhydrase 2 
4562.911 17041.593 2.71x10^-7 0.000232 
FBtr0076008 CG4328 
  
1983.544 746.264 0.00135 0.0166 
FBtr0076021 CG9760 
  
373.708 155.998 0.000619 0.0111 
FBtr0076039 CG7260-RA byn brachyenteron 2902.124 1076.679 0.00413 0.0324 
FBtr0076043 CG7248-RA 
  
227.369 978.17 0.000095 0.00429 
FBtr0076047 CG6938 
  
74.022 228.508 0.000711 0.012 
FBtr0076082 CG32092 
  
1011.187 462.586 0.00222 0.0223 
FBtr0076097 CG7512 
  
1424.103 3120.787 3.03x10^-6 0.000657 
FBtr0076146 CG6097-RA rt rotated abdomen 10643.805 4495.386 0.00154 0.018 
FBtr0076164 CG14141-RA 
  
1061.943 477.81 0.000121 0.00495 
FBtr0076181 CG6163-RA 
  
160.249 67.795 0.000429 0.00915 
FBtr0076221 CG6216-RB 
  
1123.9 536.581 0.000333 0.00787 
FBtr0076230 CG32073-RA 
  
5273.101 1556.541 0.00362 0.0298 
FBtr0076243 CG6327-RA 
  
2517.773 13173.087 7.32x10^-7 0.000348 
FBtr0076305 CG6611-RA ect ectodermal 10199.619 5037.673 0.00397 0.0316 
FBtr0076314 CG32054-RA 
  
951.438 4678.307 7.52x10^-7 0.000339 
FBtr0076338 CG32050-RA 
  
960.339 321.212 0.00709 0.0455 
FBtr0076345 CG14163 
  
175.647 409.454 0.00197 0.0209 
FBtr0076346 CG12524 
  
169.812 425.445 0.00509 0.0366 
FBtr0076371 CG33273-RA Ilp5 Insulin-like peptide 5 231.554 82.337 0.000489 0.00987 
FBtr0076432 CG32042-RF 
  
622.479 1917.505 1.34E-05 0.00165 
FBtr0076469 CG32037-RA 
  
610.692 262.2 0.0065 0.0427 
FBtr0076510 CG5008-RA GNBP3 
Gram-negative 
bacteria binding 
protein 3 
2440.153 1136.398 0.00633 0.0419 
FBtr0076512 CG13313-RA 
  
492.797 219.897 2.14E-05 0.00204 
FBtr0076521 CG5093-RA Doc3 Dorsocross3 2607.284 1075.753 0.00358 0.0296 
FBtr0076525 CG4821-RD Tequila 
 
3728.78 1835.723 0.00487 0.0357 
FBtr0076566 
 
mfr 
 
40.617 283.25 2.50x10^-7 0.000238 
FBtr0076572 CG6519-RA Cp15 Chorion protein 15 31.177 1056.717 4.98E-05 0.00298 
FBtr0076576 CG6576-RA 
  
169.865 72.241 0.00117 0.0154 
FBtr0076580 CG32024-RA 
  
26.717 63.077 0.000142 0.00536 
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FBtr0076586 
 
TrpA1 
 
45.681 4029.447 6.95x10^-7 0.00034 
FBtr0076607 CG32356-RB ImpE1 
Ecdysone-inducible 
gene E1 
1966.979 680.13 0.000534 0.0102 
FBtr0076622 CG6776-RA 
  
1679.721 9753.065 6.67x10^-7 0.000336 
FBtr0076623 CG6781-RA se sepia 
42.882 370.519 2.15x10^-6 0.00051 
FBtr0076662 CG32354-RA 
  
5383.025 1714.503 0.00016 0.00556 
FBtr0076799 CG7526 
  
5855.208 2051.938 0.008 0.0491 
FBtr0076807 CG7496-RA 
PGRP-
SD 
 
806.864 278.351 0.000438 0.00921 
FBtr0076811 CG7399-RA Hn Henna 1935.313 820.904 0.000175 0.00585 
FBtr0076826 CG14837 
  
78.511 205.753 0.000848 0.0131 
FBtr0076833 CG14826-RA 
  
1174.501 558.081 0.00403 0.0319 
FBtr0076874 
 
pst 
 
3806.502 7877.041 0.000221 0.00658 
FBtr0076887 
 
unc-13-
4A 
 
245.363 733.781 0.0021 0.0215 
FBtr0076918 CG8620-RA 
  
114.855 3402.659 1.11x10^-6 0.00037 
FBtr0076931 CG8641-RA 
  
390.211 1069.317 0.000142 0.00536 
FBtr0076948 CG32392-RB 
  
322.069 2872.605 2.74x10^-7 0.000224 
FBtr0077031 CG13288 
  
81.999 189.899 1.76x10^-7 0.000188 
FBtr0077146 CG4814 
  
115.635 244.105 0.000681 0.0117 
FBtr0077152 CG10630-RA blanks 
 
548.599 1814.266 1.13E-05 0.00149 
FBtr0077212 CG1644-RA Cyp6t1 
 
1054.618 502.78 1.13E-05 0.00149 
FBtr0077242 CG1742-RB Mgstl 
Microsomal 
glutathione S-
transferase-like 
233.239 610.084 0.000484 0.00982 
FBtr0077243 CG1742-RA Mgstl 
Microsomal 
glutathione S-
transferase-like 
3395.955 8563.939 5.28x10^-6 0.000983 
FBtr0077259 CG1501-RA unc uncoordinated 393.775 1105.789 0.000886 0.0134 
FBtr0077335 CG17058-RA 
Peritroph
in-A 
 
791.06 308.06 0.00261 0.0246 
FBtr0077338 CG1504 
  
119.802 248.247 0.00049 0.00987 
FBtr0077358 CG17600-RA 
  
3742.081 1688.479 0.00295 0.0262 
FBtr0077401 CG2837-RB 
  
664.597 2687.425 0.000253 0.00707 
FBtr0077402 CG2837-RC 
  
377.233 1330.379 0.00236 0.0231 
FBtr0077420 CG15632-RA Taf12L 
TBP-associated 
factor 30kD subunit 
α-2 
68.24 500.206 1.08E-05 0.00146 
FBtr0077434 CG33003-RA 
  
7753.962 2725.566 5.05E-05 0.00301 
FBtr0077446 CG15444-RB ine inebriated 4852.183 2349.165 0.000266 0.00713 
FBtr0077478 CG3352-RA ft fat 9546.379 4751.199 0.0023 0.0227 
118 
 
FBtr0077489 CG31772-RA 
  
534.121 258.737 0.00283 0.0258 
FBtr0077506 CG15423-RA 
  
517.71 3086.816 0.000201 0.00626 
FBtr0077532 CG2788-RA Dot Dorothy 2009.985 992.961 0.000377 0.00851 
FBtr0077542 CG31777-RA 
  
4536.002 1922.02 0.00633 0.0419 
FBtr0077543 CG31778-RA 
  
335.227 147.598 0.00191 0.0206 
FBtr0077557 CG3851-RA odd odd skipped 3858.008 1609.444 0.00107 0.0147 
FBtr0077558 CG3242-RA sob 
sister of odd and 
bowl 
2211.622 896.026 0.000873 0.0132 
FBtr0077568 CG15414-RA 
  
206.444 487.255 0.00022 0.00658 
FBtr0077586 CG3285-RA 
  
1646.527 635.218 0.000364 0.00839 
FBtr0077595 CG15412 
  
330.463 162.705 0.000311 0.0076 
FBtr0077647 CG17264-RA 
  
750.137 271.191 0.0025 0.024 
FBtr0077657 CG3524-RA 
v(2)k058
16 
 
210.448 1688.475 1.61E-05 0.00179 
FBtr0077705 CG31689-RC 
  
2886.975 6042.276 7.15E-05 0.00364 
FBtr0077807 CG31682-RA 
  
28.806 212.517 0.000371 0.00849 
FBtr0077809 CG31679-RA 
  
28.88 57.82 0.00053 0.0102 
FBtr0077820 CG4238 
  
325.898 1301.81 0.000182 0.006 
FBtr0077844 CG4265-RA Uch 
Ubiquitin carboxy-
terminal hydrolase 
1522.321 3378.817 8.83x10^-6 0.0013 
FBtr0077859 
 
lectin-
22C 
 
2656.881 1175.948 0.00744 0.047 
FBtr0077893 CG31663-RA 
  
685.671 255.693 2.06E-05 0.00199 
FBtr0077894 CG15623-RA c-cup calcutta cup 31.25 135.522 0.000361 0.00839 
FBtr0077920 CG5397-RA 
  
463.457 193.018 0.00436 0.0335 
FBtr0077924 CG5450-RA Cdlc2 
Cytoplasmic dynein 
light chain 2 
35.039 164.988 5.24E-05 0.00305 
FBtr0077925 CG5450-RB Cdlc2 
Cytoplasmic dynein 
light chain 2 
52.301 112.913 0.00119 0.0154 
FBtr0077926 CG14346-RA 
  
540.422 1841.868 8.30x10^-7 0.000347 
FBtr0077927 CG14346-RB 
  
211.946 887.633 1.35E-05 0.00165 
FBtr0077942 CG33126-RA Nlaz Neural Lazarillo 879.534 371.215 0.00076 0.0124 
FBtr0077973 CG5011-RA 
  
497.985 1327.11 1.08x10^-6 0.000385 
FBtr0077981 CG5080-RB 
  
17220.225 7639.752 0.00718 0.0458 
FBtr0078026 
 
GluRIIC 
 
2310.655 806.173 0.00259 0.0244 
FBtr0078043 CG3159-RA Eaat2 
Excitatory amino 
acid transporter 2 
120.495 278.688 9.75E-05 0.00432 
FBtr0078064 CG11822-RA 
nAcRβ-
21C 
nicotinic 
acetylcholine 
receptor beta 21C 
2865.185 1227.845 0.00172 0.0192 
FBtr0078066 CG2789-RA 
  
2408.352 6811.776 0.000891 0.0134 
FBtr0078070 CG2819-RA Pph13 
PvuII-PstI homology 
13 
183.239 524.916 2.27E-05 0.00207 
FBtr0078072 CG2851-RA Gsc Goosecoid 636.851 314.906 0.00542 0.038 
FBtr0078079 CG2914-RA Ets21C Ets at 21C 279.889 582.239 0.000624 0.0111 
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FBtr0078093 CG4213-RA 
  
3242.453 1154.054 0.00338 0.0286 
FBtr0078149 CG4648 
  
903.543 1840.003 2.16x10^-6 0.000505 
FBtr0078182 CG5665 
  
210.656 514.204 0.000461 0.00949 
FBtr0078183 CG16993-RA in inturned 1962.234 920.423 0.0042 0.0327 
FBtr0078184 CG13247-RA 
  
2044.188 795.06 0.00561 0.0387 
FBtr0078196 CG5932-RA 
  
83.005 793.203 0.000122 0.00497 
FBtr0078212 CG4761-RA knrl knirps-like 3188.65 1227.805 0.000802 0.0127 
FBtr0078213 CG4786-RA Rcd2 
Reduction in Cnn 
dots 2 
430.485 1482.485 3.68E-05 0.00263 
FBtr0078234 CG13248-RA 
  
659.9 1394.836 0.00091 0.0135 
FBtr0078306 CG18023-RA Eip78C 
Ecdysone-induced 
protein 78C 
4683.262 2144.66 0.0013 0.0163 
FBtr0078344 CG32437-RA 
  
239.24 1881.031 4.42E-05 0.0029 
FBtr0078345 CG32440-RA 
  
82.515 604.24 5.80x10^-6 0.00102 
FBtr0078380 CG7173-RA 
  
15107.922 6035.578 0.00555 0.0385 
FBtr0078402 CG12971 
  
264.027 680.271 0.00456 0.0342 
FBtr0078411 CG12974-RB 
  
936.872 2174.896 6.98E-05 0.00358 
FBtr0078415 CG9389-RA 
  
47.471 112.818 0.000358 0.00835 
FBtr0078416 CG9391 
  
1851.923 3821.576 0.000889 0.0134 
FBtr0078418 CG7807-RB AP-2 
 
1904.829 902.457 0.00022 0.00659 
FBtr0078427 CG33291-RA 
  
9781.541 4141.088 0.00166 0.0188 
FBtr0078428 CG33292-RA 
  
1102.757 436.388 0.000743 0.0123 
FBtr0078434 CG14572-RA 
  
273.358 635.463 0.00172 0.0193 
FBtr0078457 CG14570-RA 
  
406.254 3694.928 0.00013 0.00513 
FBtr0078460 CG32447-RA 
  
2504.044 1188.91 0.00118 0.0154 
FBtr0078463 CG7160-RA Cpr78E Cuticular protein 78E 939.376 315.084 0.00048 0.00976 
FBtr0078504 CG11438-RA 
  
3457.738 1255.51 0.002 0.021 
FBtr0078505 CG11437-RA 
  
3414.263 1167.556 0.00764 0.0476 
FBtr0078518 CG14456-RA 
  
286.646 957.413 0.00437 0.0335 
FBtr0078555 CG11128-RA slif slimfast 1015.965 4489.021 0.000678 0.0116 
FBtr0078560 CG12768-RA 
  
7031.689 2907.215 0.00136 0.0166 
FBtr0078586 CG31563 
  
902.904 182.411 0.00049 0.00986 
FBtr0078591 CG15589-RA 
  
3665.211 1699.35 0.00201 0.0211 
FBtr0078602 CG1154-RA Osi12 Osiris 12 4669.575 1836.408 0.00336 0.0284 
FBtr0078610 CG15598-RA Osi17 Osiris 17 2982.779 1027.51 0.00352 0.0293 
FBtr0078615 CG10303-RA Osi4 Osiris 4 129.766 62.731 0.00388 0.031 
FBtr0078616 CG31559-RA 
  
9425.749 3573.617 0.0013 0.0163 
FBtr0078618 CG31557-RA Obp83ef 
Odorant-binding 
protein 83ef 
332.485 104.775 0.00814 0.0496 
FBtr0078623 CG11459-RA 
  
315.091 80.432 0.000439 0.0092 
FBtr0078634 CG10999 
  
162.114 381.625 3.67E-05 0.00263 
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FBtr0078636 CG10999 
  
145.114 421.161 0.000809 0.0128 
FBtr0078661 CG2017-RA 
  
3688.605 7635.587 0.000218 0.00658 
FBtr0078737 CG31546-RA 
  
57.328 135.292 0.000077 0.00375 
FBtr0078841 CG1124-RA 
  
4365.458 1733.098 0.00573 0.0392 
FBtr0078847 CG2016-RB 
  
14905.689 6875.928 0.00303 0.0266 
FBtr0078848 CG14661-RA 
  
104.206 278.101 0.00492 0.0359 
FBtr0078867 CG32946 
  
1989.147 629.761 2.28E-05 0.00206 
FBtr0078881 CG14655-RA 
  
2290.457 858.872 0.00168 0.019 
FBtr0078882 CG31530-RA 
  
1895.066 645.038 3.66E-05 0.00264 
FBtr0078903 CG1102-RA MP1 
Melanization 
Protease 1 
10710.166 5127.145 0.00247 0.0238 
FBtr0078963 CG33294 
  
49.785 173.007 0.00822 0.0499 
FBtr0078989 CG18090-RA Dsk Drosulfakinin 59.712 158.702 0.000531 0.0102 
FBtr0078990 CG14044-RA 
  
57.011 222.09 0.000207 0.00635 
FBtr0079106 CG6992-RI GluRIIA 
Glutamate receptor 
IIA 
1065.315 348.742 0.00355 0.0295 
FBtr0079133 CG7236-RA 
  
664.367 1553.265 6.95x10^-8 0.000199 
FBtr0079141 CG14004 
  
88.319 290.68 0.000509 0.0101 
FBtr0079142 CG31645 
  
62.963 159.907 8.04E-05 0.00384 
FBtr0079145 CG9019-RA dsf dissatisfaction 285.4 142.682 0.000244 0.00693 
FBtr0079168 CG11149-RB 
  
532.68 2595.546 5.86x10^-7 0.000314 
FBtr0079171 CG9046-RA Vm26Ab 
Vitelline membrane 
26Ab 
437.053 122.016 0.00016 0.00557 
FBtr0079227 CG11607-RA H2.0 
Homeodomain 
protein 2.0 
2009.518 841.813 0.00185 0.0201 
FBtr0079241 CG13998-RA 
  
190.128 59.871 0.000138 0.00536 
FBtr0079275 CG11527-RA Tig Tiggrin 12414.454 6164.763 0.00273 0.0254 
FBtr0079276 CG9511 
  
336.797 133.03 0.000351 0.00822 
FBtr0079279 CG13981 
  
851.137 342.218 0.00432 0.0333 
FBtr0079367 CG18304-RA 
  
2638.547 1051.713 0.00236 0.0231 
FBtr0079419 CG4496-RA 
  
57.572 148.731 0.003 0.0265 
FBtr0079434 CG4969 
  
1082.118 415.075 0.00599 0.0404 
FBtr0079439 CG5171-RB 
  
6069.253 2109.348 0.00371 0.0302 
FBtr0079464 CG12789-RA 
santa-
maria 
scavenger receptor 
acting in neural tissue 
and majority of 
rhodopsin is absent 
3057.358 1277.596 0.00153 0.0179 
FBtr0079468 CG5160-RA 
  
717.618 1561.686 2.99x10^-8 0.000103 
FBtr0079472 CG6739-RA 
  
1827.149 662.002 0.000359 0.00836 
FBtr0079473 CG6976-RB 
Myo28B
1 
 
99.197 312.33 0.000663 0.0115 
FBtr0079474 CG6976-RC 
Myo28B
1 
 
300.109 1267.45 0.000186 0.00604 
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FBtr0079485 CG7191-RA 
  
189.717 2842.64 8.07x10^-6 0.00126 
FBtr0079499 CG7214-RA 
  
62.132 179.703 0.00111 0.0149 
FBtr0079503 CG13796-RB 
  
1629.331 651.024 0.00643 0.0424 
FBtr0079506 CG13795 
  
1996.44 793.381 0.00504 0.0364 
FBtr0079510 CG7052-RA Tepll 
Thiolester containing 
protein II 
4593.263 2242.198 0.00421 0.0328 
FBtr0079517 CG6772-RB Slob  
Slowpoke binding 
protein 
87.489 724.897 3.98x10^-7 0.000297 
FBtr0079520 CG13792-RA 
  
170.991 1806.723 6.82E-05 0.00353 
FBtr0079527 CG1706 
  
317.33 944.678 0.00287 0.0259 
FBtr0079533 CG7356-RA Tg Transglutaminase 3458.67 1292.898 0.00139 0.0168 
FBtr0079548 CG12560 
  
2326.366 794.797 0.000267 0.00713 
FBtr0079602 CG14275-RA 
  
902.248 161.065 0.00284 0.0258 
FBtr0079607 CG31901-RA Mur29B Mucin related 29B 222.169 1016.181 0.00557 0.0386 
FBtr0079649 CG17292-RA 
  
73.5 193.122 0.000568 0.0106 
FBtr0079676 CG33194-RA CheA29a 
Chemosensory 
protein A 29a 
146.217 70.936 0.000653 0.0114 
FBtr0079678 CG10595 
  
8032.115 3402.503 0.00183 0.0201 
FBtr0079679 CG10595 
  
2603.836 1127.336 0.00113 0.015 
FBtr0079680 CG10595 
  
6538.237 2980.742 0.00142 0.017 
FBtr0079684 CG13091-RA 
  
54.029 152.832 0.000206 0.00634 
FBtr0079701 CG13095-RA Bace 
beta-site APP-
cleaving enzyme 
133.823 1027.34 0.000618 0.0111 
FBtr0079711 CG13397-RA 
  
5191.923 2376.079 0.00387 0.0309 
FBtr0079731 CG9314-RA 
  
129.749 261.441 0.000128 0.00511 
FBtr0079754 CG9494-RA Tsp29Fa Tetraspanin 29Fa 
1261.966 4903.48 2.23x10^-6 0.000517 
FBtr0079755 CG9496-RB Tsp29Fb Tetraspanin 29Fb 
5302.14 16440.697 4.69x10^-6 0.000945 
FBtr0079756 CG9496-RA Tsp29Fb Tetraspanin 29Fb 
2210.825 8356.877 3.94x10^-6 0.000813 
FBtr0079785 CG9541-RA 
  
160.091 1620.693 3.28x10^-7 0.000255 
FBtr0079797 CG3694-RC Gy30A G protein γ30A 506.146 1330.196 0.000128 0.00512 
FBtr0079816 CG17011-RA 
lectin-
30A 
 
32.975 181.97 0.000276 0.00721 
FBtr0079830 CG17855-RA 
  
265.176 582.047 0.00132 0.0164 
FBtr0079837 CG3858-RA gcm2 
 
2302.206 976.957 0.00187 0.0203 
FBtr0079860 CG4405-RB jp junctophilin 761.986 306.128 0.00593 0.0401 
FBtr0079902 CG13124-RA 
  
4916.838 2323.319 0.00173 0.0193 
FBtr0079934 CG4778-RA obst-B obstructor-B 11918.047 5398.384 0.00221 0.0222 
FBtr0079943 CG4839-RB 
  
318.341 1140.53 7.03x10^-6 0.00116 
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FBtr0079963 
 
Sur 
 
1022.092 402.434 0.000388 0.00861 
FBtr0080058 CG5375-RA 
  
418.526 895.595 4.75E-05 0.00293 
FBtr0080109 CG6431 
  
173.869 57.626 0.000855 0.0131 
FBtr0080124 CG7279-RA Lip1 Lipase 1 3832.825 8245.565 0.000378 0.00851 
FBtr0080125 CG7300-RB 
  
2247.807 573.068 0.000511 0.0102 
FBtr0080131 CG7329 
  
44.217 91.61 0.00294 0.0262 
FBtr0080184 CG17137-RA Porin2 
 
41.393 116.101 0.00328 0.028 
FBtr0080194 CG16854 
  
285.046 94.157 0.00118 0.0154 
FBtr0080201 CG4779-RA hgo 
homogentisate 1,2-
dioxygenase 
1762.944 596.465 0.00368 0.0301 
FBtr0080258 
 
Pde1c 
 
388.665 976.755 5.21x10^-7 0.000308 
FBtr0080273 CG31704-RA 
  
183.848 851.79 0.000165 0.00562 
FBtr0080275 CG14934-RA Mal-B1 Maltase B1 832.186 3700.644 0.000225 0.00664 
FBtr0080281 CG16963-RA Cry Crystallin 110.027 824.141 0.00197 0.0209 
FBtr0080294 CG14945-RB 
  
2279.862 954.042 0.00257 0.0244 
FBtr0080297 CG14947-RA 
  
111.511 1235.656 1.62x10^-6 0.00044 
FBtr0080307 CG6785-RA 
  
5646.589 2732.754 0.000362 0.00837 
FBtr0080321 CG31757 
  
765.384 2132.179 7.13E-05 0.00364 
FBtr0080324 CG31758 
  
1475.491 3370.002 0.000606 0.0109 
FBtr0080336 CG17211-RA 
  
7660.672 3314.019 0.00125 0.016 
FBtr0080338 CG31760-RA 
  
52.67 128.787 0.00133 0.0164 
FBtr0080362 CG6618-RA Patsas 
 
651.161 1508.911 0.000685 0.0117 
FBtr0080371 CG17024-RA 
  
186.243 465.624 0.000851 0.0131 
FBtr0080389 CG31764-RB vir-1 virus-induced RNA 1 3589.372 7788.166 0.00162 0.0186 
FBtr0080391 CG31764-RC vir-1 virus-induced RNA 1 2147.297 7663.062 0.00138 0.0167 
FBtr0080408 CG17036-RA 
  
162.953 585.425 0.00332 0.0283 
FBtr0080433 CG5204-RA 
  
98.377 198.561 0.000376 0.00851 
FBtr0080450 CG5945-RA 
  
29.409 90.796 0.00363 0.0298 
FBtr0080452 CG16820-RA 
  
726.306 2220.513 0.000912 0.0136 
FBtr0080487 CG15482-RA 
  
65.496 385.272 5.66x10^-7 0.000313 
FBtr0080503 CG16849 
  
54.079 253.471 0.00576 0.0394 
FBtr0080504 CG31846 
  
75.107 555.769 7.87E-05 0.00378 
FBtr0080505 CG16850 
  
128.941 556.282 0.000266 0.00713 
FBtr0080523 CG16957-RA 
  
56.583 162.241 0.000146 0.00535 
FBtr0080549 CG7916-RA 
  
662.901 3525.954 0.000461 0.0095 
FBtr0080550 CG7953-RA 
  
1139.779 3652.137 0.00753 0.0472 
FBtr0080551 CG7968-RA 
  
277.729 1780.484 0.000501 0.01 
FBtr0080554 CG16869-RA Ance-2 
 
165.536 473.269 0.000211 0.00644 
FBtr0080563 CG8997-RA 
  
1346.799 9243.867 0.000474 0.00968 
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FBtr0080580 CG31814-RA 
  
59.17 149.691 0.00318 0.0274 
FBtr0080583 CG31841 
  
167.453 80.424 0.0051 0.0366 
FBtr0080584 CG31765 
  
198.344 92.966 0.00485 0.0356 
FBtr0080585 CG33119-RA nimB1 nimrod B1 1085.616 353.815 0.00582 0.0398 
FBtr0080590 CG4501-RA bgm bubblegum 3176.583 1563.477 0.00278 0.0256 
FBtr0080596 CG16879-RA 
  
2040.317 633.41 0.000951 0.0138 
FBtr0080607 CG31840 
  
103.243 30.65 0.00529 0.0374 
FBtr0080608 
 
I(2)32Fa 
 
463.018 119.635 0.000914 0.0136 
FBtr0080610 CG8930-RA rk rickets 471.089 228.852 0.00083 0.013 
FBtr0080656 CG15282-RA 
  
3828.103 1738.511 0.0061 0.0409 
FBtr0080670 CG4691-RA 
  
28.962 67.523 0.00015 0.00546 
FBtr0080685 CG15279-RB 
  
785.101 2128.15 0.000375 0.00851 
FBtr0080690 CG4650 
  
81.572 39.996 0.00178 0.0198 
FBtr0080697 CG15274 
  
915.773 1945.575 0.000563 0.0105 
FBtr0080701 CG3506 
  
716.941 3261.176 2.23E-05 0.00206 
FBtr0080704 CG15269-RA 
  
1376.924 450.278 0.000362 0.00838 
FBtr0080714 CG3994-RA ZnT35C 
 
5052.705 2385.737 0.00306 0.0268 
FBtr0080716 CG4168 
  
98.071 205.634 0.000529 0.0102 
FBtr0080753 CG11865-RA 
  
123.481 37.759 1.21E-05 0.00156 
FBtr0080763 CG18801-RA Ku80 
 
749.805 1654.069 0.000318 0.00769 
FBtr0080785 CG15255-RA 
  
151.878 1681.41 0.000111 0.00466 
FBtr0080794 CG4793 
  
348.454 57.873 0.000178 0.00594 
FBtr0080869 CG13260 
  
100.231 625.912 7.46E-05 0.00375 
FBtr0080888 CG13263-RA Cyt-c-d Cytochrome c distal 244.635 657.465 5.54E-05 0.00313 
FBtr0080909 CG13270-RA Ugt36Ba 
 
3217.934 7930.803 4.54E-05 0.00289 
FBtr0080923 CG6012-RA 
  
150.461 1177.171 9.09x10^-6 0.0013 
FBtr0080925 CG31810-RA 
  
356.402 745.336 0.00292 0.0262 
FBtr0080951 
 
beat-IIIb 
 
190.941 484.698 7.07x10^-8 0.000173 
FBtr0080961 CG12621 
  
485.179 1062.312 0.000197 0.00621 
FBtr0080981 CG5050-RA 
  
63.429 135.626 0.000165 0.00562 
FBtr0081004 CG6639-RA 
  
45.786 145.409 0.000963 0.0139 
FBtr0081035 CG5758-RC 
  
662.86 2834.126 2.04x10^-8 0.000117 
FBtr0081036 CG5758-RA 
  
1106.098 4521.696 4.65x10^-7 0.000307 
FBtr0081044 CG31785 
  
56.657 199.917 0.00112 0.015 
FBtr0081068 CG10178-RA 
  
2994.474 1304.229 0.000943 0.0138 
FBtr0081105 CG17322-RA 
  
950.883 225.505 0.00119 0.0154 
FBtr0081118 CG33120-RA 
  
354.296 130.694 0.00642 0.0423 
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FBtr0081124 CG10348 
  
3013.006 980.231 0.003 0.0265 
FBtr0081136 CG15169-RA 
  
440.163 58.522 1.52x10^-6 0.000434 
FBtr0081149 CG10493-RA Phlpp 
PH domain leucine-
rich repeat protein 
phosphatase 
651.726 1636.705 0.000232 0.00678 
FBtr0081184 CG15170-RA 
  
30.151 77.029 0.00632 0.0419 
FBtr0081197 CG13086-RA 
  
145.157 333.26 0.00599 0.0405 
FBtr0081206 CG9994-RA Rab9 
 
513.586 6340.248 1.53x10^-7 0.000218 
FBtr0081208 CG10237-RB 
  
879.71 361.579 0.00699 0.045 
FBtr0081228 CG17566-RA γTub37C γ-Tubulin at 37C 116.849 265.403 0.00111 0.0149 
FBtr0081241 CG13083  
  
1323.334 230.136 4.53x10^-7 0.00031 
FBtr0081242 CG13083-RB 
  
2003.591 296.963 4.30x10^-7 0.000307 
FBtr0081251 CG13082-RA 
  
9022.819 3714.495 0.00613 0.041 
FBtr0081252 CG13081-RA 
  
152.506 59.954 0.000463 0.00951 
FBtr0081256 CG13078-RA 
  
41.222 96.4 0.00113 0.0151 
FBtr0081302 CG16772-RA 
  
62.312 180.137 0.0035 0.0292 
FBtr0081326 CG13968 
  
294.75 6900.03 7.73x10^-9 0.000133 
FBtr0081334 CG10722-RB nesd nessun dorma 1966.812 4856.548 4.55E-05 0.00289 
FBtr0081336 CG10723-RA Kua 
 
549.565 1731.216 5.48x10^-7 0.000313 
FBtr0081350 CG10659-RA 
  
157.323 1805.424 1.76E-05 0.00187 
FBtr0081359 CG11019 
  
760.029 1764.858 0.000202 0.00628 
FBtr0081366 CG15130 
  
112.054 226.155 0.00704 0.0453 
FBtr0081368 CG10947 
  
355.763 1461.098 0.000053 0.00306 
FBtr0081371 CG16798-RA 
  
4419.747 1944.257 0.000244 0.00697 
FBtr0081397 CG1864-RB Hr38 
Hormone receptor-
like in 38 
68.876 231.291 0.00306 0.0268 
FBtr0081398 CG1864-RC Hr38 
Hormone receptor-
like in 38 
96.952 233.726 0.000808 0.0128 
FBtr0081406 CG17470-RA 
  
341.019 126.091 0.00406 0.0321 
FBtr0081430 CG14401-RA 
  
666.656 311.037 0.00524 0.0371 
FBtr0081449 CG14400-RA 
  
155.569 51.103 1.34E-05 0.00166 
FBtr0081517 CG8665-RA 
  
2220.218 5101.703 1.88E-05 0.00189 
FBtr0081519 CG8663-RC nrv3 nervana 3 1837.714 4348.506 0.00111 0.0149 
FBtr0081520 CG8663-RD nrv3 nervana 3 457.222 938.339 0.00517 0.0368 
FBtr0081521 CG8663-RB nrv3 nervana 3 449.394 1003.3 0.000741 0.0123 
FBtr0081541 CG31146-RD Nlg1 Neuroligin 1 1919.131 610.771 0.000774 0.0126 
FBtr0081542 CG14597 
  
244.13 804.849 0.000754 0.0124 
FBtr0081543 CG32465 
  
248.272 810.177 0.000272 0.00718 
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FBtr0081545 CG1257-RA α-Est3 α-Esterase-3 1120.327 3646.163 3.14E-05 0.00241 
FBtr0081554 CG1287-RA 
  
87.211 300.513 0.00187 0.0203 
FBtr0081555 CG1128 
  
931.467 4614.674 1.41E-05 0.00167 
FBtr0081628 CG1979-RA 
  
26.676 99.457 1.41E-05 0.00167 
FBtr0081672 CG15186-RA 
  
744.398 306.958 0.00113 0.015 
FBtr0081674 CG15186-RC 
  
700.842 283.523 0.00141 0.017 
FBtr0081704 CG33202-RB drp11 
 
155.919 514.033 5.66E-05 0.00316 
FBtr0081744 CG10086-RA 
  
361.004 1394.945 2.65E-05 0.0022 
FBtr0081762 CG10445 
  
75.915 155.286 0.000491 0.00986 
FBtr0081773 CG3014-RA 
  
246.165 95.582 0.00146 0.0172 
FBtr0081774 CG18744 
  
49.206 260.275 0.000378 0.0085 
FBtr0081775 CG18746-RA 
  
93.061 614.377 4.77E-05 0.00292 
FBtr0081777 CG18745-RA 
  
135.757 345.228 0.00542 0.038 
FBtr0081780 CG3027-RA pyd3 
 
4482.722 1730.749 0.00223 0.0223 
FBtr0081781 CG3250 
  
331.94 138.636 0.00326 0.0278 
FBtr0081857 
 
Poxm 
 
923.372 390.485 0.00227 0.0225 
FBtr0081875 CG7994 
  
77.636 473.27 0.000066 0.00345 
FBtr0081876 CG8007 
  
54.121 441.323 8.41x10^-6 0.00127 
FBtr0081877 CG8007 
  
213.641 705.585 0.000966 0.0139 
FBtr0081942 CG13318-RA 
  
226.782 710.996 0.000785 0.0126 
FBtr0081943 CG11768-RA 
  
249.692 1324.921 0.000122 0.00496 
FBtr0081961 CG11977 
  
238.544 111.943 0.000842 0.0131 
FBtr0082011 CG31100-RA 
  
1944.984 941.227 0.00226 0.0225 
FBtr0082014 CG11966-RA 
  
13951.999 6798.656 0.000329 0.00783 
FBtr0082025 CG18473-RA 
  
2310.33 932.099 0.000923 0.0136 
FBtr0082041 CG9363-RB 
  
257.972 725.031 0.00142 0.017 
FBtr0082042 CG9363-RA 
  
146.513 312.304 0.00137 0.0167 
FBtr0082080 CG8348-RA Dh44 Diuretic hormone 44 113.05 619.092 9.55E-05 0.0043 
FBtr0082151 CG12806-RA Teh1 tipE homolog 1 322.399 1285.922 0.000508 0.0101 
FBtr0082159 CG12946-RA Whamy 
 
383.403 1442.011 0.000203 0.0063 
FBtr0082195 CG6208-RA 
  
141.633 412.263 0.000108 0.00457 
FBtr0082203 CG12812-RA Fancl 
 
109.423 309.694 0.000221 0.00657 
FBtr0082249 CG14680 
  
150.031 329.257 0.000259 0.00709 
FBtr0082315 CG6515-RA Takr86C 
Tachykinin-like 
receptor at 86C 
96.951 444.103 0.000756 0.0124 
FBtr0082323 CG6465-RA 
  
3463.264 1322.47 0.00179 0.0198 
FBtr0082335 CG14695-RA 
  
180.283 654.057 0.00285 0.0258 
FBtr0082337 CG4739-RA Ugt86Dc 
 
168.174 651.596 1.68E-05 0.00181 
FBtr0082340 CG4772-RA Ugt86Dh  
 
533.854 2873.509 4.33E-05 0.00287 
FBtr0082341 CG18577-RA 
  
351.775 731.853 0.00171 0.0191 
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FBtr0082374 CG6644-RA Ugt35a 
 
2675.151 11736.407 1.12x10^-6 0.000366 
FBtr0082375 CG6649-RA Ugt35b 
 
195.316 83.996 0.000885 0.0134 
FBtr0082378 CG6658-RA Ugt86Di 
 
38.432 93.232 0.00155 0.018 
FBtr0082385 CG5247-RA Irbp 
Inverted repeat-
binding protein 
907.695 2108.617 1.06x10^-6 0.000384 
FBtr0082428 CG14720-RA 
  
1054.277 264.823 0.000938 0.0137 
FBtr0082436 CG18765 
  
304.54 1739.954 1.26E-05 0.0016 
FBtr0082439 CG6830-RA 
  
898.694 6254.408 1.30x10^-6 0.000419 
FBtr0082470 CG14723-RA HisCl1 
Histamine-gated 
chloride channel 
subunit 1 
55.521 770.884 2.42E-05 0.00211 
FBtr0082471 CG14723-RB HisCl1 
Histamine-gated 
chloride channel 
subunit 1 
85.446 1057.975 3.04E-05 0.00239 
FBtr0082472 CG14723-RC HisCl1 
Histamine-gated 
chloride channel 
subunit 1 
48.606 709.503 2.16E-05 0.00205 
FBtr0082531 CG17360-RA 
  
1266.821 2669.873 0.000263 0.00713 
FBtr0082550 CG4702-RA 
  
20954.041 10451.499 0.00378 0.0305 
FBtr0082551 CG14741 
  
648.19 3194.57 1.27E-05 0.0016 
FBtr0082564 CG11502-RB svp seven up 1048.151 501.997 0.000693 0.0118 
FBtr0082569 CG4181-RA GstD2 
Glutathione S 
transferase D2 
938.226 20451.816 1.64x10^-8 0.000141 
FBtr0082570 CG4381-RA GstD3 
Glutathione S 
transferase D3 
3994.702 9796.483 0.000529 0.0102 
FBtr0082571 CG11512-RA GstD4 
Glutathione S 
transferase D4 
325.306 994.57 0.000177 0.00592 
FBtr0082573 CG4423-RA GstD6 
Glutathione S 
transferase D6 
104.987 3353.07 9.42x10^-6 0.00133 
FBtr0082574 CG4371-RA GstD7 
Glutathione S 
transferase D7 
798.173 10562.622 9.53x10^-7 0.000355 
FBtr0082575 CG4421-RA GstD8 
Glutathione S 
transferase D8 
179.997 1446.985 0.000077 0.00376 
FBtr0082582 CG4940 
  
40.03 101.048 0.000886 0.0134 
FBtr0082598 CG11466-RA Cyp9f2 
 
3672.054 8236.055 2.19E-05 0.00207 
FBtr0082599 CG11466-RB Cyp9f2 
 
688.237 2128.992 1.58E-05 0.00178 
FBtr0082603 CG10096-RA 
  
84.272 203.753 0.000705 0.0119 
FBtr0082607 CG10045-RA GstD1 
Glutathione S 
transferase D1 
10266.338 26293.084 8.42x10^-6 0.00126 
FBtr0082608 CG10091-RA GstD9 
Glutathione S 
transferase D9 
1429.798 4515.095 0.0026 0.0246 
FBtr0082609 CG18548-RA GstD10 
Glutathione S 
transferase D10 
809.643 2503.336 0.00121 0.0156 
FBtr0082610 CG10090-RA Tim17a1 
 
43.053 288.699 0.00079 0.0126 
FBtr0082613 CG10041-RA 
  
39.333 96.587 4.15E-05 0.00279 
FBtr0082636 CG5834-RA Hsp70Bb
 
4232.817 8525.526 0.00165 0.0187 
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b 
FBtr0082650 CG14395 
  
10221.039 3584.357 0.000268 0.00715 
FBtr0082657 CG5724-RA 
  
328.887 3925.562 5.37E-05 0.00309 
FBtr0082659 CG5999 
  
61.383 10565.303 9.20x10^-6 0.00131 
FBtr0082660 CG10120-RB Men  Malic enzyme 12415.408 26893.655 2.22E-05 0.00207 
FBtr0082684 CG31298-RA beat-Vb 
 
137.664 62.153 0.00571 0.0391 
FBtr0082689 CG31345-RA 
  
559.918 5428.338 3.62E-05 0.00262 
FBtr0082725 CG7381 
  
1006.651 4457.543 9.50x10^-7 0.000362 
FBtr0082740 CG8774-RB 
  
1682.51 3895.355 0.000989 0.014 
FBtr0082757 CG9792-RA yellow-e 
 
338.656 2172.029 9.49E-05 0.0043 
FBtr0082758 CG17044 
  
4917.845 1809.09 0.00287 0.0259 
FBtr0082762 CG14375-RA CCHa2 CCHamide-2 860.261 2036.262 0.000408 0.00887 
FBtr0082773 CG8795-RA 
  
657.976 178.502 0.000242 0.00694 
FBtr0082775 CG8458-RA wntD 
wnt inhibitor of 
Dorsal 
185.091 499.2 0.0035 0.0292 
FBtr0082786 CG18290-RB Act87E Actin 87E 499.549 221.283 0.00143 0.0171 
FBtr0082789 CG14369-RA 
  
55.89 318.941 0.0048 0.0354 
FBtr0082790 CG31337-RA 
  
665.603 229.841 0.00608 0.0408 
FBtr0082821 CG9345-RA Adgf-C 
Adenosine 
deaminase-related 
growth factor C 
98.922 213.083 0.000968 0.0138 
FBtr0082837 CG14363 
  
65.261 28.975 0.000366 0.00843 
FBtr0082888 CG3153-RB Npc2b 
Niemann-Pick type 
C-2b 
4768.596 2279.192 0.00264 0.0247 
FBtr0082890 CG14360-RA Or88a Odorant receptor 88a 66.591 156.199 0.00699 0.045 
FBtr0082911 CG9913 
  
115.169 4621.107 2.21x10^-8 
0.000094
5 
FBtr0082913 CG14357 
  
43.92 101.174 0.00409 0.0322 
FBtr0082926 CG31321-RB 
  
955.789 317.965 0.00435 0.0334 
FBtr0082960 CG14853-RB 
  
326.505 768.636 0.000519 0.0102 
FBtr0082966 CG3505-RA 
  
1373.914 664.129 0.00142 0.017 
FBtr0082982 CG31313-RA 
  
5575.17 2381.116 0.00462 0.0345 
FBtr0083012 CG17304-RA 
  
151.745 384.075 0.00357 0.0295 
FBtr0083080 CG4843-RC Tm2 Tropomyosin 2 819.628 334.161 0.00279 0.0257 
FBtr0083102 CG6118 
  
15136.278 6389.256 0.00376 0.0304 
FBtr0083152 CG18519-RA 
  
2248.106 931.712 0.00589 0.04 
FBtr0083155 CG31296-RA 
  
22.295 119.952 0.000668 0.0116 
FBtr0083157 CG14872-RA 
  
393.775 1342.149 0.00118 0.0154 
FBtr0083248 CG9734-RD glob1 globin 1 488.209 243.576 0.000139 0.00535 
FBtr0083249 CG14877-RA 
  
83.946 277.522 0.000732 0.0122 
FBtr0083250 CG4316-RA Sb Stubble 1441.516 601.164 0.000438 0.0092 
FBtr0083253 CG8925-RA 
  
1140.937 514.799 0.00118 0.0154 
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FBtr0083254 CG8927-RA 
  
630.972 1567.605 0.000199 0.00626 
FBtr0083266 CG6898-RA Zip3 
Zinc/iron regulated 
transporter-related 
protein 3 
1865.765 845.615 0.00468 0.0348 
FBtr0083271 CG17930-RA 
  
1114.244 3684.553 0.000164 0.00565 
FBtr0083306 CG14900 
  
3997.226 1330.028 0.00114 0.015 
FBtr0083329 CG17562-RA 
  
1308.624 372.847 0.00144 0.0171 
FBtr0083330 CG17560-RA 
  
934.132 318.365 0.00506 0.0365 
FBtr0083354 CG14907-RA 
  
1214.571 5008.832 2.56x10^-6 0.000569 
FBtr0083355 CG14906 
  
494.192 1895.097 5.15E-05 0.00303 
FBtr0083367 CG31447-RA MESK4 
Misexpression 
suppressor of KSR 4 
5067.846 2260.664 0.00723 0.046 
FBtr0083372 CG8907-RA 
  
1376.004 4691.793 2.55E-05 0.00213 
FBtr0083379 CG8956-RD Ahcy89E 
Adenosylhomocystei
nase 89E 
940.933 469.244 0.00402 0.0318 
FBtr0083512 CG16766-RA TyrRII Tyramine receptor II 107.964 401.791 0.000068 0.00353 
FBtr0083530 CG14318 
  
2611.017 930.95 0.00654 0.0429 
FBtr0083532 CG7431-RA TyrR Tyramine receptor 231.584 624.877 2.48E-05 0.00213 
FBtr0083542 CG7847-RA sr stripe 3607.646 1685.239 0.000555 0.0104 
FBtr0083581 CG7675-RA 
  
21720.595 10248.854 0.00672 0.0439 
FBtr0083582 CG7675-RB 
  
1969.004 655.238 0.00369 0.0301 
FBtr0083584 CG7672-RA gl  glass 207.331 505.257 0.000659 0.0115 
FBtr0083587 CG15803 
  
178.668 411.008 0.00275 0.0255 
FBtr0083588 CG31235-RA 
  
2803.856 991.727 0.00515 0.0368 
FBtr0083589 CG7125-RA PKD Protein Kinase D 9546.382 4497.729 0.000607 0.0109 
FBtr0083617 CG7208-RA 
  
164.561 503.595 0.00487 0.0357 
FBtr0083618 CG7208-RB 
  
149.36 439.484 0.000394 0.00867 
FBtr0083624 CG7676-RA cona corona 127.48 256.436 0.000684 0.0117 
FBtr0083654 CG10864-RA 
  
1542.411 707.905 5.11x10^-6 0.000982 
FBtr0083678 CG7720-RB 
  
2615.917 1047.655 0.00188 0.0203 
FBtr0083694 CG7695-RA 
  
760.353 212.6 0.000316 0.00766 
FBtr0083711 CG14285-RA 
  
2086.589 729.403 0.00124 0.0159 
FBtr0083729 CG6040-RA 
  
8288.925 3873.911 0.000265 0.00713 
FBtr0083730 CG11821-RA Cyp12a5 
 
195.439 1119.297 0.00201 0.0211 
FBtr0083736 CG3772-RA cry cryptochrome 
322.368 3056.951 1.89x10^-6 0.000491 
FBtr0083755 CG3734-RA 
  
1007.307 3930.556 0.0014 0.0169 
FBtr0083756 CG18493-RA 
  
1833.732 8241.409 5.09E-05 0.00301 
FBtr0083762 CG31221-RA 
  
125.064 987.23 0.000246 0.00694 
FBtr0083788 CG7535-RB GluClα 
 
750.588 359.336 0.00459 0.0343 
FBtr0083791 CG11453-RA 
  
868.971 6189.535 9.59E-05 0.00427 
FBtr0083820 CG4733 
  
4173.217 1468.67 0.00249 0.0239 
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FBtr0083852 CG4468-RA 
  
158.414 690.034 0.000164 0.00564 
FBtr0083868 CG5030 
  
294.127 608.36 0.000148 0.0054 
FBtr0083886 CG5115 
  
79.056 180.706 4.47E-05 0.00289 
FBtr0083894 CG4335-RA 
  
1232.007 449.394 0.000293 0.00742 
FBtr0083923 CG31203 
  
148.013 325.873 0.000529 0.0102 
FBtr0083932 CG3856-RA Oamb 
Octopamine receptor 
in mushroom bodies 
59.962 310.441 4.64E-05 0.00289 
FBtr0083933 CG3856-RB Oamb 
Octopamine receptor 
in mushroom bodies 
85.188 205.494 0.00752 0.0472 
FBtr0083934 CG3856-RC Oamb 
Octopamine receptor 
in mushroom bodies 
41.752 367.108 1.62E-05 0.00177 
FBtr0083936 CG4058-RB Nep4 Neprilysin 4 1368 560.913 0.000969 0.0138 
FBtr0083938 CG18039-RA KaiRIA 
 
4036.541 1934.315 0.00517 0.0368 
FBtr0083957 CG15690 
  
492.945 1033.67 0.00109 0.0148 
FBtr0083968 CG15696-RA 
  
553.578 188.775 6.09E-05 0.00329 
FBtr0083987 CG3822-RA 
  
3510.644 1281.579 0.00145 0.0172 
FBtr0084001 CG5697-RA 
  
512.641 194.806 0.000218 0.00657 
FBtr0084044 CG31207-RA 
  
41.355 118.269 1.93x10^-6 0.000487 
FBtr0084053 CG5911-RB ETHR 
 
406.312 1001.318 5.65E-05 0.00317 
FBtr0084054 CG5911-RA ETHR 
 
320.303 644.209 0.000631 0.0112 
FBtr0084098 CG10823-RA SIFR SIFamide receptor 62.47 136.744 0.000581 0.0106 
FBtr0084101 CG3301-RB 
  
43.662 109.344 0.00168 0.0189 
FBtr0084123 CG6534-RA slou slouch 2716.74 1245.223 0.00113 0.015 
FBtr0084128 CG31198-RA 
  
4507.782 12851.177 0.00243 0.0236 
FBtr0084137 CG31431-RA 
  
6715.448 14611.871 0.000146 0.00536 
FBtr0084138 CG31178-RA 
  
95.018 290.01 0.000541 0.0103 
FBtr0084140 CG33092-RA P5CDh2 
delta-1-Pyrroline-5-
carboxylate 
dehydrogenase 2 
57.697 431.263 0.000101 0.00435 
FBtr0084147 CG31465-RA 
  
42.322 182.236 0.000036 0.00263 
FBtr0084150 CG17843-RA 
  
4988.687 2148.432 0.00175 0.0195 
FBtr0084153 CG17820-RA fit 
female-specific 
independent of 
transformer 
120.906 12867.788 9.83x10^-8 0.000211 
FBtr0084154 CG31174-RA 
  
83.445 213.473 0.00254 0.0242 
FBtr0084169 CG18389-RA Eip93F 
 
87.421 534.17 2.05E-05 0.002 
FBtr0084179 CG13408-RA 
  
226.498 552.531 9.18E-05 0.00425 
FBtr0084180 CG5791-RA 
  
125.568 336.803 0.00127 0.0161 
FBtr0084194 CG33334 
  
1771.29 710.888 0.00332 0.0282 
FBtr0084195 CG5740 
  
2654.299 1058.386 0.00125 0.016 
FBtr0084215 CG7069-RA 
  
42.431 88.668 0.00661 0.0433 
FBtr0084234 CG13857-RA 
  
773.426 278.111 0.00132 0.0164 
FBtr0084240 CG5386-RA 
  
224.753 85.478 0.000204 0.00631 
FBtr0084242 CG5391-RA 
  
999.741 392.249 0.00375 0.0304 
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FBtr0084243 CG13858 
  
819.393 249.407 9.04E-05 0.00422 
FBtr0084244 CG13859 
  
1272.809 372.52 0.00138 0.0167 
FBtr0084245 CG13860 
  
1220.51 376.557 0.00137 0.0167 
FBtr0084246 CG13861 
  
1842.113 615.471 0.00188 0.0203 
FBtr0084259 CG7046-RA 
  
609.057 236.01 0.00536 0.0377 
FBtr0084260 CG6919-RA oa2 
octopamine receptor 
2 
211.869 1242.079 8.84E-05 0.00414 
FBtr0084292 CG5376-RA 
  
2707.028 1044.828 0.00748 0.047 
FBtr0084296 CG13847 
  
1525.503 564.927 0.00104 0.0144 
FBtr0084297 CG13848-RA pinta 
prolonged 
depolarization 
afterpotential (PDA) 
is not apparent 
1591.801 3493.625 0.00209 0.0215 
FBtr0084304 CG12800-RA Cyp6d4 
 
1414.572 5729.763 0.000474 0.00967 
FBtr0084305 CG6972-RA 
  
6569.077 2856.901 0.00713 0.0456 
FBtr0084343 CG6688-RA 
  
928.786 332.919 0.00243 0.0236 
FBtr0084351 CG17109-RA 
  
2860.917 14950.953 6.52x10^-6 0.0011 
FBtr0084354 CG13830 
  
1032.979 2172.93 0.000281 0.0073 
FBtr0084355 CG17111 
  
562.12 198.948 0.00348 0.0291 
FBtr0084361 CG17121-RA 
  
10867.194 4748.457 0.0036 0.0297 
FBtr0084365 CG13834 
  
213.009 486.967 0.00668 0.0436 
FBtr0084419 CG16732-RA 
  
86.738 409.159 0.00128 0.0161 
FBtr0084420 CG10170-RA 
  
755.78 4708.877 2.56E-05 0.00213 
FBtr0084427 CG4374 
  
2135.081 804.613 0.00018 0.00595 
FBtr0084431 CG4408-RA 
  
859.234 2409.268 2.87E-05 0.0023 
FBtr0084433 CG10152-RA beat-IV 
 
268.936 662.468 0.000045 0.0029 
FBtr0084434 CG13822-RA 
  
1268.405 261.759 0.00354 0.0294 
FBtr0084439 CG18754 
  
111.495 349.65 0.000298 0.00748 
FBtr0084440 CG16705-RA SPE 
Spatzle-Processing 
Enzyme 
3973.746 1940.428 0.00734 0.0466 
FBtr0084444 CG10301 
  
257.881 116.704 0.00437 0.0335 
FBtr0084454 CG10371-RA Plip 
PTEN-like 
phosphatase 
217.541 87.114 0.00311 0.0271 
FBtr0084457 CG10374-RB Lsd-1 
Lipid storage droplet-
1 
3582.759 1592.908 0.00751 0.0471 
FBtr0084472 CG10250-RA nau nautilus 2257.608 735.263 0.00182 0.02 
FBtr0084474 CG10251 
  
129.011 259.226 0.000266 0.00713 
FBtr0084484 CG16723 
  
24.165 111.683 0.000675 0.0116 
FBtr0084519 CG5338-RB RpS19b 
Ribosomal protein 
S19b 
523.396 1052.07 0.000691 0.0117 
FBtr0084549 CG6173-RA Kal1  
Kallmann syndrome 
1 ortholog 
1141.145 512.513 0.0002 0.00626 
FBtr0084589 CG5436-RA Hsp68 
Heat shock protein 
68 
1067.784 2542.53 0.000257 0.00712 
FBtr0084610 CG33339 
  
1092.431 265.127 0.000536 0.0102 
FBtr0084611 CG33340-RA 
  
459.623 135.437 6.23E-05 0.00334 
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FBtr0084612 CG13613 
  
411.606 106.01 0.000094 0.00428 
FBtr0084613 CG33341-RA 
  
226.439 88.203 0.000204 0.00631 
FBtr0084614 CG13614-RA 
  
2217.904 697.942 6.53E-05 0.00344 
FBtr0084615 CG13614  
  
1671.127 513.875 3.21E-05 0.00243 
FBtr0084617 CG13615-RA 
  
3340.714 1032.695 0.000792 0.0126 
FBtr0084618 CG13616-RA 
  
2999.646 1155.919 0.00676 0.044 
FBtr0084619 CG5610-RA 
nAcRα-
96Aa 
nicotinic 
Acetylcholine 
Receptor alpha 96Aa 
648.412 270.484 0.00425 0.033 
FBtr0084620 CG5768-RA 
  
1988.568 577.548 0.000958 0.0139 
FBtr0084621 CG17780-RB 
  
416.313 122.953 0.00195 0.0208 
FBtr0084622 CG17780-RA 
  
3790.824 1179.376 2.74E-05 0.00224 
FBtr0084623 CG17781-RA 
  
2499.228 737.34 7.71E-05 0.00374 
FBtr0084624 CG17782-RA 
  
2983.107 903.135 0.0017 0.0191 
FBtr0084625 CG18669 
  
260.787 75.266 0.000216 0.00656 
FBtr0084626 CG17784-RA 
  
808.321 187.37 0.000326 0.0078 
FBtr0084627 CG5762-RA 
  
1241.184 326.618 0.000752 0.0124 
FBtr0084634 CG5715-RA 
  
200.02 472.704 0.00568 0.039 
FBtr0084639 CG6844-RA 
nAcRα-
96Ab 
nicotinic 
Acetylcholine 
Receptor alpha 96Ab 
823.499 400.05 0.00588 0.04 
FBtr0084643 CG13618-RA 
  
372.494 1527.915 0.00395 0.0315 
FBtr0084659 CG6677-RB ash2 
absent, small, or 
homeotic discs 2 
199.483 467.113 0.00451 0.0339 
FBtr0084665 CG31125-RA 
  
991.83 2145.418 0.000775 0.0126 
FBtr0084680 CG13622 
  
2225.534 920 0.00321 0.0276 
FBtr0084689 CG6863-RB tok tolkin 3502.604 1377.123 0.00179 0.0198 
FBtr0084691 CG6868-RA tld tolloid 425.985 1069.66 0.000144 0.0054 
FBtr0084694 CG13632 
  
1599.255 473.375 0.000321 0.00772 
FBtr0084695 CG6879 
  
6414.171 2471.233 0.00201 0.0211 
FBtr0084702 CG13636-RA 
  
259.12 771.544 0.00177 0.0196 
FBtr0084703 CG7005-RA Esp 
Epidermal stripes and 
patches 
7849.756 3666.604 0.00467 0.0347 
FBtr0084707 CG7016-RA 
  
1532.108 603.766 0.000892 0.0134 
FBtr0084722 CG13643 
  
426.855 197.08 0.00487 0.0357 
FBtr0084723 CG31121-RA 
  
5531.827 2636.636 0.00199 0.021 
FBtr0084742 CG13634-RA 
  
698.855 227.724 0.00146 0.0173 
FBtr0084751 CG13646-RA 
  
33.191 139.209 0.000568 0.0105 
FBtr0084798 CG31422 
  
468.215 132.937 7.69E-05 0.00377 
FBtr0084807 CG31103 
  
1820.307 607.88 0.000821 0.0129 
FBtr0084821 CG11878-RA 
  
32.958 66.877 0.00417 0.0325 
FBtr0084825 CG31104-RA 
  
79.363 891.54 6.37E-05 0.00337 
FBtr0084827 CG11893-RA 
  
48.207 154.64 0.00162 0.0186 
FBtr0084828 CG13659-RA 
  
129.108 1417.293 1.58E-05 0.00177 
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FBtr0084829 CG31370 
  
316.879 844.819 0.00284 0.0258 
FBtr0084849 CG10675-RA CHKov2 
 
1010.154 350.78 0.000156 0.00554 
FBtr0084851 CG10562-RA 
  
322.906 4276.733 1.05E-05 0.00144 
FBtr0084857 CG10550-RB 
  
3019.017 6096.971 0.000423 0.00909 
FBtr0084858 CG10550-RC 
  
302.029 646.984 0.000778 0.0126 
FBtr0084859 CG10550 
  
319.438 678.117 0.000214 0.00651 
FBtr0084860 CG31288-RA 
  
661.116 2493.482 0.00322 0.0276 
FBtr0084861 CG31097 
  
50.14 143.909 0.00368 0.0301 
FBtr0084871 CG13664 
  
2022.515 4870.358 0.000236 0.00682 
FBtr0084872 CG10421 
  
2734.073 5712.82 0.000312 0.00761 
FBtr0084913 CG14545-RA 
  
350.126 820.792 0.00346 0.0291 
FBtr0084942 CG31089-RA 
  
43.588 132.021 0.000551 0.0104 
FBtr0084950 CG14541 
  
95.206 207.444 0.000387 0.00863 
FBtr0084955 CG8333-RA HLHmy 
E(spl) region 
transcript mγ 
7307.704 15213.535 3.93E-05 0.0027 
FBtr0084979 CG6096-RA HLHm5 
E(spl) region 
transcript m5 
705.319 288.872 0.00745 0.047 
FBtr0085014 CG14238-RA 
  
140.245 315.737 0.00182 0.02 
FBtr0085023 CG6490 
  
259.073 669.095 0.000329 0.00784 
FBtr0085048 CG6438-RA amon amontillado 249.356 564.241 0.00692 0.0447 
FBtr0085050 
 
beat-VII 
 
271.094 1235.612 0.000914 0.0135 
FBtr0085051 
 
beat-VII 
 
272.247 1267.719 0.000806 0.0128 
FBtr0085052 CG14248 
  
155.7 654.185 0.000162 0.00562 
FBtr0085110 CG5889-RA Men-b Malic enzyme b 2098.308 5534.193 0.00134 0.0165 
FBtr0085112 CG5896-RB grass 
Gram-positive 
Specific Serine 
protease 
1073.368 339.164 0.00311 0.0271 
FBtr0085117 CG31066 
  
684.441 278.986 0.00176 0.0195 
FBtr0085181 CG5984-RA 
  
2838.645 849.912 0.00755 0.0473 
FBtr0085197 CG31057-RA tau 
 
1901.222 4071.077 0.0037 0.0302 
FBtr0085198 CG31058-RA 
  
507.363 2582.8 0.00151 0.0177 
FBtr0085202 CG5639-RA 
  
1015.392 2479.294 0.000499 0.00999 
FBtr0085307 CG9989-RA 
  
1133.67 407.517 0.00784 0.0483 
FBtr0085348 CG33203-RC 
  
109.866 220.159 0.00028 0.0073 
FBtr0085349 CG14523-RA 
  
1559.173 646.061 0.00203 0.0212 
FBtr0085390 CG11899-RA 
  
770.73 3447.092 3.73E-05 0.00263 
FBtr0085403 CG11951-RA 
  
681.74 270.793 0.000025 0.00215 
FBtr0085408 CG14509 
  
1562.564 3641.108 4.65E-05 0.00289 
FBtr0085427 CG2010-RB 
  
1916.762 631.306 0.0019 0.0205 
FBtr0085451 CG18287-RA ppk19 pickpocket 19 120.282 48.501 0.00751 0.0471 
FBtr0085455 CG15505-RA Obp99d 
Odorant-binding 
protein 99d 
415.877 128.322 0.00532 0.0376 
FBtr0085462 CG7592-RA Obp99b 
Odorant-binding 
protein 99b 
584.23 166.294 0.00723 0.046 
FBtr0085466 CG7577-RA ppk20 pickpocket 20 103.271 40.17 0.00536 0.0377 
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FBtr0085485 CG7802-RA neo neyo 12141.813 5779.596 0.000307 0.00755 
FBtr0085488 CG31009-RA Cad99C 
 
7836.407 3833.751 0.00109 0.0148 
FBtr0085494 CG31038-RA 
  
8592.789 3745.945 0.00098 0.0139 
FBtr0085495 CG31038-RB 
  
481.909 175.937 0.0017 0.0191 
FBtr0085497 CG31038-RC 
  
3985.147 1816.859 0.00132 0.0164 
FBtr0085503 CG15522-RA 
  
83.536 1317.322 2.10x10^-6 0.000513 
FBtr0085545 CG7896-RA 
  
6632.671 2376.115 0.00101 0.0141 
FBtr0085567 CG15529-RA 
  
398.139 187.595 0.00168 0.0189 
FBtr0085601 CG15527-RA RpS28a 
Ribosomal protein 
S28a 
38.883 108.122 0.000405 0.00883 
FBtr0085653 CG1546-RA 
PH4αSG
2 
prolyl-4-hydroxylase-
alpha SG2 
5325.563 1427.007 0.000573 0.0106 
FBtr0085683 CG2239-RC jdp 
 
881.576 360.021 0.00229 0.0226 
FBtr0085687 CG31371 
  
1921.824 729.919 0.00625 0.0416 
FBtr0085688 CG9728-RA 
PH4αNE
1 
prolyl-4-hydroxylase-
alpha NE1 
643.846 256.978 0.00398 0.0316 
FBtr0085698 CG1342-RA Spn100A Serpin 100A 20423.444 9629.781 0.00115 0.0152 
FBtr0085708 CG15544-RA 
  
154.147 73.781 0.00133 0.0164 
FBtr0085715 CG15547-RA 
  
1662.806 3356.561 0.00254 0.0242 
FBtr0085737 CG15556-RA 
  
460.617 226.937 0.00192 0.0206 
FBtr0085739 CG11318-RA 
  
341.765 917.873 0.00329 0.0281 
FBtr0085753 CG1470-RA 
Gycβ100
B 
Guanylyl cyclase β-
subunit at 100B 
273.556 974.198 2.28E-05 0.00207 
FBtr0085761 CG3669 
  
281.356 115.182 0.004 0.0317 
FBtr0085769 CG31005-RA qless 
 
2779.908 1312.746 0.000833 0.013 
FBtr0085785 CG1607-RA 
  
4348.254 2013.89 0.00113 0.0151 
FBtr0085867 CG11550-RA 
  
398.835 172.001 0.00561 0.0387 
FBtr0085990 CG8335-RA 
  
80.089 193.226 0.000177 0.00591 
FBtr0086046 CG7796 
  
856.924 1901.536 0.000107 0.00455 
FBtr0086142 CG30446-RA Tdc2 
Tyrosine 
decarboxylase 2 
741.585 352.263 5.23E-05 0.00305 
FBtr0086160 CG15236-RB 
  
96.067 47.689 0.00537 0.0377 
FBtr0086163 CG9456 
  
950.777 337.496 0.0022 0.0222 
FBtr0086164 CG9460-RA Spn42De Serpin 42De 4296.325 1731.832 0.00665 0.0435 
FBtr0086179 CG12847-RA Tsp42Ec Tetraspanin 42Ec 1005.396 4381.176 0.000514 0.0102 
FBtr0086218 CG13424-RA lms 
lateral muscles 
scarcer 
956.997 339.535 0.00355 0.0295 
FBtr0086235 CG13437-RA 
  
112.386 278.851 0.000973 0.0138 
FBtr0086238 CG13439-RA dpr 
defective proboscis 
extension response 
849.778 3662.651 3.81E-05 0.00266 
FBtr0086253 CG11175-RA Rcd6 
Reduction in Cnn 
dots 6 
7397.346 2726.214 0.00062 0.0111 
FBtr0086266 CG30148-RA 
  
224.565 90.018 0.000155 0.00551 
FBtr0086275 CG8908-RB 
  
79.63 274.85 0.000484 0.00983 
FBtr0086290 CG33041 
  
693.221 247.521 0.000536 0.0102 
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FBtr0086316 CG11048-RA Efhc1.2 EFHC1 homologue 2 200.159 85.506 9.83E-05 0.0043 
FBtr0086321 CG11209-RA ppk6 pickpocket 6 
42.141 281.066 1.79x10^-6 0.000477 
FBtr0086323 CG13869-RA 
  
415.62 124.924 0.00361 0.0298 
FBtr0086325 CG16898-RA 
  
163.633 1896.045 0.000102 0.00437 
FBtr0086344 CG12501-RA Or56a Odorant receptor 56a 28.087 80.88 0.000304 0.0075 
FBtr0086463 CG15120-RA 
  
366.622 4839.617 1.75x10^-7 0.0002 
FBtr0086469 CG18367-RA 
  
147.652 56.637 0.00607 0.0408 
FBtr0086471 CG15125-RA 
  
33.285 80.733 0.00117 0.0153 
FBtr0086491 CG15905 
  
1831.25 720.008 0.00431 0.0333 
FBtr0086522 CG10062-RA 
  
243.238 692.187 0.00126 0.016 
FBtr0086524 CG10081-RA 
  
29.177 1896.657 9.47x10^-7 0.000369 
FBtr0086555 CG9416-RA 
  
9926.273 4320.114 0.00348 0.0291 
FBtr0086556 CG30127 
  
474.904 1843.462 0.000249 0.00699 
FBtr0086572 CG15105-RB abba 
another B-box 
affiliate 
3285.62 1156.744 0.00337 0.0285 
FBtr0086610 
 
Mctp 
 
209.575 746.385 0.000186 0.00602 
FBtr0086672 CG17525-RA GstE4 
Glutathione S 
transferase E4 
101.633 465.302 0.000258 0.00711 
FBtr0086675 CG17531-RA GstE7 
Glutathione S 
transferase E7 
2152.066 4357.258 0.00131 0.0164 
FBtr0086676 CG17533-RA GstE8 
Glutathione S 
transferase E8 
1538.238 9663.673 2.09x10^-6 0.000518 
FBtr0086677 CG17534-RA GstE9 
Glutathione S 
transferase E9 
1037.905 4805.701 2.42x10^-6 0.000544 
FBtr0086698 CG5226 
  
1376.311 3513.346 0.00063 0.0112 
FBtr0086726 CG17522-RA GstE10 
Glutathione S 
transferase E10 
1003.807 485.62 0.00592 0.0401 
FBtr0086794 CG30111 
  
2277.523 846.446 0.00208 0.0215 
FBtr0086802 CG5076-RA elk eag-like K+ channel 121.616 286.018 0.00423 0.0329 
FBtr0086808 CG10911-RA 
  
818.129 3926.277 0.00289 0.0259 
FBtr0086826 CG15844 
  
292.69 1665.083 4.52E-05 0.00289 
FBtr0086955 CG6530-RA mthl3 methuselah-like 3 352.762 993.689 0.00532 0.0376 
FBtr0086956 CG6536 
  
147.434 836.125 2.35E-05 0.00208 
FBtr0086975 CG6953-RA 
fat-
spondin 
 
9024.325 4128.538 0.000269 0.00715 
FBtr0086982 CG15611 
  
275.888 617.02 0.00496 0.0362 
FBtr0086987 CG11395-RA 
  
3021.014 1368.813 0.00193 0.0207 
FBtr0087005 CG8938-RB GstS1 
Glutathione S 
transferase S1 
16233.75 44221.014 2.52E-05 0.00215 
FBtr0087047 CG6518-RA inaC 
inactivation no 
afterpotential C 
115.428 433.858 0.00084 0.0131 
FBtr0087048 CG6622-RB Pkc53E Protein C kinase 53E 
388.77 896.159 8.72x10^-6 0.00129 
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FBtr0087056 CG6702-RA Cbp53E Calbindin 53E 285.246 820.218 0.00223 0.0223 
FBtr0087071 CG8910-RA 
  
238.823 556.035 0.00268 0.025 
FBtr0087076 CG8652-RA Ugt37c1 
UDP-
glycosyltransferase 
37c1 
2408.67 983.536 0.000825 0.0129 
FBtr0087098 CG4945-RA 
  
2374.807 950.153 0.00117 0.0153 
FBtr0087099 CG4945-RB 
  
2145.03 855.526 0.00306 0.0268 
FBtr0087107 CG5089-RA 
  
138.467 68.41 0.000931 0.0137 
FBtr0087137 CG15705-RA 
  
263.458 125.6 0.00603 0.0406 
FBtr0087142 CG15924 
  
480.973 175.665 0.00611 0.0409 
FBtr0087143 CG3896 
  
1785.604 672.278 0.00372 0.0302 
FBtr0087157 CG4398-RA 
  
1030.608 477.348 0.000696 0.0118 
FBtr0087221 CG8421 
  
3469.879 1627.803 0.0073 0.0464 
FBtr0087248 
 
Ptp52F 
 
709.058 1479.403 4.08E-05 0.00275 
FBtr0087276 CG18255-RG 
Strn-
Mlck Stretchin-Mlck 
805.983 243.064 0.00122 0.0157 
FBtr0087310 CG8249-RA 
  
2585.201 1181.107 0.00449 0.0338 
FBtr0087311 CG8246-RA Poxn Pox neuro 1742.277 830.444 0.00234 0.023 
FBtr0087319 CG30080-RA 
  
3114.483 1394.434 0.00184 0.0201 
FBtr0087323 CG12958 
  
85.462 339.997 0.000764 0.0125 
FBtr0087324 CG12959 
  
72.735 231.768 0.00622 0.0415 
FBtr0087325 CG8179-RA 
  
264.87 1199.693 0.000275 0.00722 
FBtr0087326 CG30470 
  
207.88 621.738 0.00447 0.0338 
FBtr0087338 CG12963 
  
84.056 204.808 0.00219 0.0222 
FBtr0087361 CG18285-RA igl igloo 610.345 2236.804 0.00318 0.0274 
FBtr0087371 CG16827-RA αPS4 
 
96.386 298.794 0.0022 0.0222 
FBtr0087401 CG8093-RA 
  
67.33 3876.264 1.34x10^-6 0.000416 
FBtr0087408 CG10257-RA 
  
621.809 247.507 0.00389 0.031 
FBtr0087445 CG10200-RA 
  
1115.661 555.393 0.00229 0.0226 
FBtr0087452 CG10242-RA Cyp6a23 
 
1318.031 4402.433 0.00352 0.0293 
FBtr0087457 CG10246 
  
243.066 669.558 0.00428 0.0331 
FBtr0087504 CG33469-RA 
  
43.364 231.128 0.00424 0.033 
FBtr0087536 CG8503-RA 
  
8806.241 4002.617 0.00438 0.0335 
FBtr0087537 CG8523-RA Mdr50 
Multi drug resistance 
50 
160.459 1628.362 9.94E-05 0.00431 
FBtr0087547 CG13941-RA Arc2 
 
499.658 3097.419 1.95E-05 0.00195 
FBtr0087551 CG30070 
  
457.541 151.406 0.00129 0.0163 
FBtr0087556 CG13939-RA Obp50e 
Odorant-binding 
protein 50e 
32.914 2407.565 1.79x10^-6 0.00047 
FBtr0087559 CG10102 
  
7324.993 30505.15 1.57E-05 0.00178 
FBtr0087560 CG12505-RA Arc1 
 
4643.487 27357.479 1.90x10^-6 0.000486 
FBtr0087566 CG8547 
  
5603.067 2783.054 0.0028 0.0257 
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FBtr0087609 CG6704-RA 
  
2279.375 956.428 0.00195 0.0208 
FBtr0087628 CG6280-RA 
  
168.91 2078.369 7.63E-05 0.00378 
FBtr0087664 CG4812-RA Ser8 
 
302.578 626.196 0.0036 0.0297 
FBtr0087722 CG13325-RA 
  
40.037 140.832 0.00242 0.0235 
FBtr0087753 CG17047-RA 
  
5551.119 2126.382 0.00105 0.0145 
FBtr0087754 CG4734-RA 
  
1071.039 2960.365 0.000498 0.00998 
FBtr0087766 CG12251-RA AQP aquaporin 296.938 145.76 0.00415 0.0324 
FBtr0087785 CG3830-RA vg vestigial 1864.666 812.178 0.00221 0.0222 
FBtr0087799 CG3884-RB 
  
2120.882 9958.686 0.000221 0.00658 
FBtr0087800 CG3884-RA 
  
547.791 5478.612 7.82E-05 0.00378 
FBtr0087817 CG30486-RA 
  
72.552 267.964 6.21E-05 0.00334 
FBtr0087818 CG30488-RA 
  
185.158 569.068 1.01E-05 0.00141 
FBtr0087847 CG13148-RB 
  
1367.596 593.238 0.000843 0.013 
FBtr0087848 CG13148-RA 
  
522.348 216.335 0.00251 0.024 
FBtr0087855 CG17579-RA 
  
2181.88 5753.982 0.000217 0.00657 
FBtr0087856 CG17579-RB 
  
1140.427 3395.187 0.00004 0.00272 
FBtr0087881 CG8785-RA 
  
1540.783 3273.436 0.000433 0.00915 
FBtr0087892 CG13165 
  
73.667 480.383 2.24E-05 0.00206 
FBtr0087895 CG30046-RB 
  
1066.77 482.885 1.61x10^-6 0.000443 
FBtr0087914 CG30042-RA Cpr49Ab 
 
213.579 61.047 0.00372 0.0302 
FBtr0087925 CG13157-RA 
  
493.39 246.068 0.000388 0.00863 
FBtr0087972 CG8850-RB 
  
1562.209 550.925 0.000525 0.0102 
FBtr0087984 CG12367-RA Hen1 
 
283.236 621.022 0.00042 0.00905 
FBtr0087992 CG8453-RA Cyp6g1 
 
90.855 253.905 0.00391 0.0312 
FBtr0088019 CG13178-RA 
  
280.547 3017.022 1.23x10^-7 0.000191 
FBtr0088021 CG30040-RA jeb jelly belly 81.643 213.891 0.00376 0.0304 
FBtr0088061 CG18188-RA Damm 
Death associated 
molecule related to 
Mch2 
207.087 614.379 0.00198 0.0209 
FBtr0088064 CG8991-RA Sobp 
Sine oculis-binding 
protein 
4103.399 1869.06 0.00234 0.023 
FBtr0088077 CG8238-RA Buffy 
 
1054.556 2124.507 9.92E-05 0.00432 
FBtr0088120 CG13209-RA sha shavenoid 10135.613 4102.226 0.000431 0.00914 
FBtr0088133 CG7759-RA 
  
7358.044 2986.554 0.00778 0.0482 
FBtr0088136 CG7777-RB 
  
381.26 905.699 5.39x10^-6 0.000971 
FBtr0088137 CG7777-RA 
  
3055.765 7084.332 1.87E-05 0.0019 
FBtr0088141 CG9023-RA Drip 
 
1736.808 4241.983 0.000963 0.0139 
FBtr0088142 CG9023-RB Drip  
 
852.235 2174.17 1.83E-05 0.00189 
FBtr0088151 CG9033-RB Tsp47F Tetraspanin 47F 794.21 1821.45 0.000978 0.0139 
FBtr0088152 CG9033  
  
1057.689 2236.628 0.00385 0.0309 
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FBtr0088186 CG13214 
  
196.587 58.225 0.000991 0.014 
FBtr0088187 CG13214 
  
189.732 56.864 0.000894 0.0134 
FBtr0088197 CG9084-RB 
  
521.966 2713.826 1.77E-05 0.00186 
FBtr0088246 CG12344-RA 
  
126.98 864.481 1.10x10^-6 0.000382 
FBtr0088309 CG30320 
  
577.166 241.557 0.00217 0.022 
FBtr0088390 CG2328-RA eve even skipped 1168.488 489.452 5.21E-05 0.00305 
FBtr0088407 CG2269-RC 
  
292.616 988.056 0.00305 0.0268 
FBtr0088467 CG1773-RA 
  
596.227 213.347 0.00143 0.0171 
FBtr0088475 CG1652-RA 
lectin-
46Cb 
 
1174.584 393.27 0.000547 0.0104 
FBtr0088476 CG1656-RA 
lectin-
46Ca 
 
1761.529 600.352 0.00102 0.0142 
FBtr0088494 CG1648-RB 
  
1329.636 485.515 0.000387 0.00863 
FBtr0088498 CG30004 
  
3691.508 1625.228 0.00121 0.0156 
FBtr0088502 CG12926-RA 
  
3086.524 8028.436 5.63E-05 0.00316 
FBtr0088584 CG30345 
  
262.999 621.31 0.00766 0.0477 
FBtr0088620 CG8046-RA 
  
423.682 198.564 0.0047 0.0349 
FBtr0088622 CG8008-RA 
  
252.769 531.138 0.000375 0.00852 
FBtr0088636 CG30350-RA 
  
388.361 160.532 0.000754 0.0124 
FBtr0088660 CG13747-RA 
  
190.317 42.665 0.000349 0.00817 
FBtr0088662 CG13743-RA 
  
59.422 135.55 0.00324 0.0277 
FBtr0088666 CG13744-RA 
  
1918.537 611.467 0.00306 0.0268 
FBtr0088671 CG8216-RA 
  
50.142 179.853 0.000979 0.0139 
FBtr0088687 CG30352 
  
412.379 179.586 0.00114 0.0151 
FBtr0088690 CG2397-RA Cyp6a13 
 
321.315 3828.303 3.09x10^-6 0.000661 
FBtr0088698 CG30353 
  
495.105 221.4 0.006 0.0405 
FBtr0088705 CG8738-RA 
  
554.742 177.694 0.000436 0.0092 
FBtr0088725 CG8586-RA 
  
793.268 230.2 0.00412 0.0324 
FBtr0088729 CG8642 
  
328.433 138.055 9.56E-05 0.00429 
FBtr0088734 CG8687 
  
72.118 2462.584 9.06E-05 0.00422 
FBtr0088735 CG8687 
  
198.068 6978.219 1.47E-05 0.00169 
FBtr0088746 CG2062-RA Cyp4e1 
Cytochrome P450-
4e1 
2784.988 809.075 0.000947 0.0138 
FBtr0088747 CG8694-RA Mal-A2 Maltase A2 248.695 2457.264 0.000114 0.00476 
FBtr0088748 CG8693-RA Mal-A4 Maltase A4 260.43 2512.901 5.49E-05 0.00313 
FBtr0088749 CG30359-RA Mal-A5  Maltase A5 2890.921 1221.623 0.00148 0.0175 
FBtr0088757 CG11669-RA Mal-A7 Maltase A7 26.077 266.915 1.63E-05 0.00178 
FBtr0088760 CG2110-RA Cyp4ad1 
 
452.6 5028.172 5.21x10^-6 0.00098 
FBtr0088780 CG8713-RA 
  
2917.759 1226.919 0.00288 0.0259 
FBtr0088794 CG14760-RA 
  
189.644 80.127 0.000165 0.00562 
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FBtr0088808 CG8708 
  
600.005 236.371 0.00204 0.0212 
FBtr0088810 CG30374 
  
41.943 142.29 0.000153 0.0055 
FBtr0088827 CG12769-RB 
  
8243.293 3592.973 0.00732 0.0465 
FBtr0088867 CG14762-RA 
  
751.418 3454.232 1.07E-05 0.00146 
FBtr0088868 CG11191-RA 
  
279.798 1466.696 6.00x10^-6 0.00103 
FBtr0088922 CG2065-RA 
  
1365.707 4279.96 0.00468 0.0348 
FBtr0088927 CG1941-RA 
  
1255.768 3210.73 6.55E-05 0.00344 
FBtr0089004 CG11145-RA 
  
303.982 137.863 0.00427 0.0331 
FBtr0089025 CG12844  
  
362.752 145.859 0.000447 0.00928 
FBtr0089026 CG12844-RB Tsp42Eh Tetraspanin 42Eh 1290.344 447.888 0.00436 0.0335 
FBtr0089027 CG12844 
  
832.014 225.72 0.00706 0.0454 
FBtr0089028 CG12843-RA Tsp42Ei Tetraspanin 42Ei 2581.502 882.944 0.00824 0.05 
FBtr0089052 CG1857-RA nec necrotic 4212.59 1947.117 4.46E-05 0.00289 
FBtr0089054 CG1865-RA Spn43Ab 
Serine protease 
inhibitor 43Ab 
521.049 259.131 0.00312 0.0271 
FBtr0089055 CG4486-RA Cyp9b2 
Cytochrome P450-
9b2 
919.157 5365.576 0.00185 0.0202 
FBtr0089056 CG4485-RA Cyp9b1 
Cytochrome P450-
9b1 
173.071 440.294 0.00216 0.022 
FBtr0089118 CG1674  
  
1004.128 353.098 0.00232 0.0229 
FBtr0089119 CG1674-RD 
  
489.246 117.756 0.000157 0.00555 
FBtr0089123 CG32850-RA 
  
1721.652 4223.851 7.64E-05 0.00377 
FBtr0089287 CG3477-RA Pxd Peroxidase 1011.685 3009 0.000139 0.00536 
FBtr0089292 CG8799 
  
299.213 1094.307 0.00115 0.0151 
FBtr0089319 CG10604-RA bsh 
brain-specific 
homeobox 
443.719 211.733 0.000948 0.0138 
FBtr0089324 CG6806-RA Lsp2 
Larval serum protein 
2 
280.494 108.996 0.00287 0.0259 
FBtr0089326 CG11538 
  
176.671 55.66 0.000145 0.00538 
FBtr0089327 CG11049-RA sv shaven 1194.212 2701.332 0.00109 0.0148 
FBtr0089329 CG11143-RA Inos 
 
1737.226 3518.482 0.00275 0.0255 
FBtr0089376 CG33485-RA dpr9 
 
306.207 934.821 1.43E-05 0.00167 
FBtr0089427 CG2411-RA ptc patched 5971.374 2937.655 0.00236 0.0231 
FBtr0089490 CG4432-RA 
PGRP-
LC 
Peptidoglycan 
recognition protein 
LC 
2508.372 899.512 0.000627 0.0111 
FBtr0089491 CG4432-RB 
PGRP-
LC 
Peptidoglycan 
recognition protein 
LC 
1505.226 555.692 0.00306 0.0268 
FBtr0089492 CG4432-RC 
PGRP-
LC 
Peptidoglycan 
recognition protein 
LC 
1642.909 683.646 0.00542 0.038 
FBtr0089500 CG5472-RA Pal2 
Peptidyl-α-
hydroxyglycine-α-
amidating lyase 2 
543.465 1766.01 0.00706 0.0454 
FBtr0089502 CG5472  
  
1222.616 5230.481 0.000197 0.0062 
FBtr0089560 CG6385-RA 
  
1548.121 757.607 0.000306 0.00753 
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FBtr0089569 CG6449-RA NijA Ninjurin A 363.338 95.79 0.00502 0.0364 
FBtr0089570 CG6449-RB NijA Ninjurin A 1792.399 828.856 0.00155 0.018 
FBtr0089571 CG6449-RC NijA Ninjurin A 1620.408 710.404 0.000288 0.00737 
FBtr0089577 CG7234-RI GluRIIB 
Glutamate receptor 
IIB 
1771.551 501.41 0.00213 0.0217 
FBtr0089599 CG9398-RA 
king-
tubby 
 
2228.42 4710.653 0.000675 0.0116 
FBtr0089608 CG33495-RA Dup99B 
Ductus ejaculatorius 
peptide 99B 
134.336 43.508 0.000779 0.0126 
FBtr0089695 CG14901-RA Gr89a 
 
32.81 114.789 0.00717 0.0458 
FBtr0089789 CG31795 
  
904.59 2283.364 0.00212 0.0217 
FBtr0089790 CG31795 
  
1757.181 4008.634 0.00223 0.0223 
FBtr0089804 CG32688 
  
172.966 369.465 0.000487 0.00985 
FBtr0089812 CG3277 
  
561.125 1924.192 0.00031 0.00758 
FBtr0089813 CG3277  
  
223.46 887.152 9.26E-05 0.00427 
FBtr0089931 CG8024-RB Itd lightoid 7356.838 3433.146 0.00169 0.019 
FBtr0089937 CG8852-RA 
  
508.893 248.338 0.00242 0.0235 
FBtr0089956 CG9932-RA 
  
3622.112 1449.49 0.000416 0.00901 
FBtr0089969 CG15102  
  
2104.929 6769.214 4.19E-05 0.00281 
FBtr0089970 CG15102-RA Jheh2 
Juvenile hormone 
epoxide hydrolase 2 
2406.313 7170.17 7.85E-05 0.00378 
FBtr0091456 CG33514-RA 
  
1261.179 2588.641 0.00193 0.0207 
FBtr0091458 CG33516 
  
80.484 205.967 0.00448 0.0338 
FBtr0091491 CG33528-RE Vmat 
Vesicular 
monoamine 
transporter 
593.975 226.525 0.00413 0.0324 
FBtr0091497 CG33531-RA Ddr 
Discoidin domain 
receptor 
483.612 1603.57 8.01x10^-6 0.00126 
FBtr0091508 
 
upd3 
 
40.389 336.101 0.000146 0.00535 
FBtr0091534 CG33557-RA 
  
351.525 166.262 0.0069 0.0447 
FBtr0091616 CG33639-RA 
  
145.465 311.547 0.00143 0.0171 
FBtr0091658 CG33678 
  
83.339 280.283 0.00283 0.0258 
FBtr0091765 CG33764-RA 
  
897.057 272.592 0.000139 0.00537 
FBtr0091796 CG33792-RA 
  
56.995 256.012 1.86E-05 0.00189 
FBtr0091915 CG33911 
  
353.261 108.579 0.00115 0.0152 
FBtr0091930 CG33926-RA 
  
70.241 3069.858 0.000039 0.00271 
FBtr0099998 
 
Octbeta3
R 
 
442.931 942.8 4.72E-05 0.00292 
FBtr0100035 CG33989-RD pHCl 
 
80.853 971.006 0.000235 0.00681 
FBtr0100036 CG33989-RE pHCl 
 
98.324 689.612 4.91x10^-6 0.000967 
FBtr0100037 CG33989-RF pHCl 
 
80.43 755.563 0.000456 0.00943 
FBtr0100060 CG34005 
  
123.638 469.634 0.00232 0.0229 
FBtr0100068 CG34013 
  
254.106 110.958 0.00399 0.0316 
140 
 
FBtr0100086 CG34031 
  
125.606 926.919 1.12x10^-7 0.000212 
FBtr0100087 CG34032-RA 
  
41.785 141.677 0.000686 0.0117 
FBtr0100093 CG34038 
  
967.433 361.841 0.000272 0.00717 
FBtr0100101 CG34046 
  
211.565 61.181 0.000111 0.00467 
FBtr0100110 CG8927-RB 
  
490.658 1197.995 0.00016 0.00558 
FBtr0100117 CG14681 
  
325.207 99.414 0.000122 0.00497 
FBtr0100118 CG14681 
  
1615.342 738.546 0.00586 0.0399 
FBtr0100125 CG31764-RD vir-1 virus-induced RNA 1 32.418 118.671 2.46E-05 0.00213 
FBtr0100131 CG9918-RD Pk1r Pyrokinin 1 receptor 179.305 74.594 0.00188 0.0203 
FBtr0100158 CG6772-RD Slob 
Slowpoke binding 
protein 
86.939 1271.413 0.000011 0.00147 
FBtr0100225 CG7399-RB Hn Henna 3720.967 1586.081 0.000246 0.00695 
FBtr0100258 CG8938-RC GstS1 
Glutathione S 
transferase S1 
9156.039 36054.215 8.84x10^-6 0.00129 
FBtr0100264 CG15279 
  
710.297 1666.562 0.000277 0.00723 
FBtr0100290 CG14946 
  
5756.493 12998.247 2.31E-05 0.00208 
FBtr0100344 CG11049-RF sv shaven 5098.3 13266.336 0.000184 0.00602 
FBtr0100345 CG11049-RG sv shaven 2390.216 7457.296 5.96E-05 0.00327 
FBtr0100410 CG10045-RB GstD1 
Glutathione S 
transferase D1 
390.18 1108.065 0.000523 0.0102 
FBtr0100506 CG4637-RB hh hedgehog 2076.027 793.895 0.00386 0.0309 
FBtr0100524 CG10097-RA 
  
204.813 440.583 0.00398 0.0316 
FBtr0100525 CG10097-RB 
  
155.963 453.959 0.000549 0.0104 
FBtr0100600 CG11153-RB Sox102F 
 
1040.752 497.669 0.00006 0.00329 
FBtr0100857 CG34063-RA mt:ND2 
mitochondrial 
NADH-ubiquinone 
oxidoreductase chain 
2 
7875.08 3668.335 0.00534 0.0376 
FBtr0110821 CG17205 
  
146.212 770.356 3.16E-05 0.00241 
FBtr0110837 CG31201-RB GluRIIE 
Glutamate receptor 
IIE 
886.54 293.152 0.00118 0.0154 
FBtr0110849 CG14597 
  
504.8 1317.832 1.04E-05 0.00144 
FBtr0110881 CG7255-RH 
  
768.455 285.666 0.00196 0.0209 
FBtr0110955 CG31499 
  
167.716 399.146 0.00125 0.0159 
FBtr0110963 CG14885-RC 
Gyc-
89Da 
Guanylyl cyclase at 
89Da 
282.699 130.748 0.00517 0.0368 
FBtr0110970 CG15078-RA Mctp 
Multiple C2 domain 
and transmembrane 
region protein 
313.17 1388.03 4.84x10^-6 0.000963 
FBtr0111026 CG9610-RC Poxm Pox meso 1726.735 79.004 0.00746 0.047 
FBtr0111188 CG40486-RB 
  
61.52 598.667 0.000124 0.00499 
FBtr0112536 CG34334-RA 
  
154.603 395.538 5.81E-05 0.00321 
FBtr0112566 CG34356-RC 
  
199.733 509.51 0.000182 0.00599 
FBtr0112607 CG34375-RA 
  
564.856 1206.016 0.00214 0.0219 
FBtr0112610 CG34377-RA 
  
1364.888 488.315 0.00033 0.00785 
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FBtr0112619 CG34381-RB 
  
73.374 181.48 0.00117 0.0153 
FBtr0112626 CG14469 
  
858.466 2042.586 0.00197 0.0209 
FBtr0112645 CG34396-RD 
  
1854.109 606.229 0.00258 0.0244 
FBtr0112648 CG34398-RA 
  
1236.417 533.66 0.00675 0.044 
FBtr0112650 CG34399-RC Nox NADPH oxidase 1110.815 370.101 0.00219 0.0222 
FBtr0112729 CG34428-RA 
  
383.949 119.434 0.00226 0.0225 
FBtr0112747 CG34443-RA 
  
753.561 188.902 0.000924 0.0136 
FBtr0112750 CG34446-RA 
  
490.159 135.854 0.00434 0.0334 
FBtr0113018 CG15412-RB 
  
265.118 103.121 0.0023 0.0227 
FBtr0113108 CG6044-RD 
  
397.634 1542.841 7.23x10^-6 0.00117 
FBtr0113163 CG7512-RB 
  
1643.317 3910.023 2.81E-05 0.00228 
FBtr0113174 CG11905-RI 
  
14252.4 6935.335 0.00115 0.0151 
FBtr0113177 CG13027-RB Obp73a 
Odorant-binding 
protein 73a 
51.778 207.118 0.0021 0.0216 
FBtr0113266 CG17622 
  
29.777 92.574 0.000423 0.00908 
FBtr0113278 CG13613 
  
228.146 59.6 0.00247 0.0237 
FBtr0113313 CG3669-RB 
  
250.373 87.283 0.000521 0.0102 
FBtr0113329 CG18669 
  
829.248 202.882 0.00253 0.0241 
FBtr0113345 CG18748-RC 
  
748.589 1702.015 3.32E-05 0.00247 
FBtr0113346 CG18765-RB 
  
733.326 3035.243 2.03E-05 0.00199 
FBtr0113347 CG10251-RB 
  
75.405 182.07 0.00563 0.0388 
FBtr0113389 CG31103-RB 
  
1599.304 455.378 0.00356 0.0295 
FBtr0113424 CG32121-RB 
  
99.536 34.16 0.00123 0.0157 
FBtr0113429 CG32204-RB 
  
99.803 396.614 0.00222 0.0223 
FBtr0113465 CG33542-RB upd3 unpaired 3 89.716 681.848 2.69E-05 0.0022 
FBtr0113769 CG2893-RD 
  
8220.388 3937.402 0.00663 0.0434 
FBtr0113803 CG40122 
  
1985.349 5860.401 0.00027 0.00716 
FBtr0113992 CG41113 
  
80.259 463.079 0.00714 0.0457 
FBtr0114043 CG41284 
  
556.869 1121.771 0.000441 0.00922 
FBtr0114456 CG16801-RC Hr51 Hormone receptor 51 495.197 201.903 0.00166 0.0188 
FBtr0114460 CG3277-RC 
  
490.345 1356.101 0.00163 0.0187 
FBtr0114504 CG10301-RB 
  
503.421 240.403 0.00129 0.0162 
FBtr0114515 CG18531-RB Gr2a Gustatory receptor 2a 331.877 721.145 0.000244 0.00694 
FBtr0114516 CG18744-RB 
  
72.933 434.535 0.00153 0.0179 
FBtr0114525 CG32036-RC 
  
198.654 52.39 0.00162 0.0186 
FBtr0114535 CG4382-RB 
  
299.642 66.206 0.00308 0.0269 
FBtr0114541 CG5428-RB 
  
7142.822 2561.425 0.00449 0.0338 
FBtr0273227 CG3502-RB 
  
1083.371 225.764 0.00357 0.0296 
FBtr0273244 CG4226-RC GluRIIC 
Glutamate receptor 
IIC 
2488.503 836.191 0.00272 0.0253 
FBtr0273260 CG11898-RB 
  
96.785 279.48 8.47E-05 0.00401 
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FBtr0273295 CG5751 
  
123.684 8253.471 2.70x10^-7 0.000243 
FBtr0273308 CG30263-RB 
  
45.161 804.128 2.39E-05 0.0021 
FBtr0273399 CG8588-RF pst pastrel 3215.018 6516.272 0.000556 0.0104 
FBtr0273416 CG32335-RB 
  
691.167 3439.606 8.17x10^-6 0.00127 
FBtr0273450 CG33179-RC beat-IIIb 
 
49.136 211.952 0.00171 0.0191 
FBtr0289971 CG13622-RB 
  
2003.594 831.905 0.00199 0.021 
FBtr0290001 CG32381-RB 
unc-13-
4A 
 
208.118 569.174 0.00507 0.0365 
FBtr0290002 CG32547-RC 
  
136.868 729.594 7.75E-05 0.00376 
FBtr0290021 CG5321-RB 
  
5852.553 2536.334 0.00439 0.0335 
FBtr0290044 CG9449-RF 
  
6061.955 2138.659 0.0011 0.0149 
FBtr0290055 CG31370-RB 
  
478.47 1188.405 0.00292 0.0262 
FBtr0290087 CG12507-RB 
  
983.979 4665.691 0.000145 0.00539 
FBtr0290126 CG34400-RC 
  
210.159 1069.005 0.00138 0.0167 
FBtr0290129 CG34400-RE 
  
392.246 1693.177 0.00108 0.0148 
FBtr0290131 CG6938-RB 
  
84.093 461.547 0.00184 0.0201 
FBtr0290223 CG14837-RC 
  
40.529 91.483 0.00316 0.0273 
FBtr0290268 CG5772-RB Sur Sulfonylurea receptor 1085.874 447.038 0.00757 0.0474 
FBtr0290276 CG7440-RD tgy twiggy 1552.341 761.386 0.000114 0.00477 
FBtr0290328 CG42242-RD beat-VII 
 
192.519 1113.823 0.000528 0.0102 
FBtr0290335 CG42244-RG Octβ3R 
 
232.314 486.791 0.000217 0.00656 
FBtr0299509 CG42247-RC 
DCX-
EMAP 
Doublecortin-
domain-containing 
echinoderm-
microtubule-
associated protein 
ortholog 
46.662 95.519 0.00701 0.0452 
FBtr0299541 CG12996 
  
923.094 327.93 0.00528 0.0374 
FBtr0299575 CG42261-RA 
  
342.758 700.838 0.0017 0.0191 
FBtr0299576 CG42262-RA 
  
700.898 2101.681 0.000389 0.00859 
FBtr0299649 CG42280-RE ome omega 3798.856 1293.307 0.000813 0.0128 
FBtr0299663 CG42284-RC 
  
244.922 828.161 2.67x10^-6 0.000587 
FBtr0299676 CG42296-RA 
  
2863.051 1404.609 0.00322 0.0276 
FBtr0299697 CG42309-RB Mlp60A 
Muscle LIM protein 
at 60A 
248.747 66.073 0.00475 0.0351 
FBtr0299707 CG42311-RK grh grainy head 4086.598 1950.314 0.00136 0.0167 
FBtr0299785 CG42325-RF Pde1c Phosphodiesterase 1c 1299.363 3487.2 0.000946 0.0138 
FBtr0299786 CG42325-RG Pde1c Phosphodiesterase 1c 1038.487 2768.807 4.76E-05 0.00293 
FBtr0299842 CG42331-RB 
  
2648.182 700.624 2.35E-05 0.00209 
FBtr0299843 CG42331-RC 
  
7813.099 3174.48 0.00207 0.0214 
FBtr0299862 CG42339-RB 
  
415.685 1044.923 4.11x10^-6 0.000838 
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FBtr0299879 CG3635-RB 
  
1041.433 114.065 0.0033 0.0281 
FBtr0299926 CG40305-RB FucTC 
 
964.688 2050.746 2.82E-05 0.00227 
FBtr0299930 CG42347-RC 
  
6155.811 3057.292 0.00288 0.0259 
FBtr0299934 CG42348 
  
278.181 825.55 5.12E-05 0.00302 
FBtr0299937 CG42349-RD Pkcδ Protein kinase C δ 1002.843 397.034 0.00438 0.0335 
modified_GF
P_1 
   
381.054 38016.171 0.00184 0.0201 
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Appendix C. Microarray analysis comparing Hindsight Depleted 
embryos with the Control  
 
Transcript 
Fbtr ID  Gene ID 
Official 
Symbol  Official Name  
Control 
- linear 
value 
Knockdown 
- linear 
value 
P value 
before 
FDR 
P value 
after FDR 
FBtr0070003 CG32825-RA Or19b Odorant receptor 19b 2561.851 89.264 0.000309 0.0365 
FBtr0070032 CG9571-RA fd19B forkhead domain 19B 283.48 41.77 0.000115 0.0203 
FBtr0070234 CG11420-RA png pan gu 444.974 181.153 4.36E-05 0.0106 
FBtr0070349 CG3857-RA 
  
1781.162 880.167 0.000332 0.0374 
FBtr0070490 CG2759-RA w white 
1313.361 9026.976 5.91x10^-7 0.00102 
FBtr0070534 CG12535-RB 
 
191.401 531.041 0.00056 0.049 
FBtr0070535 
   
207.563 569.189 0.000472 0.0444 
FBtr0070881 CG5928-RA 
  
1923.211 348.455 1.19E-05 0.00498 
FBtr0070890 CG4746-RA mab-21 
 
141.544 44.634 9.15E-05 0.0175 
FBtr0070893 CG14445-RA 
 
146.933 607.147 1.04E-05 0.00467 
FBtr0071201 CG15350-RA Cp7Fb 
Chorion protein b at 
7F 
85.997 31.192 3.90x10^-6 0.00257 
FBtr0071311 CG15371-RA Gr8a Gustatory receptor 8a 
268.337 30.914 6.73x10^-7 0.000886 
FBtr0071335 CG12120-RA t tan 
3576.465 1554.193 2.68x10^-6 0.00219 
FBtr0071386 CG32698-RA 
 
428.459 947.771 0.000311 0.0364 
FBtr0071870 CG13517-RB Obp59a 
Odorant-binding 
protein 59a 
151.54 60.627 0.000411 0.0415 
FBtr0071871 CG13518-RA Obp59b 
Odorant-binding 
protein 59b 
282.117 106.679 1.63E-05 0.00605 
FBtr0071872 CG13519-RA Obp59d 
Odorant-binding 
protein 59d 
304.653 22.98 1.98x10^-8 0.000113 
FBtr0071920 CG13524-RA Obp59c 
Odorant-binding 
protein 59c 
3844.284 71.111 1.64x10^-6 0.00165 
FBtr0071921 CG30259-RA 
 
282.788 79.096 4.07E-05 0.0103 
FBtr0071928 CG4373-RA Cyp6d2 
 
192.701 782.574 0.00028 0.035 
FBtr0071952 
   
123.376 47.965 0.000303 0.0368 
FBtr0071967 CG30192-RA 
 
76.815 27.914 0.000591 0.0489 
FBtr0072049 CG9871-RA 
RpL22-
like 
Ribosomal protein 
L22-like 
135.12 775.781 4.03x10^-6 0.00256 
FBtr0073062 CG10812-RA dro5 drosomycin-5 
4338.918 57.443 3.56x10^-9 0.000061 
FBtr0073094 CG17746-RB 
 
680.926 328.442 5.37E-05 0.0121 
FBtr0073111 CG14963-RA 
 
623.391 288.944 4.37x10^-6 0.00267 
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FBtr0073511 CG11697-RA 
 
60.446 4625.189 1.18x10^-7 0.000335 
FBtr0074703 CG15882-RA 
 
31.154 77.127 8.37E-05 0.0167 
FBtr0074790 CG14234-RA 
 
69.981 162.574 0.000223 0.0306 
FBtr0074797 CG11941-RA skpC 
 
166.027 544.701 0.000362 0.039 
FBtr0074876 
   
694.317 174.083 3.18E-05 0.00878 
FBtr0075316 CG13032-RA 
 
57.696 839.168 1.18x10^-7 0.000289 
FBtr0075361 CG4098-RA 
  
1051.603 363 9.08E-05 0.0175 
FBtr0075588 
   
573.81 262.463 6.44E-05 0.0137 
FBtr0075618 CG12327-RA Best3 Bestrophin 3 366.93 41.638 3.01E-05 0.00844 
FBtr0076701 CG8023-RA eIF4E-3 
 
992.76 2559.475 9.71E-05 0.0181 
FBtr0076805 CG32373-RA 
 
734.735 259.267 0.000129 0.0218 
FBtr0076823 
   
1840.402 843.363 0.000409 0.0414 
FBtr0076831 CG8539-RA 
  
132.164 49.443 1.58E-05 0.00599 
FBtr0076893 
   
631.754 298.154 0.000181 0.0267 
FBtr0076918 CG8620-RA 
  
114.855 755.566 1.55E-05 0.00604 
FBtr0076920 
   
46.558 121.094 0.000312 0.0364 
FBtr0077047 CG6602-RA 
  
291.801 98.586 2.78x10^-6 0.00217 
FBtr0077087 
   
167.771 49.039 3.51E-05 0.00955 
FBtr0077152 CG10630-RA blanks 
 
548.599 1772.647 2.33E-05 0.00753 
FBtr0077271 CG1304-RA 
  
20.276 725.988 6.39x10^-7 0.000912 
FBtr0077420 CG15632-RA Taf12L 
TBP-associated factor 
30kD subunit α-2 
68.24 168.533 0.000282 0.0348 
FBtr0077523 CG31956-RA pgant4 
polypeptide GalNAc 
transferase 4 
516.05 1118.149 0.000402 0.0413 
FBtr0077924 CG5450-RA Cdlc2 
Cytoplasmic dynein 
light chain 2 
35.039 108.953 0.000116 0.0202 
FBtr0077926 CG14346-RA 
 
540.422 2139.851 2.24E-05 0.00738 
FBtr0077927 CG14346-RB 
 
211.946 1074.247 7.28x10^-6 0.0039 
FBtr0078344 CG32437-RA 
 
239.24 911.829 0.000306 0.0367 
FBtr0078345 CG32440-RA 
 
82.515 356.347 3.62E-05 0.00938 
FBtr0078567 CG32461-RA 
 
51.469 114.652 0.000312 0.0362 
FBtr0078861 CG12001-RA 
 
392.895 67.639 1.35x10^-6 0.00154 
FBtr0078867 
   
1989.147 621.798 8.01x10^-6 0.00404 
FBtr0078882 CG31530-RA 
 
1895.066 673.098 8.76E-05 0.0171 
FBtr0079062 CG10833-RA Cyp28d1 
 
1981.125 4124.493 0.000198 0.0282 
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FBtr0079171 CG9046-RA Vm26Ab 
Vitelline membrane 
26Ab 
437.053 43.373 8.69x10^-8 0.000298 
FBtr0079241 CG13998-RA 
 
190.128 35.361 8.93x10^-6 0.00425 
FBtr0079516 CG18585-RA 
 
1805.472 782.21 2.56E-05 0.00781 
FBtr0079548 
   
2326.366 1052.496 1.60x10^-8 0.000137 
FBtr0080281 CG16963-RA Cry Crystallin 110.027 475.228 0.000149 0.0243 
FBtr0080670 CG4691-RA 
  
28.962 167.274 2.62E-05 0.00786 
FBtr0080753 CG11865-RA 
 
123.481 35.032 0.000145 0.0239 
FBtr0080821 CG31819-RA 
 
21.81 76.871 4.36E-05 0.0107 
FBtr0081136 CG15169-RA 
 
440.163 55.61 6.17x10^-6 0.00352 
FBtr0081241 
   
1323.334 118.17 3.51x10^-8 0.000151 
FBtr0081242 CG13083-RB 
 
2003.591 195.636 1.20x10^-6 0.00147 
FBtr0081309 CG33117-RA Victoria  
 
2426.257 1121.74 0.000393 0.0413 
FBtr0081406 CG17470-RA 
 
341.019 46.697 1.73x10^-6 0.00164 
FBtr0081435 
   
2061.212 436.962 7.93x10^-6 0.00412 
FBtr0081514 CG8667-RA dimm dimmed 482.031 217.855 0.000486 0.045 
FBtr0081603 CG14606-RA 
 
104.302 308.62 0.000241 0.0325 
FBtr0082428 CG14720-RA 
 
1054.277 523.599 0.000576 0.0494 
FBtr0082571 CG11512-RA GstD4 
Glutathione S 
transferase D4 
325.306 805.361 4.74E-05 0.0112 
FBtr0083790 CG11407-RA 
 
183.779 1146.993 0.00021 0.0292 
FBtr0083968 CG15696-RA 
 
553.578 199.401 6.18E-05 0.0136 
FBtr0084003 CG12278-RA 
 
288.601 67.945 2.55E-05 0.00792 
FBtr0084243 
   
819.393 388.261 0.000358 0.039 
FBtr0084420 CG10170-RA 
 
755.78 1928.483 0.000362 0.0392 
FBtr0084431 CG4408-RA 
  
859.234 3629.057 6.18x10^-7 0.000961 
FBtr0085860 CG2191-RA Smvt 
Sodium-dependent 
multivitamin 
transporter 
842.85 2286.264 5.16E-05 0.0118 
FBtr0085962 
   
44.657 274.341 4.48x10^-7 0.000852 
FBtr0086215 CG30154-RA 
 
776.784 353.525 0.000467 0.0444 
FBtr0086662 CG18108-RA IM1 
Immune induced 
molecule 1 
45.575 237.696 0.00032 0.0366 
FBtr0086665 CG16844-RA IM3 
Immune induced 
molecule 3 
96.231 673.418 0.000516 0.047 
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FBtr0086956 
   
147.434 574.72 0.000063 0.0137 
FBtr0087137 CG15705-RA 
 
263.458 745.228 1.98x10^-6 0.00178 
FBtr0087408 CG10257-RA 
 
621.809 92.857 6.36x10^-6 0.00352 
FBtr0087467 
   
430.898 1003.889 0.000142 0.0237 
FBtr0087560 CG12505-RA Arc1 
Activity-regulated 
cytoskeleton 
associated protein 1 
4643.487 13957.684 7.43E-05 0.0152 
FBtr0087640 CG30485-RA 
 
125.226 40.41 0.000058 0.0129 
FBtr0087642 CG6553-RA 
  
201.092 49.158 3.19x10^-7 0.000683 
FBtr0087643 CG6543-RA 
  
668.007 287.22 0.000132 0.0222 
FBtr0087644 CG6543-RB 
  
92.322 39.915 4.57E-05 0.0109 
FBtr0087909 CG33012-RA 
 
91.66 196.911 0.000398 0.0411 
FBtr0088190 CG9079-RA Cpr47Ea 
 
48.168 384.422 3.92E-05 0.0101 
FBtr0088591 CG1944-RA Cyp4p2 
 
3861.651 225.132 2.85x10^-6 0.00203 
FBtr0088660 CG13747-RA 
 
190.317 43.02 0.000263 0.0341 
FBtr0089563 CG6416-RF Zasp66 
Z band alternatively 
spliced PDZ-motif 
protein 66 
248.588 569.835 0.000111 0.02 
FBtr0089569 CG6449-RA NijA Ninjurin A 
363.338 48.259 2.82x10^-6 0.0021 
FBtr0089570 CG6449-RB NijA Ninjurin A 1792.399 330.56 1.17E-05 0.005 
FBtr0089571 CG6449-RC NijA Ninjurin A 
1620.408 349.201 5.00x10^-6 0.00296 
FBtr0089804 
   
172.966 352.331 8.80x10^-6 0.00431 
FBtr0091448 CG33508-RA ppk13 pickpocket 13 
194.013 50.262 1.36x10^-6 0.00145 
FBtr0100357 
   
358.352 123.17 0.000511 0.0468 
FBtr0100835 CG34057-RB 
 
379.469 176.441 9.22E-05 0.0174 
FBtr0112747 CG34443-RA 
 
753.561 271.663 0.000348 0.0385 
FBtr0113170 CG13481-RB 
 
111.459 262.957 0.000238 0.0323 
FBtr0114530 CG33276-RB 
 
1487.78 709.946 0.000118 0.0201 
FBtr0273260 CG11898-RB 
 
96.785 238.161 0.000438 0.0438 
FBtr0299926 CG40305-RB FucTC 
 
964.688 2793.575 0.000028 0.00811 
FBtr0299946 
   
58.655 354.651 2.57x10^-6 0.0022 
 
 
